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Abstract 
Exposure of the embryo or fetus to perturbations in utero can result in intrauterine 
growth restriction (IUGR), a primary risk factor for the development of adult disease. 
One critical window that can result in developmental programming, is the 
periconceptional period which comprises maturation of the oocyte, conception and the 
formation of the blastocyst prior to embryo implantation. Alcohol is a common 
exposure during this period, as it is consumed prior to pregnancy recognition, and 
often ceases soon after. Maternal periconceptional alcohol exposure (PC-EtOH) in rat 
dams has been previously shown to cause fetal growth restriction and changes to the 
late gestation placenta. PC-EtOH also results in the development of adult onset 
disease, including insulin insensitivity, often in a sexually dimorphic manner. However, 
the mechanisms by which PC-EtOH can cause programming are relatively 
unexplored. This thesis aimed to characterise the effects of alcohol on 1. sex-specific 
pre-implantation development and trophoblast differentiation using in vitro (cell 
culture) and in vivo (rodent model) techniques, 2. alterations to the early uterine 
environment and 3. the interactions and communication between the embryo and 
uterus, and the resultant impacts on placental development across gestation.  
The direct effect of EtOH on in vitro differentiation was assessed in mouse trophoblast 
stem cells (Chapter 4). Results demonstrated that doses of 0.2% and 1% EtOH 
reduced total cell count and expression of trophoblast subtype markers at terminal 
differentiation (day 6 of culture). Using our in vivo rat model, we also examined basal 
sex differences in blastocyst and placental development from pre-implantation to late-
gestation in naturally cycling dams (Chapter 3). Although there were no significant 
differences between sexes in pre-implantation development (blastocyst cell numbers, 
trophoblast differentiation), by mid-gestation (E15) placentas from males were heavier 
and had increased blood space volume and surface area (to both maternal and fetal 
compartments) than those from females. This likely contributed to the greater fetal 
body weight in males at E20. This study confirmed the need to examine the effects of 
PC-EtOH in a sexually dimorphic manner across all of pregnancy.  
To study the effects of PC-EtOH in vivo, Sprague-Dawley rat dams were given a liquid 
diet containing either control (0% v/v EtOH) or EtOH (12.5% v/v EtOH) from embryonic 
(E) day -4 to E4. The following day dams were returned to chow for the remainder of 
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gestation. Dams were sacrificed at E5 to determine cell number of the pre-implantation 
embryo and its capacity to differentiate into cells required for invasion (Chapter 5). 
Pre-implantation studies showed PC-EtOH altered inner cell mass count, trophoblast 
differentiation to trophoblast giant cells (TGCs) and trophoblast behaviour in a sexually 
dimorphic manner, with females showing the most deleterious outcomes. PC-EtOH 
females also showed reduced expression of Prl4a1, a gene exclusively expressed by 
TGCs for communication with decidual natural killer cells (dNK).  
Maternal plasma and uterine samples were collected over the peri-implantation period 
(E5-E7) to assess the maternal hormonal environment, and uterine responses for 
implantation and maintenance of pregnancy in response to the invading PC-EtOH 
exposed embryo (Chapter 5). Whilst no changes to oestrogen or progesterone levels 
were observed, alterations to their receptors (Esr1 and Pgr), and downstream 
response genes (including those involved in uterine decidualisation, vasculogenesis 
and embryo attachment) were found, particularly at E7. Genes involved in dNK 
maturation and function were also markedly decreased by PC-EtOH at E7, suggesting 
that the uterine responses are altered by inappropriate communication by the embryo. 
By E11, a 25% increase in dNK cells was found in PC-EtOH exposed females, which 
may suggest that reduced timing of dNK cell homing has resulted from perturbed TGC 
communication.  
Placental morphogenesis was further examined after PC-EtOH in the immature (E13), 
definitive (E15) and late gestation (E20) placenta (Chapter 6). Investigation of invasion 
of spiral artery trophoblast giant cells at E13 demonstrated a decrease in PC-EtOH 
females only. At E15, PC-EtOH, caused increased resorptions and reduced maternal 
blood space volume in both sexes. This suggests impaired or slowed development of 
the definitive placenta in mid-gestation by PC-EtOH, but was followed by 
compensatory growth of the late gestation E20 placenta. This ‘catch-up’ in placental 
growth, however, was not sufficient to prevent the fetal growth deficit.  
This thesis has provided novel insights into sexually dimorphic placentation and the 
deleterious effects of early alcohol exposure on the developing embryo and placental 
morphogenesis. This study supports guidelines that abstinence from alcohol exposure 
when planning a pregnancy is the safest option.   
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Chapter 1 – Literature Review 
1.1 Introduction to the developmental origins of health and disease 
A “sub-optimal” maternal environment such as a result of poor diet, stress, or hypoxia 
during critical “developmental windows” has been shown to cause fetal intrauterine 
growth restriction (IUGR), (Barker, 1995, Gluckman et al., 2007). The developmental 
origins of health and disease hypothesis emphasises that adaptations in response to 
maternal perturbations in the short-term may ensure fetal survival; however, in the 
long-term they may become a disadvantage (Barker, 1995, 2000). Fetuses sense 
maternal nutrient and substrate availability to predict the postnatal environment and 
co-ordinate their growth trajectories accordingly (Bloomfield and Harding, 1998). 
Those that exhibit IUGR often undergo compensatory adaptations in the postnatal 
period when they experience an unanticipated environment. It is these later 
adaptations which are thought to be the most deleterious, and which act as 
independent risk factors for developing adult-onset cardiovascular disease, chronic 
kidney disease, and metabolic syndrome (Barker, 2000, Gluckman and Hanson, 
2006).  
It is now well established that the period around conception is a “critical window” during 
development that can cause programming of adult disease (Kwong et al., 2000, 2006). 
A poor maternal environment as a result of poor nutrition (Grieger et al., 2014), 
smoking (Homish et al., 2012), and alcohol exposure (Muggli et al., 2016), are likely 
perturbations during this period as many women are unaware of being pregnant. One 
major contributing factor to this is unplanned pregnancies, which accounts for 
approximately 50% of pregnancies in Australia and America (Colvin et al., 2007, Finer 
and Zolna, 2016).  
Over the past two decades, the periconceptional period has been investigated for 
events occurring pre-conception prior to fertilisation of the oocyte by the sperm, 
including oocyte maturation and ovulation, and post-fertilisation in the pre-implantation 
period. The maturing oocyte relies on the surrounding granulosa cells within the 
preovulatory follicle for essential nutrients and other factors for growth and metabolism 
before it is released at ovulation. After fertilisation and prior to the establishment of the 
placenta for access to the maternal circulation, the pre-implantation embryo relies on 
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oviductal and uterine fluidal secretions for these same requirements. Maternally 
derived factors can thus affect early cell division and primary differentiative events in 
development that result in the formation of the mature blastocyst and progenitors to 
the embryo proper and the placenta. The pre-implantation embryo is thus highly 
susceptible to maternal perturbations not only because it has a unique metabolic 
profile and set of nutritional requirements to facilitate morphological development, but 
also because it undergoes genome wide epigenetic reprogramming after fertilisation 
and activation of its new genome (reviewed by Fleming et al. 2004). The female pre-
implantation embryo in the extraembryonic (placental) lineage also receives during 
this time double dosage of X chromosome genes prior to X chromosome inactivation 
in the early post-implantation embryo (Hemberger, 2002). This may contribute to 
sexually dimorphic outcomes in morphogenesis and physiology of the early embryo in 
response to any adverse environment prior to placental formation (Kalisch-Smith et 
al., 2017a).  
The pre-implantation embryo must also be “activated” to allow appropriate interactions 
with the uterine luminal epithelium, and become invasive to facilitate implantation into 
the maternal endometrium. Likewise, the endometrium must attain a hormonally 
regulated, transient state of “receptivity” for embryo implantation to be initiated. An 
intricately orchestrated embryonic-uterine dialogue is therefore essential for the 
dynamic morphological events of oocyte and embryonic growth, and to establish an 
appropriate growth trajectory in anticipation of the postnatal environment. Given that 
the cells of pre-implantation embryo act as a progenitor pool for all tissues required for 
development, any adaptive responses set during this phase will have lasting 
consequences both throughout gestation and into adult life. Not surprisingly perhaps, 
subtle changes to the maternal substrates such as glucose (Moley, 2001) or protein 
(Kwong et al., 2000, 2006), have been shown to cause alterations in early 
development, lead to IUGR and “programme” adult onset disease.  
The placenta is also increasingly being recognised as a critical mediator of intrauterine 
programming during gestation. Placental adaptations are likely to depend on the type 
of stressor, duration, severity and the window of exposure during development. 
Regardless of the type of stressor, altered placental formation can result and 
contribute to impaired placental function and consequently, adaptation in fetal 
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development. This includes the periconceptional period, in which alterations to the 
trophectoderm, the progenitor pool to the placenta, can influence placentation days 
after the initial exposure (Kwong et al., 2000, Watkins et al., 2015, MacLaughlin et al., 
2005, Tan et al., 2016a, Bloise et al., 2012). The placenta also can mediate sexually 
dimorphic outcomes, with perturbations in early development associated with female 
lethality (Tan et al., 2016b), while mid-late gestational exposures are largely 
associated with male-specific lethality (reviewed by Kalisch-Smith et al. 2017a).  
The following literature review will focus on pre-implantation development, uterine 
responses for implantation, placental formation, as well as sexual dimorphism which 
can influence programming in response to maternal perturbations. This review will also 
highlight alcohol as another agent in the programming of adult disease, which is not 
as well explored in the periconception period as it is in other chronic gestational 
models.  
1.2 Evidence of fetal programming in humans 
Non-communicable diseases such as cardiovascular disease, stroke, chronic kidney 
disease and diabetes, continue to be the leading causes of premature death 
worldwide. In 2012, the World Health Organisation estimated these conditions were 
responsible for 38 out of 56 million deaths (WHO, 2014). In Australia, these conditions 
are estimated to cost the health system $7.7 billion for cardiovascular disease, and 
$1.52 billion for diabetes from 2008-2009 (AIHW, 2014). While prevention of these 
disorders is largely focused on lifestyle factors including smoking, poor diet (high fat, 
high sugar), and a lack of exercise, prenatal origins of disease outcomes are becoming 
increasingly realised.  
The first evidence that an in utero environment could adversely affect the developing 
fetus and influence the onset of adult disease came from a study in Hertfordshire 
(United Kingdom), which associated low infant weight gain with coronary heart disease 
and type 2 diabetes (Barker et al., 1989). Since then, low birth weight has been 
confirmed as strong predictor and a contributor to these conditions. Other large 
cohorts of undernutrition including Helsinki (Eriksson et al., 2001) and the Dutch winter 
famine (Roseboom et al., 2001, 2011) have subsequently been associated with low 
birth weight. The field of developmental programming has arisen to investigate other 
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maternal stressors during pregnancy including glucocorticoid (stress), hypoxia, 
obesity, and diabetes, and their effects on fetal organ development. However, despite 
this increase in focus around other maternal perturbations, alcohol is still relatively 
unexplored for effects on the developing embryo, placentation and adult disease 
outcomes in different developmental windows.   
 
1.3 Influence of maternal alcohol consumption on fetal programming  
1.3.1 Prevalence of maternal alcohol consumption  
Despite National Health and Medical Research (NHMRC) guidelines advocating 
abstinence, 47% of women continue to drink alcohol during pregnancy in Australia 
(NHMRC, 2009, Wallace et al., 2007). Alcohol consumption is more prevalent in the 
United States where a recent study showed that nearly 75% of women who were 
planning a pregnancy drank alcohol (Green et al., 2016). Current demographic 
analysis suggests that women who drink moderate-high levels during pregnancy are 
primarily from high income households with tertiary education (Muggli et al., 2016, 
Jansen et al., 2009).  
One critical window in which women commonly drink alcohol is the periconception 
period. A population study from Australia showed that approximately 14% of women 
drank more than 5 standard drinks in 1 day of the 3 months prior to pregnancy (Colvin 
et al., 2007). A more recent study from Australia of 1570 participants showed that 
these rates have risen to 39% (Muggli et al., 2016). This same study also analysed 
the period prior to pregnancy recognition, in which 12% of women admitted to binge 
drinking regularly, with an additional 6% admitting to binge drinking on one occasion 
(Muggli et al., 2016). In total over the periconception period, 27% of women drank 
alcohol, with 87% ceasing alcohol consumption after pregnancy recognition (Muggli et 
al., 2016). This cessation after pregnancy recognition is a common finding (Parackal 
et al., 2013, Alvik et al., 2006), and is likely to be contributed by unplanned 
pregnancies, which are approximately 50% (Colvin et al., 2007, Finer and Zolna, 
2016). This data then suggests that the early pre-implantation embryo may be highly 
exposed to alcohol during this periconceptional period.  
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1.3.2 Alcohol – another exposure capable of programming  
Alcohol consumption during pregnancy is often associated with conditions such as 
fetal alcohol syndrome (FAS) and fetal alcohol spectrum disorders (FASD) (Jones and 
Smith, 1973). These disorders are the result of high dose alcohol exposure throughout 
gestation, and are mainly associated with deficits in the offspring’s brain and 
behaviour, as these are the most teratogenic and life-altering outcomes, reviewed by 
(Riley et al., 2011). Few studies however, investigate other postnatal outcomes that 
may be ‘programmed,’ including cardiovascular disease, hypertension or diabetes. 
Whilst the focus of this study is not to mimic the conditions of FAS or FASD, we 
acknowledge that outcomes in response to a periconceptional insult may contribute to 
pathogenesis of these conditions.  
Like many different environmental exposure, maternal alcohol consumption can also 
result in low birth weight (Manning and Eugene Hoyme, 2007, O'Leary et al., 2009, 
Tai et al., 2016). Another study showed that even long-term alcohol exposure prior to 
conception could lead to low birth weight (Livy et al., 2004). Fetal abnormalities are 
also more prevalent, with alcohol shown to increase cardiac malformations (Kvigne et 
al., 2004) as well as kidney defects (Taylor et al., 1994). High doses of alcohol are 
also associated with reduced placental weight (Kaminski et al., 1978), preterm birth 
(O'Leary et al., 2009, Tai et al., 2016), still birth (Kaminski et al., 1978, Marbury et al., 
1983), preeclampsia (Meyer-Leu et al., 2011, Salihu et al., 2011), placental abruption 
(Salihu et al., 2011) and miscarriage (Maconochie et al., 2007, Avalos et al., 2014). A 
recent human FAS study has also highlighted the role of the placenta in mediating 
these outcomes, which include defects to utero-placental perfusion (Tai et al., 2016).  
In order to appreciate the potential effects of alcohol consumption around conception 
on early embryonic development, it is first necessary to review pre-implantation 
development.  
1.4 Pre-implantation development: a summary 
As the oocyte is released from the ovary, surrounded by its glycoprotein shell - the 
zona pellucida, it is swept up by the fimbrial projections of the infundibulum of the 
oviduct. Fertilisation occurs within the oviduct, with proteins on the zona pellucida 
acting as sperm receptors, to facilitate sperm entry (Wassarman and Mortillo, 1991). 
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Sperm entry activates the oocyte to complete meiosis II and begin mitosis (Maro et 
al., 1986). The first mitotic cell division results in the formation of two cells or 
blastomeres approximately 18-20 h following gamete fusion (Hogan, 1994). Maternal 
mRNAs are utilised for genetic control of growth and maturation of the oocyte, as well 
as co-ordination of the first cell cleavage until this point. A transition then occurs from 
maternal to embryonic genome control and the zygotic genome is activated following 
a wave of maternal mRNA degradation initiated during the first cell cycle. Embryonic 
genome activation (EGA) occurs by the 2-cell stage in mice and rats (Flach et al., 
1982, Schultz, 1993), and the 4-cell stage in humans (Braude et al., 1988). Without 
this critical event, the embryo fails to develop further (Poueymirou and Schultz, 1990).  
The embryo continues to divide within the zona pellucida whilst travelling along the 
oviduct towards the uterus. At the 32-cell stage, outer cells of the embryo become 
polarised and develop cell-cell junctions, giving them an epithelial-like character 
(Ducibella and Anderson, 1975, Johnson et al., 1986, McLaren and Smith, 1977, 
Schlafke and Enders, 1967). This first differentiative event produces two primary cell 
lineages within the mature blastocyst. The polarised epithelial-like sphere of outer cells 
called the trophectoderm (TE) assists in implantation of the blastocyst into the uterine 
wall and gives rise to the extra-embryonic tissues including the placenta. Conversely, 
the inner cell mass (ICM), located eccentrically within the blastocoel (fluid-filled cavity), 
gives rise to the embryo proper (Watson and Kidder, 1988). This differentiation is also 
orchestrated by distinct patterns of gene expression, with the TE expressing 
transcription factors Cdx2 (Beck et al., 1995), and the ICM expressing Oct3/4 (Palmieri 
et al., 1994). The mature blastocyst is formed by approximately embryonic day (E) 3 
in the mouse, E4 in the rat, and E5 in humans (Brinster, 1963, Schlafke and Enders, 
1967, Steptoe et al., 1971). It is interesting that while the gestation of rodents is quite 
short (18-21 days), compared to humans (approximately 9 months), the timing of pre-
implantation development is relatively conserved. This emphasises the importance of 
these developmental events in establishing a viable fetus.  
1.5 Environmental regulation of pre-implantation development 
The oviduct and uterus provide a unique microfluidal environment necessary for 
embryonic growth through the secretion of nutrients, macromolecules (e.g. amino 
acids), electrolytes, hormones, growth factors, anti-oxidants and regulated pH, 
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reviewed by Leese et al. (2008). The complexity and significance of the 
oviductal/uterine microfluid environment is highlighted by experiments that 
demonstrated the in vitro culture of embryos in defined media resulted in reduced 
embryo proliferation and elevated apoptosis, relative to those grown in vivo, indicative 
of a stress response (Bowman and McLaren, 1970, Hardy, 1997). 
Autocrine, paracrine and endocrine signals between the embryonic cell populations 
and the maternal environment regulate optimal growth and survival of the pre-
implantation embryo prior to placental formation. Glucose (Pantaleon et al., 2010), 
insulin (Heyner et al., 1989), insulin-like growth factor (IGF)1 (Mattson et al., 1988) 
and IGF2 (Rappolee et al., 1992), are produced by the oviduct and uterus, and when 
coupled with appropriate nutrient signalling, act as mitogenic pro-survival factors to 
optimise pre-implantation embryo growth (to both the TE and the ICM) and further 
development (Harvey and Kaye, 1988, Murphy and Ghahary, 1990).   
Maternal dietary perturbations during the periconception period, such as a low protein 
diet, have been shown to cause mild transient maternal hyperglycaemia and 
hypoinsulinemia (Kwong et al., 2000). This metabolic phenotype is a likely mechanism 
for the observed reductions in TE and ICM cell proliferation that accompany this 
change in maternal conditions. Alterations to either these lineages have significant 
implications for progenitor pools of the fetus or the placenta. Reductions in ICM 
number are suggested to result in reduced birth weight (Eckert et al., 2012), while 
alterations in the TE are also likely to mediate aberrant fetal growth indirectly through 
altered placental development. Nutrient and substrate modifications can thus have 
long lasting effects on cell metabolism, growth and ultimately, developmental 
competence. These changes not only impact development, but may also lead to 
disease in adulthood.  
1.6 Uterine responses required for implantation 
Embryo-uterine interactions are vital to co-ordinate implantation and establish 
appropriate interactions required for placentation and subsequent fetal growth. The 
uterine lumen provides a unique fluidal environment of secreted hormones, cytokines, 
substrates and growth factors, to facilitate blastocyst developmental competence, and 
create an epithelial surface to permit adhesion and attachment (Kennedy, 1980, Paria 
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et al., 1993). Alterations may occur to either the embryo from a periconception 
perturbation as discussed above, or may occur through alterations to the maternal 
uterine environment.  
1.6.1 Acquisition of receptivity and decidual response 
The process of implantation of the blastocyst into the uterine endometrium requires 
both the activation of the blastocyst and uterine “receptivity”. For the most part, the 
endometrium is not in a “receptive” state and does not allow embryo implantation. 
However, this changes in a spatiotemporal manner through a cascade of hormone-
dependent changes to prime the uterus (Huet-Hudson et al., 1989, McLaren, 1971). 
In the mouse and rat, an estrogen surge at ovulation primes the uterine luminal 
epithelium to proliferate through FGF signalling (Quarmby and Korach, 1984, Li et al., 
2011). Following, low levels of estrogen coupled with rising progesterone inhibits 
proliferation of the luminal epithelium (Finn and Martin, 1970, Finn and McLaren, 1967, 
Martin and Finn, 1968, Psychoyos, 1973), and switches to stromal proliferation (Huet-
Hudson et al., 1989, Paria et al., 1993). A nidatory estrogen surge on E3 (mouse) and 
E4 (rat) sensitises the progesterone-primed uterus to secrete the cytokine leukemia 
inhibitory factor (LIF) by the uterine glands, which then aids in communication with the 
blastocyst to indicate the onset of receptivity and causes its activation (Bhatt et al., 
1991, Song et al., 2000). The rise in progesterone also transforms the uterine 
epithelium in anticipation of the embryo, and primes the uterine stroma for 
decidualisation (Huet-Hudson and Dey, 1990). The beginning of nidation also 
correlates with the onset of receptivity at E4 (mouse) E5 (rat), lasting for approximately 
24 hours (Psychoyos, 1973). This optimal time window permits embryo implantation, 
and afterwards transitions to a “refractory” uterine environment hostile to embryo 
survival within 48 hours (Paria et al., 1993, Psychoyos, 1973).  
The physical interaction of the embryo with the uterine epithelium stimulates the 
underlying stromal cells to undergo “decidualisation”, a transformation into cuboidal, 
polyploid decidual cells (Finn and Martin, 1967, Psychoyos, 1973). These decidual 
cells undergo extensive proliferation and contribute to the maternal portion of the 
future placenta. Decidualisation also provides another means of cross-talk with the 
embryo as these cells secrete hormones, metabolites and growth factors which 
facilitate embryonic nutrient requirements prior to placentation, and adapt embryonic 
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development to ensure its survival (Dey et al., 2004, Huet-Hudson et al., 1989). One 
major secreted factor by the decidua is Igfbp1, which aids in modulating IGF1 and 
IGFII bio-availability to the embryo, aiding in its growth and differentiation (Irving and 
Lala, 1995). Prolactin (Prl) is another important secretory product of decidual cells 
which increases steadily after implantation (Wu et al., 1995). Here it is thought to 
stimulate endometrial gland secretions over the time of implantation to modulate the 
degree of trophoblast invasion into the endometrium (Yu-Lee, 1997). Alterations in 
both of these secretory products have been shown to alter trophoblast-uterine 
interactions, and lead to altered placental and fetal growth (Crossey et al., 2002). 
Following blastocyst adhesion and just prior to decidualisation, the uterus undergoes 
a hormone-dependent and transient local oedema at the implantation site to increase 
microvascular permeability (Psychoyos, 1973, Rockwell et al., 2002). This further 
facilitates blastocyst implantation through angiogenesis of microvessels which 
connect the maternal blood supply of the implantation site to the developing 
conceptus. As implantation is initiated, a vast vascular network begins to be 
established which is required for placentation. Therefore, a shift or impairment of the 
uterine window of receptivity, decidualisation or alterations in the initiation of blastocyst 
invasion, may have deleterious downstream consequences for embryonic viability or 
placental development. Alterations to the maternal environment such as through 
consumption of a high fat (Whyte et al., 2007) or a low protein diet (Fernandez-Twinn 
et al., 2003) during gestation can alter hormone profiles, which may subsequently 
affect these events and may result in implantation failure (Ma et al., 2003). Although 
not investigated in pre-implantation perturbations, alterations to stromal 
decidualisation (Petit et al., 2007), secretion of decidual cell products (Crossey et al., 
20022) or decidual-associated angiogenesis (Winterhager et al., 2013) have all been 
shown to affect downstream placental development. It is currently unknown whether 
alcohol consumption affects these uterine events in early pregnancy. 
1.7 Formation of the placenta  
Healthy maternal nutrition and normal placental development are crucial in the 
development of a viable fetus. The placenta provides a surface area for the exchange 
of nutrients and waste products between fetal and maternal blood supplies and is a 
key determinant of intrauterine growth. While the human placenta is largely different 
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to the rodent placenta a number of parallels and analogous structures can be drawn. 
Although this is not a major focus of this thesis, these differences are briefly mentioned 
in sections 1.5.1 primary differentiation of the parietal trophoblast giant cells, 1.5.3; 
spiral artery remodelling – establishing blood supply to the conceptus and 1.5.5; 
labyrinth formation. Despite these limitations, animal models including the rodent allow 
analysis of maternal perturbations without ethical concerns. This is particularly 
important for periconceptional models, as we will demonstrate, requires ontogeny 
analysis throughout gestation to examine placental outcomes.  
The gross structure of the mature rodent placenta is essentially composed of three 
distinct layers. First is the maternal decidua which contains maternally derived uterine 
decidual cells, infiltrating immune cells and is the site of spiral arteries that supply the 
implantation chamber with maternal blood. The middle junctional zone consists of 
migratory trophoblast giant cells (TGCs) that interact with maternal spiral arteries to 
mediate blood flow, invasive glycogen trophoblasts (GlyT), and spongiotrophoblast 
(SpT) cells, which are thought to have structural and endocrine roles (Coan et al., 
2004). Lastly, the inner labyrinth layer is the site of maternal-fetal exchange, and 
consists of trophoblast lined maternal sinusoids which are separated from the 
endothelial-lined fetal vasculature by two transporting syncytiotrophoblast (SynT) 
layers. Together these four cell layers make up the “interhaemal membrane” that 
facilitates the selective two-way exchange between the two blood compartments. The 
trophoblast cells of the placenta are derived from the TE of the blastocyst while the 
fetal endothelial cells lining the fetal circulation are derived from the ICM (Coan et al., 
2004, Simmons and Cross, 2005).  
1.7.1 Primary differentiation of the parietal trophoblast giant cells 
As aforementioned, the placental lineages are largely derived from the TE. With the 
exception of the mural TE, which differentiates into primary parietal (P-) TGCs to line 
the implantation chamber and yolk sac and facilitate early implantation, the majority of 
cell types in the definitive placenta are derived from the proximal TE, cells which 
overlie the ICM (Cross et al., 1994). These P-TGCs are functionally analogous to the 
primary syncytium formed in humans (Knofler and Pollheimer, 2013). The P-TGCs are 
the first trophoblasts to differentiate (Cross et al., 1994), and like all TGCs become 
large polyploid cells, and with differentiation, increase their golgi apparatus and 
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endoplasmic reticulum (Bevilacqua and Abrahamsohn, 1988). Upon the onset of 
differentiation, they also secrete proteinases, cytokines, hormones and extracellular 
matrix to facilitate invasion (Cross et al., 1994).  
The TGCs achieve an increase in nuclear ploidy through a specialised cell cycle 
termed endoreplication, which use continuing rounds of DNA replication without 
mitosis or cell division, and can obtain up to 1000 copies of DNA in the one cell (Zybina 
and Zybina, 1996), see Figure 1.1.  Endoreplication is likely to be initiated through the 
Cdk inhibitor P57Kip2, which prevents cell cycle entry into M phase (Ullah et al., 2008), 
as well as a decrease, and subsequent removal of mitotic cell cycle check points of 
G1 (p53 and Rb), and G2 (Snail) (Nakayama et al., 1998). A thorough analysis of TGC 
subtypes and the endocycle is reviewed by Hu and Cross. (2010).  
 
 
 
Figure 1.1. Trophoblast giant cell differentiation causes transition from mitotic 
cell cycle to the endocycle to increase ploidy. M; mitosis, G1 checkpoint, S; DNA 
replication, G2 checkpoint. E; endocycle. Adapted from Hu and Cross (2010).  
 
The endocycle of the TGCs also causes over-replication of selective parts of the TGC 
genome (Hannibal and Baker, 2016). Interestingly, these include expression of 
prolatin-like hormones, cathepsins (cysteine proteases), serpins (protease inhibitors), 
and genes in the NK/CLEC complex, involved with infiltrating maternal decidual natural 
killer cells (Hannibal and Baker, 2016).  In response to stress, cells may enter into 
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endocycling to prevent apoptosis by altering cell cycle checkpoints (Mehrotra et al., 
2008). For example, the aforementioned G1 check point p53, a tumour suppressor 
protein, regulates G1 arrest during genotoxic damage (Sherr, 2000). This may have 
long term consequences for pre-implantation exposures, such as shown by Yang et 
al. (2016), which demonstrate that hypoxic stress in culture to cause irreversible 
trophoblast differentiation despite application of FGF4 (promoting TS state), with 50% 
of trophoblasts examined being differentiated TGCs.  
Early developmental perturbations such as in vitro fertilisation (Tan et al., 2016a, 
2016b) which are known to alter TE differentiation may have the potential to form these 
invasive P-TGCs. Maintenance of the trophoblast stem cells is critical, as either excess 
or reduced P-TGC formation can lead to aberrant invasion into the uterine decidua, 
altered blood flow and implantation failure (Tompers et al., 2005, reviewed by Hu and 
Cross. 2010). This is particularly important in humans, as the human embryo is 
suggested to be highly susceptible to implantation failure, which is currently estimated 
between 30-45% of all pregnancies (Wilcox et al., 1988, Norwitz et al., 2001). In 
addition, early miscarriages have been associated with alcohol maternal exposure 
(Andersen et al., 2012, Avalos et al., 2014), low maternal body mass index, increased 
maternal or paternal age, stress, assisted conception, or change of partner 
(Maconochie et al., 2007). This highlights the importance of the P-TGCs in establishing 
the pregnancy. However, it is currently unknown how mild alterations in the P-TGCs 
may affect long-term placentation.  
1.7.2 Trophoblast differentiation and lineage segregation  
The proximal TE differentiates into two early structures of the placenta the EPC and 
the chorion. The EPC contributes to junctional zone trophoblast subtypes while the 
chorion gives rise to the labyrinthine layers (Coan et al., 2004). By E12.5 in the mouse 
and E14.5 in the rat, trophoblast subtypes are terminally differentiated, the structure 
of the definitive placenta is laid down and the onset of placental function is evident 
(Simmons, 2014). Quantification of these mature trophoblasts is becoming a useful 
tool in establishing their functions in the placenta, and the mechanisms behind 
placental perturbations (Jauniaux et al., 2001). For a summary of all the placental 
trophoblast subtypes and genetic markers, see Figure 1.2.  
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Figure 1.2. Trophoblast lineages that give rise to the placental and decidual zones. Markers of trophoblast subtypes are shown 
in red. Parietal (P-) trophoblast giant cells (TGCs) are derived from both the mural TE (primary TGCs) during early post-implantation 
development, as well as from the ecto-placental cone (EPC) in mid-gestation (secondary TGCs). C-TGCs; canal-associated TGCs. 
EXE; extra-embryonic ectoderm. ICM; inner cell mass. GlyT; glycogen trophoblasts. S-TGC; sinusoidal TGCs. SpA TGCs; spiral 
artery associated TGCs. SpT; spongiotrophoblast. Syn-T1/2; syncytiotrophoblast layer 1/2 cells. TE; trophectoderm. Adapted from 
Simmons and Cross, 2005, Simmons et al., 2007, Simmons, 2014.
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1.7.3 Spiral artery remodelling – establishing blood supply to the 
conceptus 
After the first invasive event by primary TGCs, one junctional zone-derived trophoblast 
subtype - the spiral artery trophoblast giant cells (SpA-TGCs), invade from the 
periphery of the EPC into the deciuda at E10 (rodent), and with the cooperation of 
supporting maternal decidual cells and decidual natural killer (dNK) cells, remodel the 
spiral arteries into high flow, low-resistance vessels more suited to deliver high blood 
volume required for placental function in later gestation (Guimond et al., 1997, 
Chakraborty et al., 2011). These invasive SpA-TGCs are analogous in the human to 
extravillous trophoblasts, which through endovascular invasion, and interactions with 
dNK cells, similarly remodel the spiral arteries (reviewed by Kaufmann et al. 2003).  
This process is of particular importance in humans, as alterations in either the dNK 
cells or trophoblast invasions, and thus spiral artery remodelling and ongoing placental 
perfusion, has been associated with pregnancy complications including low birth 
weight and preeclampsia (Wallace et al., 2012, Ball et al., 2006). Animal models of 
excess oedema (Lu et al., 2013) and obesity (Hayes et al., 2013), have also associated 
alterations to either dNK or SpA-TGC invasion with improper spiral artery remodelling, 
reviewed by Croy et al. (2000). Although periconceptional insults are currently not 
investigated for aberrant spiral artery remodelling, considering the high expression of 
dNK cell-associated pathways by the P-TGCs, perturbation to P-TGC differentiation is 
one mechanism of programming which may have long term consequences for 
placentation.   
1.7.4 Junctional zone formation 
The junctional zone consists of mostly SpT cells, with the addition of small populations 
of TGC subtypes which line the maternal circulation entering the implantation site 
(spiral arteries) to the venous return (Simmons, 2014). Additionally, the EPC contains 
progenitors for another junctional zone trophoblast cell type, the glycogen trophoblasts 
(GlyT), analogous to the human interstitial extravillous trophoblast. GlyTs are a poorly 
characterised cell type which are vacuolated and accumulate glycogen (Coan et al., 
2006). By E14.5, the intermediate SpT layer can be seen projecting into the labyrinth, 
defining and supporting the structure of this inner vascular layer (Tanaka et al., 1997). 
A vast expansion of GlyT cells occurs in mid-gestation and they begin migrating out of 
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the SpT layer into the maternal decidua through interstitial invasion (Adamson et al., 
2002, Coan et al., 2004, 2006). By E16.5-18.5, their numbers halve (Coan et al., 2004), 
and are thought to act as late gestational energy source through the production of 
IGF2 and the breakdown of glycogen to glucose to facilitate fetal growth just prior to 
birth (Redline et al., 1993). Glycogen accumulation can appear in TE cells when grown 
in culture (Edirisinghe et al., 1984), EPC cells (Tesser et al., 2010), as well as in mature 
placenta after maternal perturbations (Barash et al., 1983, 1986, Gardebjer et al., 
2014), which may be a stress response or adaptive mechanism to maximise fetal 
survival.  
The junctional zone trophoblast subtypes, are relatively uncharacterised in function. 
However, all these cell types produce prolactin-like protein hormones, which may 
suggest a role in communication with the maternal physiology during pregnancy and 
regulation of fetal growth (Cross et al., 2002, Wiemers et al., 2003). This is supported 
by rodent models which show reduced area of the junctional zone to be associated 
with fetal growth restriction (Mark et al., 2011). Few studies however, have explored 
the mechanisms behind altered junctional zone function, such as through altered cell 
allocation from EPC progenitors, development of its trophoblast subtypes, or migration 
of the invasive subtypes to the maternal vasculature where they can influence 
maternal physiology and fetal growth.   
1.7.5 Labyrinth formation  
Labyrinth development requires both fetal and trophoblast-derived cell types to interact 
for formation of the villous tree and the interhaemal membrane, required for protection 
of the growing fetus and a mode for nutrient exchange (Sibley et al., 1997). The 
labyrinthine zone of the placenta begins to form mid-gestation (E7.5 mouse), with the 
development and attachment of the chorionic trophoblasts with the fetally-derived 
allantoic mesoderm (Watson and Cross, 2005). Chorionic trophoblasts differentiate 
into lineage restricted multinucleated syncytiotrophoblast cells which compose 
syncytiotrophoblast layers SynT-I and -II. Another perforated layer exists above these 
consisting of cuboidal-like mononuclear sinusoidal trophoblast giant cells (S-TGCs), 
currently of an unknown origin, which line the maternal blood sinusoids where they 
may have an endocrine role (Simmons et al., 2007, Simmons et al., 2008a). As the 
chorion and allantois begin to fold, they form primary villi which later extend into a vast 
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vascular tree via branching morphogenesis. Expression of the transcription factor 
Gcm1 begins at E7.5, marks future branching initiation sites along the leading edge of 
the flat chorionic disc. Later Gcm1 is confined to the branch tips, allowing it to be used 
as a marker for the degree of branching morphogenesis (Anson-Cartwright et al., 
20000). Gcm1 can also be used as a marker of SynT-II cells, as it drives the 
expression of Synb which mediates the fusion of trophoblast cells into the SynT-II 
layer. This process consequently causes the up-regulation of Syna in cells at the distal 
edge of the chorion, which fuse into the SynT-I layer (Dupressoir et al., 2005, 2009). 
By E8.0, TS cell markers are down-regulated upon differentiation into labyrinthine 
trophoblasts (Chawengsaksophak et al., 1997, Luo et al., 1997). During this process, 
the fetal mesoderm also begins to differentiate into endothelial blood vessels, required 
to establish the fetal portion of the circulation. These endothelial cells then interdigitate 
with the maternal blood space for the exchange of nutrients, supplied by decidual 
sinuses and spiral arteries (Cross, 2000, Rossant and Cross, 2001). Involution of the 
chorionic S-TGCs, SynT-I and –II layers towards the maternal sinuses at E9.5, 
followed by ingrowth of the developing endothelial-lined fetal circulation, produces a 
barrier between the fetal and maternal blood spaces – the interhaemal membrane 
(Enders, 1965, Hernandez-Verdun, 1974, Simmons et al., 2008a). This is somewhat 
different to the human placenta which contains fetal endothelial cells, and one layer of 
syncytiotrophoblasts and a stem cell population that replenishes this outer layer; the 
cytotrophoblasts (Rossant and Cross, 2001).  
Passive diffusion of the placenta plays a large part in facilitating growth of the fetus, 
so the surface area (fetal blood vessel density), permeability and distance of perfusion 
through the interhaemal membrane are critical in determining the capacity for nutrient 
transport (Sibley et al., 2004). Measurement of interhaemal membrane thickness and 
labyrinth surface area are thus used to assess this diffusion capacity (Hernandez-
Verdun, 1974). Altered placental perfusion and consequent fetal grow can be caused 
by perturbations to chorionic patterning through allantoic budding and extension to 
reach the chorionic surface, trophoblast differentiation, chorioallantoic adhesion and 
attachment, subsequent branching morphogenesis (vascularisation), can all affect the 
labyrinthine architecture and the permeability of interhaemal membrane, and therefore 
the transport capacity of the placenta (Watson and Cross, 2005). In most extreme 
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cases, such as through inhibited allantoic budding, labyrinth development is arrested, 
becoming embryonic lethal by E9.5-10.5 (Zhadanov et al., 1999).  
1.8 Potential placental perturbations from a periconceptional model 
Perturbations may occur to numerous aspects of placental development to affect fetal 
growth and result in programming. If the growth trajectory of the placenta is 
unsynchronised with that of the fetus, it cannot meet the fetus’ required nutritional 
demands for rapid growth. There are many critical windows during development that 
can impact placentation, see Figure 1.3. However, a periconceptional insult may be 
able to affect all of these critical windows through programming of TE, epigenetic 
alterations, or through improper communication with the maternal environment, 
required for placental development. These changes may contribute to the 
development of: 
• altered cell allocation to the TE, affecting the progenitor pool to the placenta 
and subsequent trophoblast lineages (Gundogan et al., 2013),  
• poor trophoblast invasion into the decidua, impairing spiral artery 
transformation required for placental perfusion (Pijnenborg, 1994, Genbacev et 
al., 1996),  
• aberrant formation and vascularisation of the labyrinthine villous tree which may 
affect the surface area for nutrient exchange (Anson-Cartwright et al., 2000), 
and finally,   
• perturbed development the interhaemal membrane, or altered expression of its 
nutrient transporters (Sibley et al., 2004), which may both impair the transport 
capacity of the placenta.  
Questions now arise to what aspects of placental formation are most susceptible to 
modification after a periconceptional perturbation, and do these modifications occur in 
a sexually dimorphic manner. 
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Figure 1.3. Critical windows during placental development which are susceptible to perturbation. The developmental timeline 
of mouse placentation is presented, with formation in the rat requiring an additional +1 day at the blastocyst stage, and +2 days post-
implantation, with birth taking place at approximately day 22. All critical windows presented can alter placental growth and result in 
altered fetal development. Early exposures, prior to implantation, can alter development of the trophectoderm (TE), and may alter 
differentiation of the TE to form parietal trophoblast giant cells (P-TGCs], required to facilitate implantation into the maternal uterine 
epithelium. These may also alter formation of the ecto-placental cone (EPC) and chorion, progenitors to the two major placental 
compartments – the junctional zone and the labyrinth. Invasion of the spiral artery TGCs (SpA-TGCs – red) via endovascular invasion 
and glycogen trophoblasts (GlyT – black) by interstitial invasion are also rarely investigated, which have the potential to alter spiral 
artery remodelling, blood flow, or nutrient release. 
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1.9 Influence of genetic sex on placental programming* 
Sexual dimorphism arises in the timing and severity of disease outcomes, with males 
often displaying earlier onset and more severe disease than females (Barker, 1995). 
This can be traced back to the in utero environment, where male fetuses are more 
likely to be born preterm, experience neonatal complications or die in utero (Stevenson 
et al., 2000, Walker et al., 2012). This has led to the common view that males are more 
susceptible to developmental perturbations than females (Clifton, 2010). However, 
recent evidence suggests that female fetuses may be more affected by disorders 
during pregnancy such as maternal hypertension, preeclampsia, villous infarction, and 
in some studies, preterm birth (Walker et al., 2012, Shiozaki, et al. 2011, Vatten and 
Skjaerven, 2004, Verburg et al., 2016). These sexually dimorphic pregnancy outcomes 
make it essential that placental phenotypes be characterised in a sex-specific manner 
to allow further understanding into the mechanisms involved. 
1.9.1 Epidemiological evidence of sexually dimorphic programming  
Clinically, investigation of sexual dimorphism in the placenta is usually limited to 
analysis of the placenta at delivery and includes measurement of weight and gross 
placental structure. Recent studies have demonstrated the human term placenta 
shows sex-specific differences expression profiles for genes regulating cell 
proliferation, hormone function, maintenance of pregnancy and immune tolerance 
(Buckberry et al., 2014, Verburg et al., 2016). Males often have heavier placentas than 
females in uncomplicated pregnancies (Eriksson et al., 2010). Indeed, a recent study 
of nearly 80,000 deliveries in Japan demonstrated that males had a heavier placenta 
at every gestational age examined (week 24 to week 41) (Ogawa et al., 2016). Boys 
also show greater growth in utero than girls at any placental weight, suggesting that 
the male placenta is more efficient than the female (Eriksson et al., 2010). However, 
male fetuses are suggested to be at greater risk when nutrients are limited (Clifton, 
2010, van Abeelen et al., 2011). For example, babies exposed in utero to the Dutch 
winter famine have shown sex specific adaptations in placental growth associated with 
offspring disease: in males, an oval placenta was associated with hypertension in men 
whilst in females, hypertension correlated with a small placental area (van Abeelen et 
al., 2011, Roseboom et al., 2011). Asymmetric growth of the placenta, therefore 
altering its shape, may perturb maternal blood flow and therefore placental perfusion 
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(Kajantie et al., 2010), which may also affect the development of the placenta-heart 
axis (Thornburg et al., 2010). This is also suspected to be a result of altered 
implantation and/or spiral artery remodelling, affecting placental formation from very 
early in pregnancy (Thornburg et al., 2010). Restricted placental growth is most likely 
to affect nutrient exchange later in development during peak nutrient transfer, leading 
to a smaller fetus (Barker, 1995) and therefore programming of cardiovascular system 
by a different mechanism.   
Examination of placental development and function in animal models is becoming 
increasingly important for understanding the mechanisms of developmental 
programming. Perturbations in animal models during discrete periods of development 
result in sex–specific alterations in placental structure in late gestation, and can be 
associated with fetal growth restriction (Table 1.1). Like the human, the majority of 
studies have investigated placentation late in gestation. Considering many of these 
maternal perturbations are applied from as early as maturation of the oocyte through 
to late gestation (see Figure 1.3), there remains an expanse of placental development 
relatively unexplored, especially in the context of sexual dimorphism. Characterisation 
of phenotypes during early placental development would allow further understanding 
into sex-specific embryonic viability, sex ratios at implantation, and stage specific 
malformations. 
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Model Species 
Gestatio
nal Age 
at study 
Placenta Weight (PW),  
Body Weight (BW), PW: 
BW Ratio 
Structural Alterations / 
Pathologies in the 
Placenta 
Resorptions 
(Res) and 
viability 
Ref 
Pre-Implantation Exposure 
In vitro 
fertilisation, 
embryo transfer 
Mouse 
E7.5, 
E13.5, 
E19.5 
↔ PW, ↓ BW (E13.5),  
↑ PW:BW in males 
(E13.5, E19.5) 
↑ PW (E19.5), ↔ BW 
E19.5 
↑ Abnormal EPC (delayed, 
↓Volume, disorganised, 
E7.5 females  
↓ LAB:PW area and vessel 
density (E13.5)  
↑ Res (19%) 
E13.5 
↑ 
Male:female 
ratio E13.5 
and E19  
(Tan et al., 
2016a, 
2016b) 
Periconceptional Exposure 
Ethanol, 12.5% v/v 
liquid diet, E-4-E4,  
Rat E20 
↔ PW, ↓ BW: males 
(8%), females (7%), ↑ 
PW:BW ratio (8%) 
↑ JZ and ↓ LAB area ratio 
in both sexes.  
↑ Res (7%) 
(Gardebjer 
et al., 2014) 
Mid-Late Gestation Exposures 
Hypoxia, 12% O2, 
E14.5-E18.5 
Mouse E18.5 
↔ PW or PW:BW ratio.  
↓ BW: Males (7%), 
females (7%) 
↓ LAB blood spaces in 
females  
↔ Litter size 
(Cuffe et al., 
2014a) 
Corticosterone,  
33ug/kg/h, E12.5 –
E15  
Mouse 
E14.5, 
E17.5 
↑ Placental length, depth 
(E14.5).  
↔ PW, BW or PW:BW 
(E14.5). 
↑ PW and PW:BW in 
males (E17.5) 
↑ JZ volume in males 
(24%),  
↓ LAB:JZ in males (E14.5) 
↔ Res  
↔ Litter size 
(Cuffe et al., 
2012) 
Dexamethasone,  
0.02 mg/kg/day, 
E12.5-E15  
Mouse 
E14.5, 
E17.5 
↓ PW in females (19%, 
E14.5) 
↓ BW: Male (15%), 
females (20%, E14.5) 
↔ PW:BW (E14.5) 
↔ PW, BW or PW:BW 
(E17.5) 
↓ Whole placental and JZ 
area. 
Litter size 
N.D 
(Cuffe et al., 
2011) 
Dexamethasone,  
125 ug/kg, E20-E23 
Spiny 
Mouse 
E23, 
E37 
↔ PW, BW or PW:BW 
(23) 
↔ BW, PW (E37) 
↑ JZ area and ↓ LAB:JZ  at 
E23.  
↔ Res  
Litter size 
N.D. 
O'Connell et 
al., 2011 
2013b,c 
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↓ PW:BW ratio (E37) Blood spaces ↑ males, ↓ 
females (E37). 
Late Gestation Exposures 
Asthma Human Term 
PW: N.D. 
BW: ↔ Male, ↓ Female 
(12%) 
↓↓ Capillary volume in 
males 
↑ Females total length of 
peripheral villi and % 
trophoblast 
Mortality 
N.D. 
(Mayhew et 
al., 2008, 
Murphy et 
al., 2003) 
Premature labour, 
caused by severe 
PE or IUGR 
Human  Term 
PW: N.D. 
Severe PE and/or IUGR: 
males 53.4%, females 
46.6% 
↑ Chronic deciduitis and 
velamentous umbilical cord 
insertion in males 
↑ Villous infarctions in 
females 
31.3% 
Perinatal 
mortality  
↔ Sexes 
(Walker et 
al., 2012) 
Premature labour  
(severe <32 weeks) 
Human Term 
↔ PW and PW:BW  
BW: Males increased 
centile than females 
↑ Lesions of chronic 
inflammation of males 
N.D. 
(Ghidini and 
Salafia, 
2005) 
Chronic Gestational Exposures 
Fructose, 20% 
calories of total 
diet, E1-E10 
Rat E21 
↓ PW females, 
↔ BW 
↑ PW:BW females 
↔ LAB weight 
↔ JZ weight 
↔ Res, litter 
size or sex 
ratio  
(Vickers et 
al., 2011) 
High fat diet, 45% 
fat, E1-E21 
Rat E21 
↔ PW  
↓ BW: male (6%) and 
female (8%)  
↓ JZ weight 
↔ LAB weight 
↔ Litter size 
(Mark et al., 
2011) 
High fat diet, 60% 
of calories as fat, 
E0.5-E15  
Mouse E15.5 N.D. ↔ LAB %  ↔ Litter size 
(Gallou-
Kabani et 
al., 2010) 
Hypoxia, 13% O2, 
E0.5-E18.5.  
Mouse E18.5 
↑ PW males  
↓ BW, ↓ PW:BW  
↑ LAB blood spaces 
↔ JZ or LAB volume 
↑ Res 
↓ Litter size 
(Matheson 
et al., 2015) 
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Table 1.1. Sex-specific outcomes of placental and fetal growth in human and animal studies. BW; body weight, DEC; decidua, 
E; embryonic day, EPC; ecto-placental cone, IUGR; intrauterine growth restriction, HF; high fat, HFHS; high fat + high salt, HS; high 
salt, JZ; junctional zone, LAB; labyrinth, LF; low fat, N.D; not determined, PW; placental weight, PW:BW; placental weight:body weight 
ratio, Res; resorptions, w/w; weight per weight, v/v; volume per volume. Modifications to fetal body weight or placental parameters 
occur in both sexes unless otherwise stated.
Magnesium 
deficiency, 
moderate (0.02%), 
severe (0.005%) 
w/w Mg2+, (-) 4 
weeks – E18.5.  
Mouse E18.5 
Moderate: ↓ BW males 
(5%), females (5%) 
Severe: ↓ BW males 
(10%), females (9%) 
↔ PW or dimensions 
↑ LAB area 
↓ JZ area  
70% Res 
(Schlegel et 
al., 2015) 
Protein 
restriction, 6% 
reduction, E1- E21 
Rat 
E14, 
E18, 
E21 
↓ PW (E14, E18), ↔ PW 
E21  
↓ BW (E14, E18, E21) 
↑ PW:BW (E14), ↓ 
PW:BW (E18, E21) 
↓ LAB weight (E14, E18),  
↔ LAB weight (E21) 
↓ JZ weight (E14, E21), ↔ 
JZ weight (E18) 
Litter size 
N.D. 
(Gao et al., 
2012) 
High fat (HF)/ high 
salt (HS) / high fat 
+ high salt (HFHS) 
HS (4% NaCl); HF 
(45% kcal from fat), 
HFHS (HF+HS). E-
21-E18 
Rat  E18 
HS: ↓ PW male, ↔ 
female, ↔ BW male, ↓  
HF: ↓ PW male and 
female, ↔ BW male, ↓ 
female, HFHS: ↓ PW 
male, ↔ female 
↔ BW male or female 
LAB (%) HS: ↓ male, ↔ 
female, HF: ↔ male/ 
female, HFHS: ↓ male/ 
female, JZ (%) HS: ↑ male, 
↔ female, HF: ↔ male, ↓ 
female, HFHS; ↑ male, ↔ 
female. DEC (%) HS: ↔ 
male, ↑ female, HF: ↔ 
male, ↑ female, HFHS: ↔ 
male, ↑ female 
↔Litter size 
(Reynolds, 
et al. 2015) 
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1.9.2 Sexually dimorphic programming of the labyrinth  
The placental vasculature is essential for providing nutrients to facilitate fetal growth, 
and as such, this may be the principle structure that is affected in response to an in 
utero perturbation. The vasculature can be estimated by measurement of capillary 
density in humans (Mayhew et al., 2008), while animal models determine total 
labyrinthine area, volume, or surface area, and within the labyrinth - the fetal and 
maternal blood spaces (Coan et al., 2004). Approximately half of the studies in Table 
1.1 which investigated the placental vasculature in complicated human pregnancies 
and animal models showed that it was reduced in response to maternal perturbations. 
These outcomes were often distinctly sexually dimorphic; males had less well-
developed vasculature in response to maternal asthma in women (Mayhew et al., 
2008), or following mid-late gestational corticosterone exposure in the mouse (Cuffe, 
2012). In females, reductions in the vasculature of the mouse placenta occurred in 
response to mid-late gestation hypoxia (Cuffe et al., 2014a), and dexamethasone 
exposure (O’Connell et al., 2013b). Curiously, male spiny mice exposed to mid-
gestation dexamethasone (O’Connell et al., 2013b), showed increases in the placental 
vasculature, suggesting species variations. Reduced labyrinthine formation may act 
to temporarily reduce energy expenditure, but may come at a cost of ongoing placental 
and fetal growth. Alternatively, upregulation or maintenance of labyrinth growth may 
aid in maintaining nutrient transfer to help ensure fetal survival. Changes to the 
labyrinthine vasculature are also likely to contribute to the observed sex specific 
alterations in gene expression of glucose and nutrient transporters, glucocorticoid 
responsive genes, growth factors, as well as inflammatory responses, see reviews by 
Clifton (2010) and Rosenfeld (2015). Further research into sexual dimorphism of 
labyrinthine differentiation, vasculogenesis and branching morphogenesis, interhemal 
membrane thickness, and functional nutrient transport assays may shed light on sex 
differences in placental efficiency and adaptation to maternal perturbations.  
1.9.3 Sexually dimorphic programming of the junctional zone  
Evident in many programming models in Table 1.1 are models which associate an 
increase in junctional zone with a reduction of labyrinth. These include 
periconceptional alcohol exposure (Gardebjer, 2014), glucocorticoid exposure (Cuffe 
et al., 2012, O’Connell et al., 2011, 2013b, 2013c), maternal protein restriction (Gao 
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et al., 2012) and magnesium deficiency (Schlegel et al., 2015). In some cases, (e.g. 
following periconceptional alcohol), these changes are sex specific. The majority of 
models in which maternal nutrients are limited, span early development of the placenta 
and may affect the formation and maturation of the ecto-placental cone and the 
immature definitive placenta. A subset of these models has also investigated one 
specialised trophoblast subtype that is present in the rodent placenta – the glycogen 
trophoblast (GlyT). Excess glycogen has been shown to accumulate in the GlyT cells 
of the junctional zone in late gestation, most often in placentas from females 
(Gardebjer et al., 2014, Schlegel et al., 2015, O’Connell et al., 2011, 2013b, 2013c). 
GlyTs originate from a common progenitor to spiral-artery associated trophoblast giant 
cells (Mould et al., 2012). Thus, sexual dimorphism in differentiation of these 
trophoblasts during early placental development may also perturb spiral artery 
remodelling in a sex-specific manner. As differentiation of junctional zone trophoblast 
subtypes like GlyT are regulated by a number of imprinted genes (Lefebvre, 2012), it 
is possible these lineages are particularly sensitive to perturbations that affect 
epigenetic modifications or chromosome dosage compensation mechanisms. By 
examining earlier stages of development from the oocyte, to early embryo and 
immature placenta, we may gain a deeper understanding of the function of these cells 
and how they contribute to structural or metabolic adaptations that can lead to 
placental programming.  
1.9.4 Evidence of sexual dimorphism in the early embryo 
Current knowledge of sexual dimorphism on early developmental structure is restricted 
to the blastocyst stage, where some studies suggest males develop faster than 
females, reviewed by Gardner et al., 2010). This is largely based on assessment of 
blastocyst size or cell number, including allocation to either the TE or ICM (Tan et al., 
2016b, Valdivia et al., 1993, Peippo and Bredbacka, 1995, Perez-Crespo et al., 2005). 
Outcomes from these studies are conflicting in a variety of human and animal models 
with some studies demonstrating sex specific differences in preimplantation embryos 
whilst others detect no differences (Holm et al., 1998, Dumoulin et al., 2005). For 
example, the growth rates of human preimplantation embryos were found to be sex 
dependent after intracytoplasmic sperm injection (ICSI) but not after IVF (Dumoulin et 
al., 2005). Reasons for this may include the fact these experiments are conducted in 
vitro (utilising different types of culture media), and in some cases, use superovulation 
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to generate large quantities of embryos. These conditions are both known stressors 
to pre-implantation development (Giritharan et al., 2007, de Waal et al., 2012), which 
may potentially confound the determination of inherent sex differences, and should 
thus be interpreted with caution.  
A subset of these in vitro pre-implantation experiments has additionally determined 
differences between males and females in their physiology, genetic profiles, and 
metabolic responses to stress. Firstly, male embryos exhibit a higher metabolic rate 
than females (Tiffin et al., 1991), and in response to a heat stressor, exhibit greater 
oxidative stress responses (Perez-Crespo et al., 2005). Another IVF model showed 
successful pregnancies were associated with higher glucose consumption, with viable 
females exhibiting higher levels than males (Gardner, 2010). This dimorphism in 
glucose metabolism is contrary to that in placentation which suggests that males and 
females show the same glucose uptake in response to stress, indicating greater 
regulation during mid-late gestation (Cuffe, 2011, 2014a). Other studies suggest 
female blastocysts to be more susceptible to apoptosis prior implantation (Tan et al., 
2016b, Ghys et al., 2015). Expression profiles of male and female blastocysts show 
sexual dimorphism of both X-linked and autosomal genes (Bermejo-Alvarez et al., 
2010b). These can include DNA methyltransferases; Dnmt3a/3b, stress-induced 
enzyme; Ogt, glucose handling; G6pd, and apoptosis; Xiap, Hprt1 (Bermejo-Alvarez 
et al., 2008, 2010b). Interestingly, these are common pathways which are also 
upregulated during prenatal perturbations.  
We can also gain insight into early placental programming from IVF and ICSI 
conducted in assisted reproduction as well as animal models. A human study by 
Dumoulin et al. (2005) investigated both of these embryo procedures in a sexually 
dimorphic manner and showed that while IVF did not change cell number, ICSI 
increased TE cell number in males only (Dumoulin et al., 2005). This is an interesting 
finding as ICSI is well known for causing placentomegaly in rodents – a large 
expansion of the junctional zone with increased accumulation of GlyTs (Tanaka et al., 
2001), further illustrating that perturbation of the early embryo alters the 
communication with the normal in utero environment, leading to altered placental 
formation. This also has implications for human pregnancies, as both IVF and ICSI 
can lead to disorders including preterm birth, stillbirth, and low birth weight 
(Helmerhorst et al., 2004).  While sexual dimorphism in placental disorders and other 
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pathologies have currently not been investigated in detail, more males are born after 
blastocyst transfer (Kaartinen et al., 2015), further supporting the idea that males and 
females have different susceptibilities to perturbations in utero during different critical 
windows. While sex-specific adult outcomes of human offspring produced by IVF or 
ICSI remains to be evaluated, mouse models show that only female offspring from IVF 
and ICSI pregnancies have increased rates of glucose clearance, increased insulin 
secretion, higher peak insulin, as well as increased fat deposition (Scott et al., 2010, 
Feuer et al., 2014b).  
Mouse models using IVF have also shown reduced cell count in the early blastocyst 
in both TE and ICM lineages, reduced embryonic viability, and when allowed to 
develop into late gestation, have shown increased placental weight, labyrinth and 
junctional zone size, as well as the development of fetal growth restriction (Giritharan 
et al., 2007, Bloise et al., 2014, Delle Piane et al., 2010). While much of this information 
hasn’t investigated fetal sex, another mouse model has shown female IVF embryos 
develop abnormal ecto-placental cones, leading to skewing of the sex ratio from 50% 
male at implantation to 57% male at birth (Tan et al., 2016a). This indicates increased 
female mortality similar to that seen in humans. While both sexes developed reduced 
placental vasculogenesis later in gestation, males developed the most placental 
overgrowth (Tan et al., 2016b). This further illustrates that females in particular may 
be most susceptible to perturbations in the pre-implantation period, as they may be 
most susceptible to changes in TE lineage commitment, differentiation and invasion 
of the trophoblast giant cells, and therefore, their capacity to form a placenta.  
Further evidence for female specific TS differentiation comes from a mouse mutant for 
Eed, an X-lined gene involved in the PRC2 complex (Wang et al., 2001). Wang et al. 
(2001) showed null female embryos decreased trophoblast giant cell number and size 
at E7.5-E8.5. Other mouse mutants have also begun to investigate sexually dimorphic 
phenotypes in extraembryonic trophoblast and the placenta, where they consider the 
influence of the maternal or paternal derived X chromosomes, and X chromosome 
inactivation. Some of these models include the ATP-dependent helicase Atrx (Garrick 
et al., 2006), DNA methyltransferase Dnmt1 (McGraw et al., 2013), X-linked G6pd 
(Longo et al., 2002), and stress response Ndrg1 (Larkin et al., 2014). Curiously, it is 
again the females which seem to show the most deleterious phenotypes in these 
models, often showing reduced placental weight, labyrinth and/or junctional zones, as 
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well as embryonic viability. Males seem to develop similar pathologies, albeit at 
reduced severity. The mechanisms behind the overlap and interaction between in 
utero nutrient or stress perturbations and placental development, remains an exciting 
area of research. Sex-specific adaptations during early development and 
differentiation such as during periconception or peri-implantation periods, may be a 
result of impaired X chromosome inactivation, as demonstrated in response to IVF 
(Tan et al., 2016a). Further sex-specific adaptations later in placental development, 
however, are more speculative, but may be due to ongoing alterations in X 
chromosome dosage, imprinting on the X-chromosome, or perhaps by some other 
mechanism, and is discussed in detail by others (Gabory et al., 2013, Hemberger, 
2002). 
In summary, while currently male fetuses are suggested to be more susceptible to 
prenatal perturbations through aberrant placental formation, we suggest that these 
models are mostly due to mid-late gestational exposures. Conversely, early 
gestational models of programming are likely to be more deleterious to female 
embryos. This is of particular interest as PC-EtOH exposure has shown female 
specific GlyT accumulation in late gestation, which may suggest other sexually 
dimorphic outcomes may be present earlier in pregnancy in this model.  
1.10 Models of periconceptional programming  
Many perturbations to development during the periconception period, such as 
maternal dietary modifications or alcohol consumption, are sufficient to cause fetal 
growth restriction and result in programming of adult disease, as viewed in Table 1.2. 
The most well characterised model is a pre-implantation low protein diet, which has 
been shown to cause IUGR, increased postnatal “catch up” growth in females, and 
increased blood pressure in adult males only (Kwong et al., 2000, 2007). Sex 
differences in adult phenotypes seems to be a common finding within periconceptional 
models, which also includes a methyl deficient diet (Sinclair et al., 2007) and in vitro 
culture (Fernandez-Gonzalez et al., 2004).  
Few periconception models, however, explore placental phenotypes, but those that 
do, display zone- and sex-specific alterations in genes associated with fetal growth 
(Igf-2, Grb-10), and nutrient transporters (Slc2a1, Slc38a4) (Fowden et al., 2011), see 
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Table 1.3. Interestingly, periconception models do not explore potential sex 
differences when analysing pre-implantation phenotypes e.g. cell number. This is likely 
to be due to lack of genetic technologies in different animal models, technical 
limitations after staining procedures and the quantity required for genetic and protein 
analyses in which embryos are pooled per treatment.  
Periconceptional models do show changes in pre-implantation embryo viability 
through altered cell number and cell allocation, as well as ongoing trophoblast 
differentiation, which may highlight its plasticity or that all aspects development can be 
compromised in response to an adverse environment, see Table 1.3. Alterations in 
blastocyst cell number seems to be a common finding between models, which 
suggests a common pathway may be perturbed. Maternal dietary modifications can 
alter substrates such as glucose, insulin and amino acids (Kwong et al., 2000), 
indicative of perturbed nutrient sensing pathways. One likely mediator is the 
hexosamine signalling pathway, which culminates multiple maternal substrates in 
influencing the degree of post-translational modifications to critical regulators of cell 
cycle, stress or apoptosis (Hanover et al., 2010). The mTOR pathway can also be 
altered by nutrients and growth factors to influence cell proliferation (Eckert et al., 
2012). Maternal low protein (Kwong et al., 2000), vitamin and folate deficiency models 
(Sinclair et al., 2007) have also been shown to perturb the epigenetic environment, 
altering maternal serum homocysteine or choline levels, donor substrates which can 
influence the degree of DNA methylation and other epigenetic modifications. These 
epigenetic marks may be heritable through either the TE to effect placental 
development, or the ICM to influence fetal and postnatal growth, and may potentially 
mediate adult disease outcomes (Dean et al., 2003, Waterland and Jirtle, 2004). 
These pathways can thus signal a healthy or stressful maternal environment and 
modify pre-implantation development accordingly.   
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Animal Model and Dose Postnatal and Adult Phenotypes Ref 
Low Protein Diet, rat, in vivo, 9% casein,  
E0-E4.25 
Male: ↓ Liver and ↑ kidney weights, ↑ PN BP  
Female: ↓ BW in females, ↑PN weight 
(Kwong et al., 2000) 
Low Protein Diet, mouse, in vivo, 9% 
casein,  
E0-E3.5. 
Male: ↔ BW or PN weight, ↑ BP 
Female: ↑ BW, ↑PN weight, ↑ anxiety behaviour, ↑ BP 
(Watkins et al., 2008a) 
Low Protein Diet, mouse, in vivo, 9% 
casein,  
E-3.5-E0. 
Male: ↑ BW in males, ↑ BP 
Female: ↓ Adult organ weights, ↑ NN, ↑ BP 
(Watkins et al., 2008b) 
Undernutrition, ovine, in vivo, 70% of 
control diet, E-60 – E7 
↓ BW (twins only) 
(Edwards and McMillen, 
2002)  
Undernutrition, ovine, in vivo, 10–15% 
reduction in body weight, E-60 - E0  
Male: ↑ BW, ↑ fat mass, ↓ organ and ↑ testes weight  
Female: ↓ Ovary weight 
(Jaquiery et al., 2012) 
High Fat Diet, mouse, in vivo, -16 wks – 
E0, E4 
Male: ↓ BW, ↑ PN cholesterol and fat mass, ↓ glucose 
tolerance, Female: ↓ BW, ↑ PN fat mass 
(Jungheim et al., 2010) 
pH, mouse, in vitro, superovulation, 2 
mmol/l DMO, decreasing pH by <0.2 pH 
units, zygotes-blastocyst 
↓ BW (Zander-Fox et al., 2010) 
Ethanol, mouse, in vivo, 25% (v/v) EtOH, 
pair fed 
↓ BW, ↑ resorptions 
(Padmanabhan and 
Hameed, 1988) 
Embryo culture, mouse, in vitro, 2-cell 
stage to blastocyst stage, superovulation 
Male and Female: ↔ BW, ↑ BP (Watkins et al., 2007) 
Embryo culture, mouse, in vitro, +/- FCS 
Male: ↔ BW, altered behaviour 
Female: ↔ BW, ↑ PN weight, altered behaviour 
(Fernandez-Gonzalez et 
al., 2004) 
Embryo culture, ovine, in vitro, 2-5 days 
with granulosa cells and/or SOF medium  
↑ BW and organ weights 
(Rooke et al., 2007, 
Young et al., 2001) 
IVF or ICSI, epidemiological studies ↓ BW, ↑ birth defects  
(Hansen et al., 2002, 
Schieve et al., 2002) 
IVF and ICSI, mouse, in vitro 
Male: ↑ BW, ↔ glucose clearance  
Female: ↑ BW, glucose clearance, insulin and fat 
deposition 
(Scott et al., 2010) 
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Methyl-deficient diet, ovine, in vivo, -
8wks-E6 
Male and Female: ↑ PN weight, insulin resistance, ↑ BP (Sinclair et al., 2007) 
Table 1.2. Effect maternal perturbations during the pre-implantation period on the development of adult-onset disease. 
Several maternal pre-implantation perturbations have been explored using various animal models and techniques (in vivo or in vitro), 
showing many similar adult onset phenotypes. BP; blood pressure, BW; body weight, DMO; 5,5-dimethyl-2,4-oxazolidinedione, E; 
embryonic day, EtOH; ethanol, HPA; hypothalamic pituitary axis, ICSI; intracytoplasmic sperm injection, IP; intraperitoneal (injection), 
IUGR; intrauterine growth restriction, IVF; in vitro fertilisation, NN; nephron number, LOS; large offspring syndrome, PN; postnatal, 
SOF; synthetic oviduct fluid, wks; weeks, w/v; weight per volume.  
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Animal Model and Dose 
Oocyte and Pre-
Implantation Alterations 
Placental Alterations Ref. 
Low Protein Diet, rat, in vivo, 
9% casein, E0-E4.25 
↓ ICM and TE cell number, 
cell proliferation.  
↓ H19 in male blasts only 
↔ Igf2, Igf2R in male or 
female 
↑ EPC proliferation and TGCs  
↓ PW and PW:BW 
(Kwong et al., 2000, 
2006, Watkins et al., 
2015) 
Undernutrition, ovine, in vivo, 
70% of control diet, E-60 – 7 
days 
- 
↑ PW (twin) 
 ↔ Volume of placenta or fetal 
capillaries 
(MacLaughlin et al., 
2005) 
Undernutrition, ovine, in vivo 
60% of control diet, 8 weeks 
before oocyte collection, culture 
to blastocyst stage (8 days) 
↓ Oocyte quality  
↓ Cleavage rates and 
blastocyst formation  
- (Borowczyk et al., 2006) 
Hyperglycaemia, rat, in vitro, 
E5 embryos culture in 6 or 
28mM glucose for 24h 
↓ Cell number in blastocyst  
↑ Apoptosis 
- (Hinck et al., 2003) 
Diabetes/Insulin resistance, 
mouse or rat, in vivo, 
streptozotocin or alloxin induced 
~E-40/E-7 to E5, and/or in vitro 
for 72h 
Altered oocyte maturation, ↓ 
blastocysts, total, TE and 
ICM number 
↑ Morulae 
↓ Outgrowth of P-TGC at 72h 
culture 
(Diamond et al., 1989, 
Lea et al., 1996, Moley 
et al., 1991, Pampfer et 
al., 1994, Vercheval et 
al., 1990)  
High Fat Diet, mouse, in vivo, -
16 weeks – E0 or E4, in vitro to 
E5 
↓ Oocyte quality, ICM and 
blastocyst number, ↑ TE cells 
↑ Igf2R expression 
(Jungheim et al., 2010, 
Minge et al., 2008) 
Ethanol, mouse, in vitro, 
oocytes, 1-, 2- or 4-cell embryos 
exposed to 0-2% (w/v) EtOH on 
one day, cultured to blastocyst 
stage.  
High dose ↓ total cell 
number, blastocyst formation, 
hatching. 
↑ Apoptosis 
P-TGC outgrowth ↓ high dose, and 
↑ low dose  
(Leach et al., 1993, 
Huang et al., 2007) 
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Low dose ↑ blastocyst 
formation, cell number. 
Ethanol, mouse, in vitro, E3-4 
embryos, 0.05-1.0% (w/v), 5 min 
or 24h to E5, embryo transfer 
↑ Cavitation 
↓ P-TGC outgrowth (0.1-1.0% 
EtOH) 
↑ Implantation (term) 
(Stachecki et al., 1994a, 
1994b) 
Ethanol, rat or mouse, in vivo, 
0-4 g/kg, 10-33% EtOH via 
gavage, drinking water, vapour, 
or pair fed E>100-E5, embryo 
transfer 
↓ Cell division, cavitation, 
hatching, mitotic index, 
viability, and trophoblast 
outgrowth.  
↓ Implantation (E19)  
↑ PW 
(Checiu, 1993, Checiu, 
1995, Mitchell, 1994, 
Padmanabhan and 
Hameed, 1988, 
Pennington et al., 1984, 
Perez-Tito et al., 2014) 
Ethanol, porcine, in vitro, 0.2% 
w/v, fertilisation + 7 days 
culture.    
↓ Blastocyst rate, expansion 
rate, mitochondrial function 
- 
(Page-Lariviere et al., 
2017) 
Alcohols, mouse, in vitro, 2-cell 
in 0.05-1% butanol, propanol, 
isopropanol, propanediol, 
glycerol, or 0.1% EtOH for 1 day 
to E5  
↓ Blastocyst formation 
(except propanediol and 
glycerol) 
EtOH ↑ Cavitation 
- (Kowalczyk et al., 1996) 
Reduced pH, mouse, in vitro, 
superovulation, zygotes in 2 
mmol/l DMO 
↓ ICM and total cell number  
↑ Apoptosis 
- (Zander-Fox et al., 2010) 
Embryo Culture and IVF, 
mouse, in vitro, oocyte to 2-cell 
stage to blastocyst stage, 
embryo transfer 
↓ Total, TE and ICM cells 
↑ Abnormal EPC (delayed, ↓ 
volume, disorganised (E7.5) 
PW: ↓ E12.5, ↔ E13.5, ↑ E18.5 
and E19.5, ↓ PW:BW (E15.5, 
E18.5) 
↓ LAB vessel density E13.5 
↓ Nutrient transporters 
(Bloise et al., 2012, Delle 
Piane et al., 2010, 
Giritharan et al., 2007, 
2012, Tan et al., 2016a, 
2016b) 
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IVF/ICSI, human, in vitro, E3-6, 
term 
IVF ↔ Cell number 
ICSI ↑ TE cell number 
(males), ↓ Blastocyst 
formation 
↑ Placental thickness, 
haematomas 
↑ Placental disorders, praevia 
(ICSI) 
(Dumoulin et al., 2005, 
Kaser et al., 2015, Joy et 
al., 2012) 
 
Table 1.3. Periconceptional diet modifications of pre-implantation development, placental development. Several maternal 
periconceptional perturbations have been explored using various animal models and techniques (in vivo or in vitro), showing similar 
pre-implantation modifications, but few have explored placental phenotypes. Ca2+; calcium, DMO; 5,5-dimethyl-2,4-oxazolidinedione, 
E; embryonic day, EPC; ectoplacental cone, EtOH; ethanol, GlyT; Glycogen trophoblasts, IC; intracellular, ICM; inner cell mass, ICSI; 
intracytoplasmic sperm injection, IDD; insulin-dependent diabetes, IVF; in vitro fertilisation, LAB; labyrinth, JZ; junctional zone, PW; 
placental weight, PW:BW; ratio of placental weight to body weight, TE; trophectoderm/v; volume per volume, w/v; weight per volume.  
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1.11 Animal models of maternal alcohol exposure  
Animal models have been effective in analysing dose and critical windows in 
programming of alcohol. As mentioned in section 1.9.3, chronic high dose maternal 
alcohol exposure is categorised into FAS and FASD. However, lower doses of EtOH 
and exposure across different critical windows have not been studies as extensively 
as chronic models. While chronic models simulating FAS, such as 37% v/v EtOH in 
the rat show reduced litter sizes, indicative of miscarriage (Gundogan et al., 2008), 
and significant fetal growth restriction (Gundogan et al., 2015), lower doses show more 
variability. A chronic low dose model in the rat of 8.2% EtOH from E6-E19 showed 
increased fetal weight, while 6% v/v EtOH from E1-E20 in the rat showed reduced fetal 
weight by 3% in males, and 8% in females (Probyn et al., 2013). Binge dosing (1g 
EtOH/kg maternal body weight) on E13.5 and E14.5 in the rat resulted in reduced body 
weight at PN30 (Gray et al., 2010), while repeated EtOH exposure (0.75 g EtOH/kg 
maternal body weight) in late gestation of the fetal sheep (E95-E124) showed no 
change in birth weight (Gray et al., 2008). In addition, reduced nephron number has 
been shown in the binge model in both sexes (Gray et al., 2010), as well as the late 
gestational sheep model (Gray et al., 2008), while hypertrophy in the heart occurred 
in the low dose 6% EtOH model (Nguyen et al., 2014). A subset of models has also 
investigated postnatal disease phenotypes, with chronic low dose EtOH associated 
with hyperinsulinemia in males (Probyn et al., 2013), and the binge model resulting in 
hypertension in both sexes (Gray et al., 2010). More recently, we have shown that PC-
EtOH can also cause offspring insulin insensitivity (Gardebjer et al., 2015). One organ 
already implicated in mediating programming of alcohol exposure, is through altered 
development and function of the placenta.  
While few animal models of alcohol exposure investigate impacts on the placenta, 
those that do show dose-dependent effects. After mid-gestation at the onset of 
placental function through nutrient transport, alcohol can readily cross the placenta 
(Weinberg et al., 2008). A gestational model of 8% v/v EtOH exposure initiated on 
various day’s post E6, has also shown altered placental structure and function 
(Gundogan et al., 2013). Here they found reduced trophoblast stem cell pools, 
decreased TGCs, and reduced invasion of trophoblasts into the decidua. The invasion 
defect likely contributed to inhibited spiral artery remodelling and perturbed placental 
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blood flow. High dose (18-37% vol/vol) EtOH exposure from implantation until close to 
term (E6-E18) reduced invasion of trophoblast cells into the maternal decidua and 
caused more labyrinth disorganisation with increasing dose (Gundogan et al., 2015). 
However, it is unknown if placental defects are due to direct exposure of the 
trophoblasts of the post-implantation embryo to EtOH within the uterine cavity, or via 
other indirect mechanisms such as interactions with altered uterine cells.  
1.12 Programming of ethanol on the pre-implantation embryo  
The effects of ethanol during the periconceptional period, have been largely 
overlooked. While direct effects of ethanol have been explored on pre-implantation 
development, few examine possible indirect effects through altered maternal 
physiology, or the dialogue required for implantation and placentation. To date, no in 
vivo model other than our own has established whether PC-EtOH can result in fetal 
programming and lead to adult onset disease.  
Ethanol has been shown to be able to enter the oviductal and uterine lumen, where it 
may be able to directly affect the developing pre-implantation embryo (Sandor et al., 
1981). Ethanol was found both in the oviductal and uterine fluid (0.05-0.08%) following 
maternal administration, however, in lower concentrations than the blood (0.24%). 
This study however, used gas chromatography to measure ethanol concentrations, 
which is not considered the gold standard for substrate measurements. Several 
groups have thus studied the direct effects of ethanol on pre-implantation development 
in vitro. Interestingly, many studies show dose-dependent biphasic effects, with low 
doses (0.1% ethanol) shown to accelerate pre-implantation morphogenesis, through 
calcium-induced increases in cavitation, cell proliferation, blastocyst outgrowth, 
precocious differentiation (Stachecki et al., 1994a, 1994b, Rout et al., 1997, Mitchell, 
1994, Leach et al., 1993), and increased implantation success after transfer (Stachecki 
et al., 1994a). This is in contrast to high doses (0.3-2% ethanol), which rather show 
perturbed development as indicated by increased apoptosis, reductions in total cell 
number, blastocyst formation and hatching (Leach et al., 1993, Huang et al., 2007), 
see Table 1.3.  
In vivo models of PC-EtOH using moderate-high doses (10-33% v/v ethanol), show 
delayed pre-implantation development through reductions in cell division, hatching, 
 68 
increased pathological embryos and resorptions, reduced implantation, and fetal 
growth restriction (Checiu, 1993, 1995, Huang et al., 2007, Pennington et al., 1984, 
Perez-Tito et al., 2014, Mitchell, 1994). With the exceptions of Padmanabhan and 
Hameed (1988) and Huang et al. (2007), all other in vivo models used methods of 
ethanol administration that may be confounded with other factors. When administered 
in drinking water, animals often reduce their calorie intake by 10-40% (Shankar et al., 
2007), confounding the study with undernutrition, which in itself can cause 
programming, see Tables 1.2 and 1.3. Intravenous or intraperitoneal injection and 
gavage are also likely to cause further stress to the animal, activating glucocorticoid 
response pathways. A further limitation of these previous studies is that none have 
explored any sex effects, which may potentially mask phenotypes by combining both 
genders.  
Ethanol may also perturb the maternal environment indirectly by altering critical 
maternal hormones associated with pregnancy such as estrogen (Gavaler and 
Rosenblum, 1987) and progesterone (Budec et al., 2002), nutrient substrates of 
glucose and insulin (Forney and Harger, 1969, Snyder and Singh, 1989), growth factor 
availability (IGF1) (Gundogan et al., 2008), acetaldehyde – a teratogenic downstream 
metabolite of ethanol (Sreenathan et al., 1982), reactive oxygen species – a cause 
cellular stress (de la Monte and Wands, 2001), or other pathways such as reduced 
retinoic acid synthesis (Gray et al., 2012). Recent unpublished work from our 
laboratory has found PC-EtOH exposure of 12.5% v/v ethanol to cause mild maternal 
hyperglycaemia over the treatment period (Gardebjer, unpublished). Many of these 
other indirect implications can also affect cellular viability, metabolism or differentiation 
in either the pre-implantation embryo, or the uterine stromal and decidual cells, which 
may be important when analysing their interaction. We have also recently shown 
increased resorptions at E20 in our model (Gardebjer et al., 2014), which adds 
precedence to exploring an implantation and placentation defect. Considering the 
importance of coinciding the windows of embryo activation and uterine receptivity to 
co-ordinating implantation and placentation, it is surprising that few periconceptional 
models explore altered implantation as a mode for fetal programming.  
Ethanol can also increase homocysteine levels (Steegers-Theunissen et al., 2013), 
which may affect the degree of epigenetic modifications, especially to the embryo 
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during EGA. Given the importance of imprinting in the TE for placental development, 
alterations to the TE and subsequent trophoblast lineages could mediate differences 
in placental growth, efficiency and nutrient transport capabilities (Angiolini et al., 2006). 
Our group has also reported increased Igf2 expression in the junctional zone of E20 
placentas, further supporting a role for epigenetic modifications (Gardebjer et al., 
2014).  
Our laboratory has also reported structural and metabolic changes in the term placenta 
(Gardebjer et al., 2014). Structural changes included increased relative placental 
weight, increased junctional zone area to body weight ratio, and decreased labyrinth 
area ratio in PC-EtOH exposed fetuses. Alterations in both placental zones may 
indicate altered trophoblast cell allocation, and may explain other observed differential 
metabolic (altered glucose transport and glycogen accumulation) and vascular 
changes, as shown in other models of alcohol exposure (Gundogan et al., 2013). This 
evidence in addition to that from our own model, has led us to question whether PC-
EtOH can alter trophoblast progenitor pool differentiation, allocation to downstream 
zones of the placenta, trophoblast invasion into the maternal decidua, and remodelling 
of spiral arteries. This will further inform us how the placenta is responsible for reducing 
fetal growth after PC-EtOH.  
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1.13 Rationale 
Whilst a lot of focus has been directed on the impact of nutritional perturbations during 
this periconceptional period, maternal alcohol consumption, which is common prior to 
pregnancy recognition (Colvin et al., 2007, Muggli et al., 2016), has not received 
significant attention. Several studies have utilised in vitro models of ethanol exposure 
to explore the direct effects on pre-implantation development, however these studies 
overlook the indirect impact of perturbations to the maternal environment on the pre-
implantation period, placentation, as well as any sexually dimorphic outcomes.   
Our group has established a model of periconceptional alcohol exposure, shown to 
result in alterations to the late gestation placenta and result in fetal growth restriction 
(Gardebjer et al., 2014). These changes in development are associated with impaired 
insulin sensitivity during adulthood (Gardebjer et al., 2015) as well as renal and cardiac 
deficits (unpublished). However, we still have little understanding how PC-EtOH 
initiates these later placental and fetal abnormalities, or the full extent of the disruption 
to placental development. The placenta is critical in influencing fetal growth, so 
alteration in formation, function or adaptation can program other fetal, and therefore 
postnatal outcomes. Therefore, this study will explore the impact of PC-EtOH on the 
maternal uterine environment, its preparation for embryo implantation (uterine 
receptivity) and the development of the pre-implantation embryo in a sexually 
dimorphic manner. In addition, we will characterise the effects of PC-EtOH on the 
immature, mid- and late-gestational placenta (see Figure 1.4).  
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Figure 1.4. Summary of the putative impact of ethanol consumption on periconceptional programming. Alterations to pre-
implantation events and/or changes to the uterine environment may adversely affect implantation and thus placental formation. These 
in turn can have additive impacts on growth of the fetus and its organ structures. These alterations may then impact further growth 
of these organs and may predispose adult onset diseases. 
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1.14 Scope of thesis 
PC-EtOH exposure has been shown to cause fetal growth restriction and the 
development of adult insulin insensitivity. While some adaptations have been shown 
in the late gestation placenta, phenotypes present in earlier gestation, and the time 
points at which they arise, are currently unexplored. Therefore, this thesis aimed to 
further characterise the impacts of PC-EtOH exposure on placentation, and to 
examine whether impacts to either the pre-implantation embryo, uterine environment 
or a combination are implicated in programming by alcohol. It was also important to 
examine embryonic sex for all possible outcomes, as many phenotypes have been 
shown to be sexually dimorphic in this model.  
 
1.15 Aims and hypotheses 
 
 1.15.1 Overall aims 
To examine whether PC-EtOH exposure alters the development of the pre-
implantation embryo and/or the uterine environment, and how this may cause sex-
specific programming of placental development, and result in fetal growth restriction.  
 
 1.15.2 Overall hypotheses 
It is hypothesised that in vivo PC-EtOH exposure affects pre-implantation development 
altering key events such as cell allocation and differentiation within the blastocyst. 
Furthermore, PC-EtOH exposure will impact embryo development, through changes 
to the maternal uterine environment, the acquisition of uterine “receptivity” required for 
embryo implantation, and the capacity of the uterine stromal cells to undergo 
decidualisation, and subsequent placental formation. All embryonic and placental 
outcomes will show sexual dimorphism.  
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1.16 Aims and hypotheses for chapter 3 
It is well known that the male XY placenta is larger than the female XX to aid in the 
greater growth trajectory of the male fetus. Studies in the field of developmental 
programming highlight sexually dimorphic phenotypes in response to stress, 
particularly in placentation. However, studies showing inherent differences between 
male and female placenta, and tracing its cell lineage back to the pre-implantation 
embryo, currently have several limitations. Firstly, placentation has not been explored 
with appropriate numbers of animals, or sufficient developmental time points during 
gestation, while the pre-implantation field is currently confounded with inappropriate 
sample derivation (in vivo as opposed to in vitro, in addition to the utilisation of 
superovulation).  
Specific aims addressed in chapter 3 were to determine basal sexual dimorphism from 
in vivo-derived samples. Sex differences will be examined in: 
1. The pre-implantation blastocysts in respect to total cell number and allocation 
to either the TE or ICM lineages to determine developmental viability. 
2. Trophoblast outgrowth capacity and differentiation into P-TGCs required for 
invasion of the uterine epithelium.  
3. Morphogenesis of the placenta including its two compartments – the labyrinth 
and junctional zones, as well as the fetal and maternal blood spaces within the 
labyrinth (examined for volume and surface area), and separating them - the 
interhaemal membrane over gestation, which all contribute to ongoing placental 
development and appropriate nutrient exchange required for fetal growth.  
4. Expression of genes involved in differentiation of the labyrinthine trophoblasts, 
growth, and vasculogenesis.  
It is hypothesised that sexual dimorphism begins at the blastocyst stage with sex 
difference in the progenitor trophectoderm (TE) and its derived trophoblast lineages. 
As these cells populate the majority of cell types within the placenta during gestation, 
we will investigate sex specific differences in growth of the placental compartments by 
ontogeny.  
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1.17 Aims and hypotheses for chapter 4 
Perturbations during pregnancy, including alcohol exposure (Gardebjer et al., 2014, 
Gundogan et al., 2015) often result in modifications to placental growth (Kwong et al., 
2006, MacLaughlin et al., 2005) and zonal allocation (Gardebjer et al., 2014) in late 
gestation. However, few studies have determined whether alterations to trophoblast 
differentiation in early pregnancy may be mediating these effects. Here we utilise an 
in vitro model of differentiating mouse trophoblast stem (TS) cells to examine the direct 
effects of EtOH. 
Specific aims addressed in chapter 4 are to determine whether in vitro EtOH 
exposure alters:  
1. Cell proliferation,  
2. Differentiation to downstream trophoblast subtypes,  
3. Expression of genes involved in cell death pathways, and 
4. Whether these outcomes occur in a dose-dependent manner.   
It is hypothesised that in vitro culture with EtOH will reduce the proliferation and 
pluripotency of TS cells, causing premature differentiation into downstream cell types, 
assessed by expression of trophoblast subtype specific markers, and will occur in a 
dose-dependent manner, with higher doses showing the most severe phenotypes.   
 
1.18 Aims and hypotheses for chapter 5 
The periconceptional period is a critical window during development which is sensitive 
to maternal perturbations. Prior to placentation, the early embryo has limited capacity 
to regulate nutrients and substrates, facilitated by the oviductal and uterine 
environment. Perturbations to the uterine environment often result in reduced 
proliferation or an increase in cell death pathways of the early embryo. In addition, 
studies from mouse models of IVF suggest females to be most at risk of perturbed 
development and implantation failure, which may explain female bias in placental 
phenotypes after PC-EtOH exposure in late gestation. The uterine environment 
facilitates embryonic nutrition, including the supply of growth factors and other 
substrates, through the acquisition of uterine receptivity and the stromal cell reaction 
– decidualisation. The timing and extent of these important events can shift or reduce 
the window from implantation and can result in implantation failure, or can lead to 
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perturbation of uterine-embryo interactions, and therefore placental malformations. 
This chapter aimed to determine the effects of in vivo PC-EtOH exposure on pre-
implantation development and the peri-implantation uterine environment.  
Specific aims addressed in chapter 5 are to determine whether in vivo PC-EtOH 
exposure: 
1. Alters cell viability (by assessing total cell number) and lineage allocation (to 
the ICM or TE) in the E5 blastocyst in a sexually dimorphic manner. 
2. Results in sex specific alterations in trophoblast outgrowth capacity and 
differentiation into P-TGCs required for invasion of the uterine epithelium. 
3. Alters maternal serum hormones (estrogen, progesterone) during the pre- and 
peri-implantation period.  
4. Alters the window of receptivity, or decidual response within the early 
implantation site.  
5. Alters the maternal immune response for implantation through dNK cell 
infiltration. 
It is hypothesised that maternal PC-EtOH exposure will cause sex specific alterations 
in total cell number and cell allocation, affecting in turn trophoblast outgrowth capacity, 
the ability for the embryo to implant, and thus programming long-term development of 
the fetus and the placenta. Based on previous models of ethanol exposure (Gavaler 
and Rosenblum, 1987, Budec et al., 2002), PC-EtOH will elevate maternal estrogen 
levels, causing precocious uterine sensitisation and secretion of stromal products, 
altering the window of receptivity. Reduced progesterone levels will decrease the 
decidual cell reaction and their secretory products, diminishing the embryos ability for 
implantation. PC-EtOH will reduce the infiltration of dNK cells into uteri and SpA-TGCs 
into the decidua, which will reduce spiral artery transformation (further assessed in 
Chapter 6). 
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1.19 Aims and hypotheses for chapter 6 
PC-EtOH exposure has been previously found to alter the late gestation placenta and 
result in fetal growth restriction (Gardebjer et al., 2014). This and other 
periconceptional models rarely examine earlier gestational time points, as placental 
nutrient transfer is at maximum capacity in late gestation, required to facilitate the late 
gestational fetal growth spurt. For this reason, this thesis chapter aims to explore 
earlier developmental events in placentation including differentiation of the placental 
trophoblasts, morphogenesis and function of the placenta by ontogeny. By doing so, 
precise timing of deleterious phenotypes can be determined.  
 
Specific aims addressed in chapter 6 are to examine whether in in vivo PC-EtOH 
exposure causes sex specific alterations to:  
1. The degree of invasion of junctional zone-derived trophoblast subtypes (SpA-
TGCs) into the maternal decidua.  
2. Formation of the labyrinthine vasculature; fetal and maternal blood spaces, 
and separating them the interhaemal membrane.  
3. Differentiation of cells in the labyrinth 
4. Expression of labyrinthine nutrient transporters, effecting nutrient exchange 
to the fetus.   
It is hypothesised that based on prior placental characterisation of our model of PC-
EtOH exposure Gardebjer et al. (2014) and gestational model of alcohol exposure by 
Gundogan et al. (2013), in vivo PC-EtOH exposure will reduce the invasion of SpA-
TGCs into the maternal decidua, affecting spiral artery remodelling, and will reduce 
cell allocation to the labyrinth, reducing the volume of fetal vasculature and 
interhaemal membrane thickness. These changes in turn will reduce nutrient transfer 
of glucose and amino acids, leading to fetal growth restriction.   
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Chapter 2 – General Materials and Methods 
2.1 Ethics  
All animal experiments and procedures were approved by The University of 
Queensland Animal Ethics Committee (AEC approval number SBS/022/12/NHMRC) 
prior to commencement of this study.  
 
2.2 Animal Handling and Liquid Diet Administration 
Female Sprague Dawley rats were housed individually with controlled temperature, 
humidity and an artificial 12-hour light-dark cycle at the animal facility in the Australian 
Institute for Bioengineering and Nanotechnology at the University of Queensland. PC-
EtOH exposure was administered in vivo to Sprague Dawley dams (Rattus 
norvegicus) in a liquid diet containing 12.5% v/v EtOH as previously described 
(Gardebjer et al., 2014, 2015). The proposed diets were based upon the established 
Lieber-DeCarli nutritionally complete diet (Lieber and DeCarli, 1982, 1989), see Table 
2.1 for nutritional composition. A control liquid diet was given to all female rats prior to 
the experiment to avoid rejection. Dam weight was at least 230g before entering the 
protocol. Vaginal impedance was measured daily with an EC40 oestrous cycle monitor 
(Fine Science Tools), with 4.5 x 103 Ω or higher indicating oestrus and allocation to 
the diet regime. Dams were treated over two oestrus cycles, one prior to mating and 
the establishment of the pre-implantation period (denoted as embryonic day (E) -4 to 
E4). Dams were time-mated on E0 from 1200h to 1700h if impedance exceeded 
4.5x103Ω. If pregnancy was established by the presence of a seminal plug, the 
following day was considered E1. Timed mating’s were used in cohorts from E5-E13. 
Cohorts of E15 and E20 were allowed to mate overnight. Pregnant dams were then 
returned to individual cages and continued on the above-mentioned diets until the end 
of E4. Liquid diets were prepared fresh daily, administered at 1200h and were 
removed at 0900h the following day. Between 0900h-1200h, animals were given water 
ad libitum. On E5, dams were returned to laboratory chow until sacrifice. As this study 
aimed to determine the mechanisms behind ethanol exposure, it was important to 
allocate a separate cohort of dams to an additional control of standard rat chow which 
were not a part of the liquid diet regime to eliminate the possible effects of liquid diet 
procedures.  
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Control 
Diet 
Ethanol 
Diet 
Distributor 
Sustagen hospital 
formula (g) 
19.50 22.00 
Mead Johnson Nutritionals, 
Auckland, New Zealand 
Corn flour (g) 15.70 15.00 Coles 
Sunflower oil (mL) 0.83 2.00 Crisco 
Selenium (g) 0.03 0.60 
Selemite B; Blackmores, NSW, 
Australia 
Low fat milk (mL) 58.33 50.00 Dairy Farmers 
12.5 % EtOH (mL) 0.00 10.00 - 
Ferric citrate 
(199mM) 
0.01 0.01 Sigma Aldrich Inc, MO, USA 
Manganese 
sulphate (303mM) 
0.01 0.01 Sigma Aldrich Inc, MO, USA 
Copper (II) 
sulphate (50mM) 
0.01 0.01 Sigma Aldrich Inc, MO, USA 
Total (mL) 80.00 80.00 - 
Table 2.1. Liquid diet composition for control and ethanol treatment groups. The 
ethanol diet was modified for isocaloric consumption to control dams. Sustagen 
hospital formula composition per 60g serving: protein (13.8g), fat (1.5g), carbohydrate 
(39g), sodium (160mg), vitamin A (210ug), thiamine (0.55mg), riboflavin (0.85mg), 
niacin (5.0mg), folate (100ug), vitamin B6 (0.8mg), vitamin B12 (1.0ug), biotin (5.0ug), 
pantothenic acid (0.8mg), vitamin C (20mg), vitamin D (3.6ug), vitamin E (5.0mg), 
vitamin K (27ug), calcium (400mg), chromium (27ug), copper (0.3mg), iodine (60ug), 
iron (3.6mg), magnesium (0.7mg), manganese (0.7mg), molybdenum (34ug), 
phosphorus (420mg), selenium (9.0ug), zinc (3.6mg), potassium (660mg), chloride 
(370mg).  
 
2.3 Post-mortem and tissue collection  
 2.3.1 E5 cohort 
At 0900h on E5, dams were rapidly killed via guillotine prior to dissection of the uterine 
horns. Maternal blood was collected into a 50mL falcon tube, and transferred into 
heparin-coated or ethylenediaminetetraacetic acid (EDTA)-coated tubes. Maternal 
tissues including liver, adrenals, ovaries and uterine segments were weighed and 
taken either snap frozen in liquid nitrogen for molecular analyses, or fixed in 4% 
paraformaldehyde (PFA) for histology. Oviducts and uteri were flushed in Hepes-
KSOM media (Lawitts and Biggers, 1993), see Table 2.2, and embryos allocated to 
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either staining or culture procedures. All embryos were genotyped for sex as described 
below. 
 
Reagent 
MW 
(g/mol) C (mmol) C (g/L) 
NaCl 58.44 95 5.5518 
KCl 74.55 2.5 0.1863 
KH2PO4 136.09 0.35 0.0476 
MgSO4.7H2O 246.48 0.2 0.0493 
Glucose 180.16 0.2 0.036 
Penicillin G  
(1mg = 1670 IU) 356.37 
100 
IU/mL 0.0598 
Streptomycin 728.69 5mg/L 0.005 
Sodium Lactate  112.06 10 
1.12g solid = 1.87g of 
liquid 
NaHCO3 84.01 5 0.4201 
Sodium Pyruvate 110.4 0.2 0.0221 
CaCl2.2H20 147.02 1.7 0.2499 
EDTA 372.24 0.01 0.0037 
L-Glutamine 146.1 1 0.1461 
Hepes  238.3 20 4.766 
Table 2.2. Hepes-KSOM embryo flushing and culture media  
 
  
2.3.2 E6 and E7 cohorts 
Dams were sacrificed by guillotine with maternal blood and tissues collected as above 
(2.3.1). Left uterine implantation sites (IMS), and inter-implantation sites (IIS) were 
snap frozen in liquid nitrogen for molecular analyses, while IMS and IIS samples on 
the right uterine horn fixed in 4% PFA for histology.  
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Figure 2.1. Implantation sites of rat at E7. Panel A shows dissection of both left and 
right uterine horns with ovaries and oviducts dissected. Panel B shows magnified 
image of E7 IMS; implantation sites, and IIS; inter-implantation sites.  
 
 2.3.3 E11 and E13 cohorts 
Dams were sacrificed by guillotine with maternal blood and tissues collected as above 
(2.3.1). Implantation sites were dissected individually in 1x PBS made in 
diethylpyrocarbonate (DEPC)-treated water. Implantation sites 1-5 (counting from right 
ovary) had uterine tissue removed, embryos separated from extraembryonic tissues 
and all segments frozen for molecular analyses. The remaining implantation sites were 
dissected for the embryo, and with uterus attached were fixed in 4% PFA for histology. 
All implantation sites were genotyped for sex from extraembryonic tissue.  
 
2.3.4 E15 and E20 cohorts 
E15 and E20 dams were heavily anaesthetised with 50:50 ketamine:xylazil 
(0.1ml/100g body weight, Lyppard Australia Ltd, QLD, AUS) as previously described 
(Gardebjer, 2014). Fetal and placental weights were taken at post-mortem for E15 and 
E20 cohorts, and placentas were separated from the uterus/decidua, with the 
junctional zone and labyrinth and weighed separately. Placental measurements were 
also taken for length, width and depth using digital callipers (LCD Display Calliper 
Vernier Micrometer, Scientrific Pty. Ltd., Yamba, NSW, AUS). A subset of placentas 
A B 
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was snap frozen in liquid nitrogen prior to RNA extraction. Other placental samples 
were cut in half with uterus and decidua attached and fixed in 4% PFA prior to 
processing into paraffin for stereology. A subset of labyrinth samples taken from the 
midline of E15 and E20 placentas were cut into 1mm3 and fixed into 2.5% 
glutaraldehyde in 0.2M sodium cacodylate buffer until tissue processing for 
transmission electron microscopy (section 2.10.5). All cohorts collected fetal tissue for 
genotyping for sex as previously described (Gardebjer et al., 2014). Maternal blood 
was collected by cardiac puncture into heparinised or EDTA coated tubes.  
2.4 Trophoblast outgrowth assays 
A subset of flushed embryos at E5 were allocated to trophoblast outgrowth assays. 
Embryos were placed into preheated microdrops of trophoblast stem cell (TS) media 
(see Table 2.3 for composition) on tissue culture plates or gelatine coated coverslips 
and cultured in a humidifying chamber (Cook, Australia) at 37°C 5% CO2 / 5% O2 / 
90% N2 under paraffin oil. They were cultured for 6 days, with media changed every 2 
days, and imaged with an inverted phase contrast microscope (Leica).  Area occupied 
by outgrowths were traced in ImageJ using calibrated settings. A subset of outgrowths 
was allocated to staining procedures. The remaining were collected for RNA into 
TRIzol (Thermo Fisher Scientific).  
 
Reagent Quantity 
Conditioned medium 70% 
TS media (see below) 30% 
FGF4 1:1000 
Heparin 1:1000 
 
Table 2.3. Conditioned media. The conditioned medium is created by culture with 
TS media on embryonic fibroblast feeders, described by (Quinn et al., 2006). 
 
2.5 Culture of trophoblast stem cells 
Murine TS cells (RS26 and EGFP lines) were raised in 70% conditioned media in TS 
media (Table 2.3 and 2.4), supplemented with FGF4 and heparin to maintain 
pluripotency as described by Tanaka et al. (1998) Oda et al. (2006).  Cells were 
seeded at 5x104 (EGFP) and 1x104 (RS26), and differentiated in 0% (control), 0.2%, 
or 1% EtOH in TS media. To assess cell proliferation, cells were lifted off the culture 
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plates and counted using a hemocytometer on days 2, 4 and 6 of culture 
(N=3/treatment). Media was changed every 2 days including the addition of fresh 
EtOH. RNA was collected on day 6 (N=9/treatment, 3 technical replicates per set). 
Additional cultures on day 6 were collected fixed for staining procedures (see section 
2.10.3.3).  
 
Reagent Quantity 
RPMI-1640 192.5mL 
Penicillin / streptomycin 2.5mL 
B-mercaptoethanol 2.5mL 
Sodium pyruvate 2.5mL 
Fetal calf serum 50mL 
Total 250mL 
  
Table 2.4 Trophoblast stem cell media.  
 
2.6 Plasma analyses 
At post-mortem, maternal blood was centrifuged at 3500 rpm for 15 minutes at 4°C. 
Plasma was collected and stored at -80°C or -20°C for future analyses. 
2.6.1 COBAS Integra analyses 
Maternal plasma was analysed using the COBAS Integra 400 Plus for glucose, 
triglycerides, sodium and chloride concentrations in singular. 100-120ul of plasma 
samples were assayed.  
 2.6.2 Hormone analyses  
2.6.2.1 Estrogen 
Plasma estradiol-17beta concentrations were measured using a commercially 
available radioimmunoassay (DSL4800, Oestradiol RIA, Beckman Coulter) following 
the manufacturer’s instructions. Briefly all standards, samples, and the quality control 
were prepared by dilution in charcoal-stripped fetal bovine serum (CS-FCS; #312676, 
Gibco ThermoFisher Scientific), known to not exhibit any cross-reactivity within the 
assay. 200 µl of standards or diluted samples were combined with 100µl of primary 
antibody (rabbit anti-estradiol) and incubated for 1 hour at room temperature (RT). 
100µl of 125I-labelled estradiol tracer was then added and tubes further incubated for 
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2 hours RT.  1.0 ml of precipitating reagent (goat anti-rabbit gamma globulin in buffer 
with polyethylene glycol, sodium azide, and ProClin300) was added, before incubation 
for 20 mins RT, prior to centrifugation at 1500g for 20 mins. The supernatant was 
decanted by inversion and tubes drained before tubes were counted on a gamma 
counter (Perkin Elmer Wizard 2, model 2470) for 2 mins.  Assay analysis was 
performed using AssayZap software (Biosoft). Reported values were corrected for 
dilution in assay procedure (4x). The sensitivity of the assay was 1.0 pg/ml and the 
intra- and inter-assay coefficients of variation were 0.6% and 6.2% respectively for a 
quality control of 62.3 pg/ml. 
2.6.2.2 Progesterone 
Progesterone concentrations in hexane extracts of the plasma samples were 
measured by radioimmunoassay as described by Curlewis et al. (1985), with the 
modification of progesterone antiserum C-9817 (Bioquest). Briefly, 20µl of plasma 
sample was added to 2ml HPLC grade hexane and vortexed for 5 minutes.  The 
solution was then placed in an ethanol ice bath until aqueous fraction was frozen. The 
solvent extract was decanted into glass tubes and dried under a gentle stream of air 
using a heat block (45°C).  The extract was then reconstituted in 200µl of assay buffer 
(PB with 0.9% saline, and 0.1% gelatine).   
For the radioimmunoassay, 50µl of extracted sample, standard and quality control 
were combined with 100µl of primary antibody (sheep anti-progesterone-11alpha-
hemisuccinate, C9817 at 1:30000 dilution) and 100µl of labelled progesterone tracer 
(1,2,6,7-H3-progesterone) and incubated overnight at 4°C. For separation 500µl of 
dextran-activated charcoal (0.125% Norit-A charcoal with 0.0125% dextran in PBS 
without gelatine) was added to each tube and incubated on ice for 10mins, before 
centrifugation at 4°C centrifuge for 10min at 2500rpm. The supernatant was decanted 
into scintillation vials and 1.5ml of scintillant (IGRA-Safe Plus, Perkin Elmer) added, 
before vials were counted on a beta counter (Perkin Elmer Tri-Carb TR, model 3110) 
for 2 mins. Assay analysis was performed using AssayZap software (Biosoft). 
Reported values were corrected for dilution in assay procedure (10x). Extraction 
efficiency of spiked samples was 75% and the values reported herein were not 
corrected for these losses. The sensitivity of the assay was 0.1 ng/ml and the intra- 
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and inter-assay coefficients of variation were 8.1% and 7.9% respectively on a quality 
control of 2.7 ng/ml. 
2.7 Gene expression analyses 
 2.7.1 RNA extraction 
RNA extraction techniques differed with gestational age. Trophoblast outgrowths, E11 
and E13 samples were extracted using TRIzol (Thermo Fisher Scientific), while 
remaining E15 placenta samples utilised column extractions (Qiagen) with on column 
DNase digestion.  
Note: outgrowths utilised gDNA wipe-out in the reverse transcription Quantitek kit 
(Qiagen), while E11 and E13 samples underwent DNase digestion with RNA clean-up 
on Qiagen columns.  
 2.7.1.1 Column extractions 
RNA was extracted using the RNeasy Mini Kit protocol (Qiagen). 20-30mg samples 
were homogenised in 350μL lysate buffer (340 buffer RLT, 10ul B-mercaptoethanol) 
using a bead homogenizer (FastPrep-24 5G homogenizer, MP Biomedicals), and 
placed onto ice. Samples were centrifuged at 15000 rpm for 3 min. Supernatant was 
removed into a new tube without disturbing the pellet. An equal volume of RNase-free 
70% ethanol was added and mixed well before transfer into a spin column. Samples 
were centrifuged at full speed for 15s. Waste was discarded, and 250ul RW1 buffer 
was added before centrifugation at full speed for 15s. 80 ul DNase solution (10ul 
DNase1 + 70ul buffer RDD) was applied to the spin column membrane and incubated 
for 15 min. RW1 wash was repeated. A wash of 500 ul of buffer RPE buffer was 
performed twice. A new flow-through tube was used and centrifuged for 2 minutes. 
30μL RNase-free H2O was applied to the spin column with a new collection tube, and 
centrifuged for 1 minute. The purity of 1μL of each RNA sample was assessed using 
the NanoDrop ND1000 spectrophotometer (NanoDrop Technologies). Readings 
produced absorbance ratios comparing A260:A280nm wavelengths. Values between 
1.8 and 2.1 indicated pure RNA samples. Quantities of RNA greater than 500ng were 
used for complementary DNA (cDNA) synthesised and gene analysis. 
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 2.7.1.2 TRIzol 
As per manufacturers protocol, tissue was homogenised in 1mL of TRIzol (Thermo 
Fisher Scientific). 200ul chloroform was added and vortexed briefly before incubating 
2-3 minutes. Samples were centrifuged at 4°C 20000 x g for 15 minutes. The aqueous 
phase was removed into a separate tube. 500ul of isopropanol was added and 
vortexed. Samples were incubated for 10 minutes RT. Samples were centrifuged at 
4°C 20000 x g for 10 minutes to pellet RNA. Isopropanol was removed without 
disturbing the pellet, and subsequently washed with 1 mL 75% RNase-free EtOH. 
Samples were mixed gently prior to centrifugation at 4°C 7500 x g for 5 minutes. The 
pellet was airdried prior to resuspension in RNase-free H2O. For E11 and E13 
samples, RNA was passed through Qiagen spin columns and DNase procedures 
conducted as above in section 2.8.1.1.  
Note: Trophoblast outgrowths also had additional 1ul of GlycoBlue (Ambion) added in 
the isopropanol step and precipitated overnight at -80°C due to low abundance of RNA 
and for clear localisation of the RNA pellet. 
 
 2.7.2 RNA integrity 
To determine RNA integrity, 200ng of RNA was run on a 1% agarose gel made using 
RNase-free DEPC-treated H2O. RNA was run at 100V for 20 minutes in a tank of 0.5% 
TAE buffer in DEPC-treated H2O. 5ul of 1000kb+ DNA ladder (Invitrogen) was run with 
RNA samples.  
 
 
Figure 2.2. Gel electrophoresis of RNA samples to examine RNA integrity. The 
first lane contains a 1kb+ DNA ladder.  
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2.7.3 cDNA synthesis 
 2.7.3.1 Quantitek 
 
Trophoblast outgrowth RNA was reverse transcribed using Quantitek reverse 
transcriptase kit (Qiagen) as per manufacturers protocol. Briefly, 6ul RNA (due to low 
abundance) and 1ul 7x gDNA wipeout buffer were combined, incubated at 2 minutes 
at 42°C, and subsequently placed immediately on ice. A master mix of 0.5ul 
Quantiscript reverse transcriptase, 2ul Quantiscript 5x RT buffer and 0.5ul RT primer 
mix was added to total 10ul. Samples were incubated at 42°C for 15 minutes prior to 
inactivation of reverse transcriptase for 3 minutes at 95°C. Samples were placed 
immediately on ice prior to dilution to 200ng/ul with RNase-free H2O.  
 
 2.7.3.2 Biorad iScript 
1ug of total RNA was transcribed into cDNA as per protocol specified by iScript reverse 
transcription supermix (Bio-Rad Laboratories). 2uL per reaction of iScript reverse 
transcription supermix were added to 1ug RNA and nuclease-free water up to a total 
volume of 10uL. The above procedure was carried out on ice before being incubated 
in a thermal cycler. A StepOne Plus Real-Time PCR System (Applied Biosystems) 
was used for priming at 25°C for 5 minutes, reverse transcription for 30 minutes at 
42°C, and inactivation for 5 minutes at 85°C. cDNA was diluted 1:10 with RNase-free 
water. 
 
2.7.4 qPCR Quantification 
 2.7.4.1 TaqMan qPCR 
1uL (100-200ng) cDNA with 5ul TaqMan (Qiagen), 0.1ul TaqMan assay-on-demand 
primers (Thermofisher), and multiplexed with 18S (0.1ul). The remaining volume to 
10ul was made up with ultrapure water. Samples were run either in duplicate or 
triplicate. Genes were compared for multiplex (requiring 18S), and single-plex (no 18S) 
reactions before analysis. Additional housekeepers Rpl0 and Rpl13a (SYBR) were 
used to create a geometric mean with 18S. The 96-well plates were run in a 
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StepOneTM Real-Time PCR System (Applied Biosystems), for 1 hour. Primers and 
product codes are provided individually in Chapters 3-6.  
Results were used to calculate relative gene expression using the ΔΔCT method 
(Moritz et al., 2002). The difference between the cycle thresholds (CT) of the gene of 
interest and the housekeeping gene (18S) were calculated for each sample (ΔCT). The 
mean ΔCT for control (for cell culture experiments), or control males (for when 
analysing treatment with sex) was used to standardise against the other groups, by 
subtracting CT of each sample from ΔCT of the control (or control males), to generate 
the ΔΔCT. Relative expression was then calculated utilising Equation 1.  
Relative Gene Expression = 2 - ∆∆CT 
Equation 1. Relative gene expression calculation. Method uses ΔΔCT to calculate 
relative expression levels compared to the average of the control male group. 
 
2.7.4.2 SYBR qPCR 
SYBR reactions utilised 5ul SYBR green reagent (Qiagen) with 3ul H2O, 1ul of 4uM 
forward and reverse primers, and 1ul (100-200ng) cDNA. Samples were run in 
duplicate or triplicate. Samples utilised 3 housekeepers (18S, Rpl0, Rpl13a) as 
above. SYBR primers were purchased from commercially available predesigned 
primer pairs from KiCqStart SYBR Green (Sigma). Melt curves were assessed to 
ensure amplification of a single product. Primer efficiencies were calculated from 
amplification data “Delta Rn” and were plotted using the LinReg PCR program 
(version 11) (Ruijter et al., 2009).  
Gene Forward Primer Reverse Primer Primer 
Efficiency 
Prl7a2 GGGAGAATGTGGCCTCTGTA TTGAGCTTCGTCCAGGTTTT 2.062 
Prl7b1 GGGAGGACGTGGTCTCTGTA TTTGGTGATTTGAGTGGCAA 1.988 
Tpbpa AAGTTAGGCAACGAGCGAAA AGTGCAGGATCCCACTTGTC 2.023 
Prl3d1 
(Pl1) 
CTGCTGACATTAAGGGCA AACAAAGACCATGTGGGC 1.930 
Prl2c 
(Plf) 
TGTGTGCAATGAGGAATGGT TAGTGTGTGAGCCTGGCTTG 2.045 
Syna ATGGAGAAACCCCTTACGCT TAGGGGTCTTTGTGTCCCTG 2.099 
Ctsq TTCATTGGCCCAATACCCTA GAAAGCTCCCAGAATTCACA 1.972 
18S GTAACCCGTTGAACCCATT CCATCGAATCGGTAGTAGCG 1.976 
Table 2.5. SYBR primers (mouse) and primer efficiencies.  
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Gene Forward Primer Reverse Primer 
Primer 
Efficiency 
Rpl13a 
GCA CAA GAC CAA AAG 
AAG 
CGC TTT TTC TTG TCA TAG 
GG 2.033 
RplO 
GAG TGA CAT CGT CTT TAA 
ACC 
AAG CAT TTT GGG TAG TCA 
TC 2.023 
Prl3d1 
AGA CCT TAT ACA ACA GGA 
CTC 
ATG GCA AAA GAT GAG TGT C 
1.992 
Hand2  
CTC CAA AAT CAA GAC TCT 
GC  
CAT TCA GCT CTT TCT TCC TC  1.963 
Ncoa6  
AAA AGA TCT TCT CGA CCT 
G  
GTA TCA AGT CAT CTT CCT 
GC  1.989 
Usag1 
(Sostdc1) 
ACT GGA TCG AAA TAG 
TCG AG  
TCC AGT ACT TTG TTC CGT 
AG  1.945 
Vdup1 
(Txnip) 
CGT CAA TAC TCC TGA CTT 
AAT G  
AAA TGT CAT CAC CTT CAC 
AG  2.030 
Esr1  
ATA TGA TCA ACT GGG CAA 
AG  
CAT TTA CCT TGA TTC CTG 
TCC  2.021 
Pgr  
TCT AAT CCT GAA TGA GCA 
GAG  
GAC TTT CAT ACA GAG GAA 
CTC  2.018 
Fgf2 
AAA CTC GGA TCC AAA 
ACG  
TGT CTA AAG AGA GTC AGC 
TC  1.998 
Fgf9  
ACT ATA AAT GCT TCA TGC 
GG  
CAA TAA ATC AAG CAA GTG 
GC 1.960 
Igfbp-1 
AAA CTG AAA GTT GTT TCC 
TCC 
ATA CAA ACC CAC TTG TAC 
ATC 
1.969 
Cyp26a1 
CAA GCA GCG AAA GAA 
GGT GA  
CTT CAG CAA TCA CTG GCA 
CG  1.940 
Cnr1 (CB1) 
CAC CCA TGG CTG AGG 
GTT CC  
CCC ACG TAG AGG AGG TCT 
GT  1.985 
Klf5 
AAT CCA AAT TTA CCT GCC 
AC  
TGC AAC CAT CAT AAT CAC 
AG  1.909 
Ihh 
AAA GAC GAG GAG AAC 
ACC  
AAGATTCCTCTGAGTGATGG  
1.924 
Muc1 
CGG AAG TCA ATG TGA 
ATG AG  
CAA AAT ACA GAC CAG TAC 
CAG  1.955 
Table 2.6. SYBR primers (rat) and primer efficiencies.  
2.8 Genotyping for sex  
 2.8.1 Blastocyst and trophoblast outgrowths 
After staining procedures of the pre-implantation embryos or blastocyst outgrowths, 
they were removed mechanically from coverslips and digested overnight at 55°C in 
5ul of lysis buffer (50 mM KCl, 10 mM Tris-HCl pH 8.3, 2.5 mM, MgCl2.6H2O, 0.1 
mg/ml gelatin, 0.45% v/v Nonidet P40, 0.45% v/v Tween 20) with 1ul of 20mg/mL 
proteinase K. Proteinase K was then inactivated for 10 mins at 95°C. The total 6ul 
sample was used to amplify male determining gene Sry and B-Actin as a control. 
Amplification of both genes was carried out in the same reaction due to limited DNA 
content. Primers for Sry (317bp) and B-Actin (220bp) were derived from Miyajima et 
al. (2009) for use in the rat. Sry forward primer 5’-TACAGCCTGAGGACATATTA-3’, 
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reverse primer 5’-GCACTTTAACCCTTCGATGA-3’. B-Actin forward primer 5’-
AGCCATGTACGTAGCCATCC-3’, reverse primer 5’-
TGTGGTGGTGAAGCTGTAGC-3’. PCR conditions were 95°C for 2 mins, followed by 
35 cycles of 95°C for 1 min, 52°C for 1 min, 72°C for 1 min, and extension at 72°C for 
5 mins. A 2% gel ran for 35 mins at 100V to separate bands. Double bands 
represented male embryos and single bands represented female embryos. Samples 
with no bands were eliminated from analysis. Male and female controls were amplified 
from E20 fetal tail tissues. 
 2.8.2 E11 to E20 placental samples 
DNA from extraembryonic tissues was collected at post-mortem and extracted using 
QuickExtract (Epicentre) as per the manufacturers protocol. 50ul QuickExtract reagent 
with a small 1-2mm3 piece of embryonic tail or extraembryonic membranes was added 
and vortexed briefly. Extraction conditions were 65°C for 20 minutes and 95°C for 10 
minutes. Samples were stored at -20°C prior to analysis. A qPCR run was set up for 
Sry as per section 2.8.4.1 to detect gDNA. Cluster analysis showed E11 and E13 male 
samples of extraembryonic tissues grouped in cycles 20-25, while E15 and E20 
samples of fetal tail clustered from cycles 15-20. All other samples above these cycles 
were assumed to be female.  
 
2.9 Histology 
 2.9.1 Haematoxylin and eosin 
Slides were dewaxed in xylene for 3 x 2 min. Slides were rehydrated in 2 x 100% 
EtOH, and 1x 90% EtOH, 1x 70% EtOH for 2 min, and 1x dH2O for 2 min. Slides were 
incubated in Meyers haematoxylin for 2 mins prior to extensive washing in dH20. Slides 
were incubated in 1% alcoholic eosin for 15 mins. Slides were dehydrated in 95% 
EtOH, 2x 100% EtOH and 2x xylene washes prior to mounting in DPX mounting 
medium (Ajax Finechem). 
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2.9.2 Immunofluorescence for whole-mount pre-implantation embryos, 
trophoblast outgrowths and placenta cryo-sections 
Embryos were prepared for immunohistochemistry as previously described 
(Pantaleon et al., 2010). Briefly, embryos were fixed in 2% paraformaldehyde in 1x 
PBS for 20 minutes RT, washed in PBS, and immobilized on Cell-Tak (Collaborative 
Biomedical Products) coated coverslips. Embryos were permeabilised in 0.25% Triton 
in PBS and washed before blocking with 10% normal goat serum/BSA/Tween-20/PBS 
(PBT) for 1 h RT. Embryos were incubated in 1:50 anti-Mouse CDX2 (BiogenX, 
MU392A-UC) overnight at 4°C. Following, embryos were extensively washed in PBT 
prior to exposure of goat anti-mouse labelled secondary antibody Alexa 488 (1:1000, 
Molecular Probes) for 1 h RT. Embryos were counterstained with DAPI (Sigma Aldrich 
Inc, B2388) in PBS for 15 min and transferred through increasing concentrations of 
glycerol in PBS before mounting with Vectashield (Vector Labs, H-1000). Trophoblast 
outgrowths were treated above, incubating in anti-rabbit pan-cytokeratin (DAKO, 
Z0622) to distinguish cytoskeleton, goat anti-rabbit af568 secondary antibody, and 
DAPI (Sigma Aldrich Inc, B2388) to study number and ploidy of trophoblasts. 
Immunolocalization was carried out as above on E13 midline placental cryosections. 
Placental halves were embedded cut face down, and were cut at 10um, with every 
10th section stained with 1:200 anti-rabbit pan-cytokeratin (DAKO, Z0622) to 
distinguish invasive placental trophoblasts, and 1:100 anti-mouse alpha smooth 
muscle actin (ab7817, Abcam) to distinguish uterine spiral arteries. No invasion was 
seen in all sections regardless of treatment after section 6. Goat anti-rabbit af555 and 
goat anti-mouse af488 secondary antibodies were used. All slides were 
counterstained with DAPI (Sigma Aldrich Inc, B2388), prior to image analysis.  
 
2.9.3 In situ hybridisation and fluorescent in situ hybridisation (FISH)  
2.9.3.1 Construction of cRNA probes 
To construct ISH primers, firstly, gene sequences for the rat (Rattus norvegicus) were 
selected in the database Ensembl (Oxford). Primers were then designed with the 
program Primer3 (NIH) with specifications with oligo primer sequences between 18-
24nt, product size between 400-600bp long, melting temperature (Tm) of primers 
between 57-60°C, and % GC content between 42-62. Primers were then checked 
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using Primer-Blast (NCBI) for sequence homology. Once forward and reverse primer 
sequences were selected, T3 sequence (AATTAACCCTCACTAAAGGG) was added 
to the beginning of the forward primer, and the T7 sequence 
(TAATACGACTCACTATAGGG) was added to the beginning of the reverse primer. 
Primers were then manufactured by Sigma, see Table 2.5 for genes and respective 
sequences. Oligonucleotides were created using standard PCR and run on a 1% 
agarose gel to check product sizes. DNA was then extracted using a QIAquick Gel 
Extraction Kit (Qiagen), as per manufacturer’s instructions. Briefly, agarose gel 
containing DNA oligonucleotides were weighed and added 3x volume of buffer QG per 
100mg agarose and heated at 50°C for 10 minutes with samples vortexed every 2 min 
to aid dissolution. 1x volume of isopropanol was added and gently mixed before 
addition to a QIAquick spin column. Samples were centrifuged for 1 min RT at 
maximum speed and flow-through discarded. Washes then included 500ul buffer QG, 
and 750ul buffer PE. To elute DNA, 20ul buffer EB was added, and centrifuged. Single-
stranded DNA was quantified using the NanoDrop ND1000 spectrophotometer 
(NanoDrop Technologies). cRNA probes were then constructed using digoxigenin 
(DIG) labelling as per manufacturer’s instructions (Roche).  100-200ng DNA from PCR 
product was added to each reaction containing 2ul 10x transcription buffer (Roche), 
2ul DIG reaction mix (Roche), 2ul T7 or T3 RNA polymerase, and RNase free H2O to 
20ul. Reactions were incubated at 37°C for 2 hours prior to addition of 2ul 0.2M EDTA-
DEPC to stop reactions. 2.5ul 4M LiCl4 and 75ul 100% EtOH was added to precipitate 
cRNA, prior to centrifugation at maximum speed for 20 minutes at 4°C to form a pellet. 
cRNA was washed with 70% EtOH and centrifuged again prior to air drying pellet, and 
resuspension in 20ul RNase-free H2O. 1ul of cRNA was run on a 1% agarose gel 
made in DEPC H2O for 20 min at 100V to check RNA integrity. cRNA was stored at -
80°C prior to use.  
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Gene Direction Sequence (5’-3’) Product (bp) 
Mest 
Forward (T3) CTGCTCTGCACTCATGGAAG 
478 
Reverse (T7) CCGTCTTTGAGGAGCTTTTG 
Prf1 
Forward (T3) AGCCAGTGTCTCAAGCGAAT 
414 
Reverse (T7) CAGTCCTGGTTGGTGACCTT 
Prl8a2 (dPRP) 
Forward (T3) TGCATCAGTTCCTGCTTGTC 
871 
Reverse (T7) TTTCCCTGTTATGCGACACA 
Table 2.7 In situ hybridisation primers and product length. T3; 
AATTAACCCTCACTAAAGGG and T7; TAATACGACTCACTATAGGG sequences 
were added to the beginning of forward and reverse primers respectively. Note; Prl8a2 
is also known as decidual prolactin-related protein (dPRP).  
 
2.9.3.2 In situ hybridisation protocol for paraffin sections 
Day 1 procedures all utilised solutions made in RNase-free DEPC-treated milliQ water. 
Firstly, paraffin slides were dewaxed with xylene (2 x 10 minutes), and rehydrated in 
ethanol (2x 100% 10 minutes, and 5 minutes in 95%, 70% and 50% EtOH), and into 
1x PBS-DEPC for 5 minutes. Tissues were fixed in 4% PFA/1x PBS-DEPC for 20 
minutes prior to 2 1x PBS-DEPC washes. Slides were treated in proteinase K (30 
ug/ml) for 15 minutes prior to 1x PBS-DEPC wash and an additional 4% PFA/1x PBS-
DEPC fixation, both for 5 minutes each. Slides were incubated in acetylation buffer 
(acetic anhydride, 0.25%; Sigma) for 2x 5 minutes, with an additional 500ul acetic 
anhydride added in the second wash. Following 1x PBS-DEPC wash, slides were 
incubated in 1:2000 DIG or FITC-labelled probes in hybridisation buffer overnight at 
70°C in a humidified chamber of 1X salts (200 mM sodium choride, 13 mM tris, 5mM 
sodium phosphate monobasic, 5 mM sodium phosphate dibasic, 5 mM EDTA)/50% 
formamide. Hybridisation buffer contained 1× salts, 50% formamide, 10% dextran 
sulfate, 1 mg/ml yeast tRNA (Roche), 1× Denhardt's (1% w/v bovine serum albumin, 
1% w/v Ficoll, 1% w/v polyvinylpyrrolidone). 
Day 2 procedures began with 2 x post-hybridisation (1× saline-sodium citrate (SSC) 
buffer, 50% formamide, 0.1% tween-20) washes at 65°C for 30 minutes. Two washes 
of 1x MABT (150 mM sodium chloride, 100 mM maleic acid, 0.1% tween-20, pH7.5) 
at 30 minutes RT, 1x RNA wash (400 mM sodium chloride, 10 mM tris pH7.5, 5 mM 
EDTA, 20 ug/ml RNAse A) at 37°C for 10 minutes, 1x RNA wash with additional RNase 
A (10mg/ml) for 30 minutes at 37°C, 1x RNA wash for 5 minutes at 37°C and 1x MABT 
 93 
wash for 5 minutes RT. Slides were blocked for 1 hour in 1x MABT, 2% blocking 
reagent (Roche), 20% heat inactivated horse serum. Anti-DIG antibody was diluted 
1:2500 in blocking and incubated overnight in a humidified chamber at 4°C. 
Day 3 procedures were all conducted at RT and began with 4 washes in 1x MABT for 
15 minutes, 1 wash in NTMT buffer (100 mM NaCl, 50 mM MgCl, 100mM tris pH 9.5, 
0.1% tween-20) for 10 minutes, 1 wash in NTMT with 100mg of levamisole for 10 
minutes prior to application of colour reagent (4.5 ul/mL NBT, 2.5ul/mL BCIP in NTMT) 
as per manufactures instructions (Promega). Development of colour reactions was 
conducted in a light protected box. Upon development of appropriate colour, slides 
were incubated in 1x PBS prior to counterstaining in nuclear fast red for 2 minutes, 
dehydrating through ethanol (2 minutes in 50%, 70% 90%, 2x 100%) and xylene (2x 
2 minutes) washes, and mounting in Dibutylphthalate Polystyrene Xylene (DPX) 
mounting medium (Ajax Finechem).  
 
2.9.3.3 Modifications for fluorescent in situ hybridisation for paraffin and 
cultured cells 
Fluorescent in situ hybridisation (FISH) was used in paraffin and cell cultures as 
described by (Simmons et al., 2007). Fluorescein or DIG-labelled probes were made 
following manufacturer’s instructions (Roche) as described previously (Simmons et al., 
2007, 2008b). In brief, cells were fixed in 4% PFA for 15 min and transferred to 0.4% 
PFA until analysis. Cells were not treated with proteinase K, but were acetylated for 5 
minutes prior to administration of FITC- or DIG-labelled probes at 1:200 which were 
hybridised overnight at 65°C. The following day, cells were washed in 5xSSC pre-
warmed to 65°C for 3 x 20 min, followed by TN buffer (100mM Tris-HCl ph7.5, 150mM 
NaCl) for 5 mins prior to incubation in block consisting of 1× MABT (150 mM NaCl, 
100 mM maleic acid, 0.1% Tween-20, pH 7.5), 2% blocking reagent (Roche), and 20% 
heat inactivated horse serum for 1h. Samples were incubated in anti-DIG-POD or anti-
FITC-POD antibody (1:500, Roche) overnight. The following day, cells were washed 
in TNT buffer containing 0.05% Tween20 in TN buffer for 3 x 15 min prior to probe 
detection with 1:50 FITC- or Cy5-Tyramide in amplification reagent (TSA kit, Perkin 
Elmer) for 10 min. Samples were washed in TNT buffer for 3 x 5 min and 
counterstained with DAPI (Sigma Aldrich Inc, B2388). Coverslips were mounted in 
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70% glycerol prior to imaging. Prior to use on cultured cells, probes were tested on 
either E12.5 or E14.5 mouse placentas fixed in 4% PFA overnight to confirm subtype-
specific expression.  
 
 
2.9.4 Lectin histochemistry 
Paraffin slides were dewaxed and rehydrated as in ISH day 1 procedures (see section 
2.10.3.2), and placed into dH2O. Slides underwent antigen retrieval in sodium citrate 
buffer (10mM sodium citrate, 0.05% Tween 20, pH 6.0) was performed for 1.5 hours 
using a pressure cooker. Tissue was blocked for endogenous peroxides using 0.9% 
H2O2 in dH2O for 10 minutes. Slides were incubated in 0.1% triton with 0.1mM ions 
(MgCl2, CaCl2, MnCl2) for 10 minutes, prior to incubation of 1:200 IsolectinB4 
(conjugated, Sigma, L5391, derived from Bandeiraea simplicifolia) in 1x PBS for 2h 
RT. A 1x PBS wash for 5 minutes followed prior to colour development with NovaRED 
peroxidase (Vector Labs, SK-4800). Slides were counterstained with haematoxylin for 
2 minutes, and were dehydrated and mounted as per section 2.10.3.2.  
2.9.5 Immunohistochemistry  
Paraffin slides were dewaxed and rehydrated as in ISH day 1 procedures (see section 
2.10.3.2), and placed into dH2O. Slides underwent antigen retrieval in sodium citrate 
buffer (10mM sodium citrate, 0.05% Tween 20, pH 6.0) was performed for 2 hours 
using a pressure cooker. Slides were washed 3 times in 1x PBS for 5 minutes. Tissue 
was blocked for endogenous peroxides using 0.9% H2O2 in dH2O for 10 minutes. 
Slides were washed 3 times in 1x PBS for 5 minutes. Slides were blocked in 10% 
normal goat serum/BSA/Tween-20/PBS (PBT) for 1 h RT. E7 samples were incubated 
1:200 anti-rabbit vimentin (Thermofisher, PA5-27231) at 4°C overnight. The following 
day, slides were washed 3 times in 1x PBS for 5 minutes. Slides were incubated in 
1:200 biotinylated anti-rabbit secondary antibody (Vector laboratories, PK-6101) for 
1h at 37°C. Slides were washed 3 times in 1x PBS for 5 minutes. Slides were 
incubated in Avidin-Biotin complex (Vector laboratories, PK6100) for 1h at 37°C. 
Slides were washed 3 times in 1x PBS for 5 minutes prior to chromogen development 
utilised ImmPACT NovaRED Peroxidase Substrate (Vector Laboratories, SK-4805) as 
per manufacturers protocol.  
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2.9.6 Transmission electron microscopy 
Labyrinth samples from E15 and E20 placentas were cut into 1mm3 and fixed into 
2.5% glutaraldehyde in 0.2M sodium cacodylate buffer until tissue processing. All 
samples were washed in 0.1M sodium cacodylate buffer at 250W and fixed further in 
1% osmium tetroxide in cacodylate buffer at 80W under vacuum in a Biowave (Pelco). 
Samples were rinsed with water at 250W prior to counterstaining in 2% uranyl 
acetate(aq) at 150W under vacuum to enhance contrast. Samples were dehydrated in 
ethanol series (30%, 50%, 70%, 90%, 100%, 100%) at 250W and were infiltrated in 
increasing series of epon resin (1:3, 1:1, 3:1, 100%, 100%) under vacuum. Resin was 
polymerised for 48h at 60°C. Thick sections were cut at 500nm and stained with 
Toluidine blue to confirm localisation of the labyrinth. Thin sections of 100nm were 
post-stained with lead citrate prior to visualisation with an electron microscope (Jeol 
JEM-101). Two blocks per labyrinth samples were used to gather a minimum of 6 IHMs 
of which were averaged per block. See Chapter 3 Figure 3.5 for images.   
2.10 Imaging parameters and analysis 
 2.10.1 Blastocysts 
Embryos and outgrowths were visualised using an inverted microscope (Leica, DMi8). 
Pre-implantation embryos utilised a 40x air objective and captured in z stacks of 40. 
Excitation filters of 488nm (green), and 405nm (blue) fluorescence were imaged 
separately. CDX2 immunoreactivity (green) was localised to the TE of the E5 
blastocyst. Cells devoid of CDX2 staining were assumed to be ICM. TE and ICM cells 
were counted individually using Image J (NIH). ICM proportion was calculated with 
Equation 2. 
ICM (%) = (number of ICM cells/ number of total cells) x 100. 
Equation 2. Quantification of the percentage of inner cell mass cells to total cells 
of the E5 blastocyst. ICM; inner cell mass.  
2.10.2 Determination of CDX2 TE nuclear fluorescence 
Nuclear fluorescent of CDX2 was determined using the imaging processing tool Imaris 
(version 7.7.2, Bitplane). Firstly, a surface (or mask) was created around the DAPI 
channel, creating a 3D object around the nucleus (see Figure 2.3 below). Surface area 
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detail was 0.568 (absolute intensity), and a threshold of 20.1 was use. To segregate 
adjoining nuclei, a seed point diameter of 5um was utilised. Additional manual 
processing was also used in cases in which some adjoining nuclei were not separated. 
CDX2 fluorescence intensity was then measured within these nuclei, with all nuclear 
fluorescence summed to create final counts.  
 
 
Figure 2.3. Computer generated surface of DAPI channel enclosing cell nuclei 
using Imaris.  
  
2.10.3 Trophoblast outgrowths 
Outgrowths were imaged using an inverted microscope (Leica, DMi8) at 20x in z-
stacks of 10 in a tile scan. Excitation filters 561nm (red) and 405 (blue) were imaged 
separately. For trophoblast outgrowths, Z-stacks of the DAPI channel were 
compressed using the average intensity for manual cell counts and ploidy analysis 
using ImageJ, see section 2.11.4. ICMs - indicated by negative staining of pan-
cytokeratin, were edited out using Photoshop. Trophoblasts were considered if nuclear 
size exceeded 200um2, and those above 1000um2 were considered P-TGCs.  
 
2.10.4 Determination of nuclear DNA content of trophoblasts 
For trophoblast outgrowths, Z-stacks of the DAPI channel were compressed using the 
average intensity for ploidy analysis using ImageJ. Smallest trophoblasts with positive 
staining for pan-cytokeratin had nuclear sizes exceeding 200um2. ICM cells (2N) were 
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found to be less than 200um2 in size. Nuclear sizes above 1000um2 were considered 
P-TGCs. DNA content, a surrogate marker of ploidy, was quantified from fluorescent 
intensity of DAPI, localising the nucleus. DNA content of all trophoblasts and P-TGCs 
were normalised to ICM cells of the same image to obtain relative ploidy to 2N. 
 
 2.10.5 Quantification of trophoblast invasion at mid-gestation  
Placental cryo-sections were imaged on an upright fluorescence microscope (BX61 
Olympus) using DAPI, GFP and Cy3 filters at 4x and 10x magnification using set 
parameters.  Placentas were measured for distance of trophoblast invasion from the 
P-TGC layer (identified by large polyploid nuclei), to most distant pancytokeratin 
positive SpA-TGC.  
 
 
Figure 2.4. Immunofluorescent image of E13 placenta to examine trophoblast 
invasion and spiral artery remodelling. Pan-cytokeratin (red) marks invading 
trophoblasts, alpha smooth muscle actin (green) and counterstained with DAPI (blue). 
White arrows show spiral arteries, yellow double-edged arrow shows distance of 
invasion from P-TGC layer, and red arrow shows invaded SpA-TGC cells. The dashed 
white line shows the barrier between placental decidua and the uterus. Images were 
captured at either 4x or 10x magnification.  
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2.10.6 Quantification of FISH positive cells in culture 
Cells were counted using ImageJ (NIH). Z stacks were compressed with the maximum 
projections for DAPI and merged (DAPI and FISH marker). The greyscale DAPI image 
was converted to 8 bit, underwent watershed to separate adjoining nuclei, and counted 
with the automated “Analyse Particles” function. FISH positive cells were counted 
manually from merged images using “Cell Counter”. 
 
2.11 Stereology of placental and maternal tissues  
2.11.1 Stromal and decidual volume at E7 
E7 implantation sites were serially sectioned at 5um and collected. Sections were 
identified for midline invasion of the embryo. 5-10 equally spaced sections 1:10 were 
selected and underwent ISH for Prl8a2, to detect the primary decidual zone of the 
uterus (Dai et al., 2002), or immunohistochemistry for vimentin to localise uterine 
stroma in the rat (Glasser and Julian, 1986, Korgun et al., 2007), see Figure 2.5. A 
grid was superimposed over each section using ImageJ (NIH) and counted for Prl8a2 
positive grid area. Total volume was estimated using the Cavalieri principle displayed 
in Equation 3.  
Volume = Σ Pcompartment * a(p) * T 
Equation 3. Total volume estimation. This equation sums (Σ) the number of points 
within each section (Pcompartment), and multiplies this by the area of points or grid size 
(ap), and the thickness (T); being the cutting thickness multiplied by the sampling 
fraction. 
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Figure 2.5. Uterine histochemical markers of E7 implantation site. A; 
Immunohistochemistry for vimentin marking all uterine stromal cells. B; Prl8a2 ISH for 
primary decidual cells (anti-senseT7). C; negative staining of vimentin. D; sense probe 
staining for Prl8a2 (T3). 
 
2.11.2 Quantification of decidual natural killer cells 
In situ hybridisation for the marker Prf1 was carried out on the E11 placenta. Similarly, 
for quantification of maternal decidua in section 2.12.1, E11 samples were quantified 
from 5 sections taken at 1:50. Using ImageJ (NIH), images were split into separate 
channels, with the red channel converted to black and white for counting with the 
“Analyse Particles” function. All samples were sections at 5um in paraffin, and utilised 
the same Equation 3 (section 2.13.1) for estimation of total number.  
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Figure 2.6. Prf1 ISH for infiltrating maternal decidual natural killer cells (dNK) at 
E11 and E15 implantation sites. A (E11) and B (E15) show positive staining of Prf1 
with anti-sense probe (T7). C shows sense probe staining (T3). 
 
 
 2.11.3 Estimation of placental volumes 
Placental halves were sectioned exhaustively at 5um for the collection of 5 equally 
spaced sections, for E13 – 1:50, E15 – 1:100, and E20 – 1:150. Unbiased stereology 
for placental volumes was carried out using the Cavalieri principle, as described by 
Coan et al. (2004) using ImageJ (NIH). To identify structures within the placenta, E13 
samples were stained with haematoxylin and eosin (as per section 2.10.1) to localise 
the nucleated fetal blood cells at E13, E15 placentas underwent in situ hybridisation 
for the fetal endothelial cell marker Mest (as per section 2.10.3.1-2), and E20 
placentas were stained with the endothelial marker Isolectin B4 (as per section 2.10.4), 
also localising cells of the fetal blood space. See Chapter 3 - Figure 3.4, for 
representative images of each marker. Volumes of total placenta, labyrinth, junctional 
zone, and decidua were carried out at each age at low magnification (2x) along with 
FBS and MBS at high (40x) magnification within the labyrinth. Volume analyses also 
used Equation 3 in section 2.13.1, and doubled due to quantification of half the 
placenta. FBS and MBS were quantified in 3 small windows of the labyrinth, averaged, 
and multiplied by fractional volume for the whole labyrinthine zone. Surface areas of 
FBS capillaries and MBS spaces using randomly offset cycloid arcs as described by 
Baddeley (1986), and for use in the placenta by Coan et al. (2004). Estimation of these 
surface areas used Equation 4 (below).   
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Sv = 2* Σ Icap/( l(p) *) Σ Plab* Vlab 
Equation 4. Estimation of surface areas of fetal capillaries and maternal blood 
spaces. To determine surface area of vessels (Sv), the equation sums the number of 
intersections between cycloid arcs and the fetal capillary endothelium (Σ Icap) and 
divides this by the length of the test line l(p) and the sum of test points marking the 
labyrinth Σ Plab. This is finally multiplied by the total volume of the labyrinth (Vlab).  
 
2.12 Statistical analyses 
For embryo studies in Chapter 3 analysing differences between males and females, 
statistically significant differences (*P<0.05; **P<0.01) were analysed using student’s 
t tests. When student’s t tests showed unequal variances, Mann-Whitney’s non-
parametric tests were used. For embryo studies in Chapter 5 analysing treatment (PC-
EtOH, liquid diet control, and in some cases chow control) with sex, two-way ANOVA 
with Tukey’s multiple comparison tests were used. To analyse changing outgrowth 
area over time, repeated measures were additionally used. In cases in which 
numerous animals were utilised from one litter, litter averages were calculated. Cell 
culture experiments in Chapter 4 which analysed treatments of control, 0.2% and 1% 
EtOH were analysed by one-way ANOVA, with each treatment containing a mean of 
at least 3 replicates. For gene expression assays, mean relative expression of 
treatments were standardised to either the control group (in cell culture experiments), 
the control male group (if analysing treatment with sex), or liquid diet control (for 
maternal physiology experiments), with all data displayed as mean ± standard error of 
the mean. All graphs and statistics were performed using GraphPad Prism 6 software 
(GraphPad Software, Inc., San Diego, CA).  
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Chapter 3. Sex differences in rat placental development: from pre-
implantation to late-gestation  
 
Kalisch-Smith, J.I., Simmons, D.G., Pantaleon, M., Moritz, K.M. Sex differences in 
rat placental development: from pre-implantation to late-gestation. Accepted to 
Journal of Biology of Sex Differences, May 2017.  
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3.1 Abstract  
Background: A male fetus is suggested to be more susceptible to in utero and birth 
complications. This may be due in part to altered morphology or function of the XY 
placenta. We hypothesised that sexual dimorphism begins at the blastocyst stage with 
sex differences in the progenitor trophectoderm (TE) and its derived trophoblast 
lineages, as these cells populate the majority of cell types within the placenta. We 
investigated sex specific differences in cell allocation in the pre-implantation embryo, 
and further characterised growth and gene expression of the placental compartments 
from the early stages of the definitive placenta through to late gestation. Methods: 
Naturally mated Sprague Dawley dams were used to collect blastocysts at embryonic 
day (E) 5 to characterise cell allocation; total, TE and inner cell mass (ICM), and 
differentiation to downstream trophoblast cell types. Placental tissues were collected 
at E13, E15, and E20 to characterise volumes of placental compartments, and sex-
specific gene expression profiles. Results: Pre-implantation embryos showed no sex 
differences in cell allocation (total, TE, ICM), or early trophoblast differentiation, 
assessed by outgrowth area, number and ploidy of trophoblasts and P-TGCs, and 
expression of markers of trophoblast stem cell state or differentiation. Whilst no 
changes in placental structures were found in the immature E13 placenta, the 
definitive E15 placenta from female fetuses had reduced labyrinthine volume, fetal and 
maternal blood space volume, as well as fetal blood space surface area, when 
compared to placentas from males. No differences between the sexes in labyrinth 
trophoblast volume or interhaemal membrane thickness were found. By E20 these 
sex-specific placental differences were no longer present, but female fetuses weighed 
less than their male counterparts. Coupled with expression profiles from E13 and E15 
placental samples may suggest a developmental delay in placental differentiation.  
Conclusions: Although there were no overt differences in blastocyst cell number or 
early placental development, reduced growth of the female labyrinth in mid gestation 
is likely to contribute to lower fetal weight in females at E20. These data suggest sex 
differences in fetal growth trajectories are due at least in part, to differences in placenta 
growth.   
Keywords: Blastocyst, Trophectoderm, Placenta, Trophoblast, Sexual Dimorphism, 
Differentiation, DOHaD. 
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3.2 Introduction  
Exposure of the fetus to a sub-optimal in utero environment such as poor maternal 
nutrition, stress or hypoxia can alter its development, potentially in a sexually 
dimorphic manner (Kalisch-Smith et al., 2016). Male fetuses are often reported to be 
at greater risk of preterm birth, neonatal complications and prenatal mortality (Peacock 
et al., 2012, Walker et al., 2012). For this reason, it is commonly viewed that males 
are more susceptible to developmental perturbations than females (Clifton, 2010). 
Critical to normal growth and viability of the fetus, is adequate development of the 
mature chorioallantoic placenta. Males often exhibit larger placental growth (weight) 
than females in uncomplicated human pregnancies at term (Eriksson et al., 2010). 
This is thought to help facilitate the greater growth trajectory of the male fetus. Sexual 
dimorphism in placental development is most often examined following prenatal 
stressors (O’Connell et al., 2013b, Cuffe et al., 2014a), but inherent differences have 
rarely been investigated. Study of the placenta is normally restricted to analysis at late 
gestation or term. Interestingly, sex specific changes have been observed in the late 
gestation placenta of the rat in a model of alcohol exposure which only occurred during 
the periconception, prior to implantation (Gardebjer et al., 2014).  The question then 
arises to when does sexual dimorphism in growth of the placenta emerge, and can it 
be traced back to the pre-implantation embryo?  
The placenta and its associated trophoblast subtypes derive from the trophectoderm 
(TE) of the pre-implantation embryo. In the rodent, a subset of cells from the TE 
differentiate into invasive trophoblast giant cells, which migrate into the maternal 
uterine compartment, while the remaining TE cells form later in gestation to populate 
either the labyrinth or junctional zone compartments (Cross et al., 1994, Simmons and 
Cross, 2005). The labyrinth contains fetal and maternal vasculature for the two-way 
exchange of nutrients and waste products, while the junctional zone is thought to have 
a primary endocrine role (Coan et al., 2004). Placentas from males and females can 
alter their growth in a sex-specific and zone-specific manner when confronted with 
maternal perturbations in different critical windows, which can lead to sex-specific 
alterations in fetal viability, recently reviewed by us in Kalisch-Smith et al., (2016).  
Investigations of sex differences in the early embryo have been largely restricted to 
analysis of in vitro models which use superovulation to generate large numbers of 
embryos. Both hormone induced ovulation and in vitro culture techniques are 
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implicated in causing stress to the early embryo, influencing its development 
(Giritharan et al., 2012, de Waal et al., 2012) and therefore may be potential 
confounders for the determination of basal sex differences. Current analysis in vitro, 
suggests male mouse (Tsunoda et al., 1985, Burgoyne, 1993, Valdivia et al., 1993, 
Peippo and Bredbacka, 1995 Perez-Crespo et al., 2005), and bovine (Avery et al., 
1992, Xu et al., 1992, Ghys et al., 2015) embryos develop to the blastocyst stage at a 
faster rate than female embryos. Quantification of cell number in vitro supports this 
outcome, with males displaying increased total, TE or ICM count (Ghys et al., 2015, 
Tan et al., 2016b, Dumoulin et al., 2005). However, there is conflicting evidence in 
human (Dumoulin et al., 2005, Richter et al., 2006, Weston et al., 2009), bovine (Holm 
et al., 1998, Rizos et al., 2008, Bermejo-Alvarez et al., 2010a, porcine (Kaminski et 
al., 1996, Lechniak et al., 2000), and in vivo derived mouse model (Peippo and 
Bredbacka, 1995), which rather show equal developmental rates between the sexes. 
Indeed, culture in vitro has been shown to increase cell death in the early embryo, and 
therefore, may suggest that the reported sex differences are not in embryonic growth, 
but in differential survival from an artefact of culture. Sexual dimorphism is also 
suggested to exist in blastocyst physiology. Metabolic rate (Tiffin et al., 1991) and 
stress responses (Perez-Crespo et al., 2005) are suggested to be heightened in 
males, while females seem to more susceptible to cell death (Ghys et al., 2015, Tan 
et al., 2016b). Expression profiles of bovine male and female blastocysts show sexual 
dimorphism of both X-linked and autosomal genes (Bermejo-Alvarez et al., 2008, 
2010b), whilst sexual dimorphism has also been shown in expression profiles as early 
as the 8-cell stage in the mouse (Lowe et al., 2015).  
In this study, we use naturally cycling rat dams (without superovulation) to characterise 
sex differences in the pre-implantation embryo, through to trophoblast differentiation, 
and the formation of the placental architecture. This allowed us to examine inherent 
sex differences without prenatal stressors and highlights the importance of 
appropriately derived animals to investigate these outcomes. We hypothesised 
inherent sex differences exist in the blastocyst stage with differences in the progenitor 
trophectoderm (TE) and its derived trophoblast lineages which result in sex differences 
in growth of the definitive placenta.   
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3.3 Methods  
3.3.1 Ethics 
All animal experiments and procedures were approved by The University of 
Queensland Animal Ethics Committee (AEC approval number SBS/022/12/NHMRC) 
prior to commencement of this study.  
 
3.3.2 Animal treatment, embryo collection and culture 
Dam weight was at least 230g before entering the protocol. Sprague Dawley dams 
were maintained on standard laboratory chow. In addition, tissues (blastocysts and 
placentas) were available from dams fed either chow or a control liquid diet used 
previously as a control for ethanol fed dams (Gardebjer et al., 2014, 2015). Analysis 
of cell counts showed no differences between diet groups (data not shown). Dams 
were time-mated over a 5-hour window from 1200h to 1700h. The following day was 
considered E1. At 0900h on E5, a subset of dams (N = 17) were rapidly killed via 
guillotine prior to dissection of the uterine horns. Oviducts and uteri were flushed in 
Hepes-KSOM media (Lawitts and Biggers, 1993) and embryos allocated to either 
staining or culture procedures.  
 
3.3.3 Staining procedures for pre-implantation embryos 
Embryos were prepared for immunohistochemistry as previously described 
(Pantaleon et al., 2010). Briefly, embryos were fixed in 2% paraformaldehyde in 1x 
PBS for 20 minutes at room temperature (RT), washed in PBS, and immobilized on 
Cell-Tak (Collaborative Biomedical Products) coated coverslips. Embryos were 
permeabilised in 0.25% Triton in PBS and washed before blocking with 10% normal 
goat serum/BSA/Tween-20/PBS (PBT) for 1 h RT. Embryos were incubated in 1:50 
anti-Mouse CDX2 (BiogenX, MU392A-UC) overnight at 4°C. Following, embryos were 
extensively washed in PBT prior to exposure to goat anti-mouse secondary antibody 
labelled with Alexa 488 (1:1000, Molecular Probes) for 1 h RT. Embryos were 
counterstained with DAPI (Sigma Aldrich Inc, B2388) in PBS for 15 min and 
transferred through increasing concentrations of glycerol in PBS before mounting with 
Vectashield (Vector Labs, H-1000).  
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3.3.4 Blastocyst outgrowth assays 
E5 embryos were placed into preheated microdrops of trophoblast stem cell (TS) 
media on tissue culture plates or gelatine coated coverslips and cultured in a 
humidifying chamber (Cook, Australia) at 37°C 5% CO2 / 5% O2 / 90% N2 under 
paraffin oil. They were cultured for 6 days, with media changed every 2 days, and 
imaged with an inverted phase contrast microscope (Leica).  Areas occupied by 
outgrowths were traced in ImageJ using calibrated settings. A subset of outgrowths 
was immunolabelled as described for staining procedures above with anti-rabbit pan-
cytokeratin (DAKO, Z0622) to distinguish cytoskeleton, goat anti-rabbit Alexa 568 
secondary antibody, and DAPI (Sigma Aldrich Inc, B2388) to assess number and 
ploidy of trophoblast nuclei. The remaining outgrowths were collected and extracted 
for DNA and RNA with Trizol (Life Technologies), and cDNA synthesis from Quantitek 
reverse transcription kit (Qiagen) using as per manufacturer’s protocol.  
 
3.3.5 Confocal microscopy, image analysis and quantification  
Embryos and outgrowths were visualised using an inverted microscope (Leica, DMi8). 
Pre-implantation embryos utilised a 40x air objective and captured in z stacks of 40, 
while outgrowths were imaged at 20x in z-stacks of 10 using a tile scan. Excitation 
filters of 488nm (green), 561nm (red) and 405nm (blue) fluorescence were imaged 
separately. CDX2 immunoreactivity (green) was localised to the TE of the E5 
blastocyst. Cells devoid of CDX2 immunoreactivity were assumed to be ICM. TE and 
ICM cells were counted individually using Image J (NIH). ICM proportion was 
calculated as: ICM (%) = (Number of ICM cells/ Number of total cells) x 100.  
For trophoblast outgrowths, Z-stacks of the DAPI channel were compressed using the 
average intensity for manual cell counts and ploidy analysis using ImageJ. Smallest 
trophoblasts with positive staining for pan-cytokeratin had nuclear sizes exceeding 
200um2. ICM cells (2N) were found to be less than 200um2 in size. Nuclear sizes 
above 1000um2 were considered P-TGCs. DNA content, a surrogate marker of ploidy, 
was quantified from fluorescent intensity of nuclear DAPI. DNA content of all 
trophoblasts and P-TGCs were normalised to ICM cells of the same image to obtain 
relative ploidy to 2N. 
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3.3.6 Genotyping for sex of pre-implantation embryos and blastocyst 
outgrowths 
After analysis, the pre-implantation embryos and blastocyst outgrowths were removed 
mechanically from coverslips and digested overnight at 55°C in 5ul of lysis buffer 
(50mM KCl, 10mM Tris-HCl pH 8.3, 2.5mM MgCl2.6H2O, 0.1mg/ml gelatin, 0.45% v/v 
Nonidet P40, 0.45% v/v Tween 20) with 1ul of 20mg/mL proteinase K. Proteinase K 
was then inactivated for 10 mins at 95°C. The total 6ul sample was used to amplify 
male determining gene Sry and B-Actin as a control. Amplification of both genes was 
carried out in the same reaction due to limited DNA content. Primers for Sry (317bp) 
and B-Actin (220bp) were derived from Miyajima et al. (2009), for use in the rat (see 
table below for primer sequences and PCR conditions). A 2% agarose gel was run for 
35 mins at 100V to separate the bands. Double bands indicated male embryos and 
single bands represented female embryos. A number of samples (~10%) failed to 
result in clear bands and were eliminated from analysis.  
 
Gene Direction Sequence (5’-3’) Product (bp) 
Sry 
Forward  TACAGCCTGAGGACATATTA 
317bp 
Reverse  GCACTTTAACCCTTCGATGA 
B-actin 
Forward AGCCATGTA CGTAGCCATCC 
220bp 
Reverse TGTGGTGGTGAAGCTGTAGC 
Primer pair sequences for genotyping for sex. PCR conditions were 95°C for 2 
mins, followed by 35 cycles of 95°C for 1 min, 52°C for 1 min, 72°C for 1 min, and 
extension at 72°C for 5 mins. 
 
3.3.7 Collection of placental tissues at mid- and late-gestation 
A subset of dams was maintained for collection of fetal and placental tissues at E13 
(4 litters), E15 (9 litters) and E20 (14 litters). For E13, dams were sacrificed by 
guillotine as above. E15 and E20 dams were heavily anaesthetised with 50:50 
ketamine: xylazil as previously described (Gardebjer et al., 2014). Fetal and placental 
weights were taken at post-mortem for E15 and E20 cohorts, and placentas were 
separated from the uterus, with the junctional zone and labyrinth and weighed 
separately. In addition, a ratio of placental weight to body weight was calculated to 
estimate placental efficiency. A subset of placentas was snap frozen in liquid nitrogen 
prior to RNA extraction. Other placental samples were cut in half with uterus and 
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decidua attached and fixed in 4% paraformaldehyde prior to processing into paraffin 
for stereology. It was assumed that tissue shrinkage was even between groups. A 
subset of labyrinth samples from E15 and E20 placentas were cut into 1mm3 and fixed 
into 2.5% glutaraldehyde in 0.2M sodium cacodylate buffer until tissue processing for 
transmission electron microscopy. Fetal tissue for genotyping for sex was collected as 
previously described (Gardebjer et al., 2014).  
3.3.8 Stereology for placental volumes 
Placental halves were sectioned exhaustively at 5um for the collection of 5 equally 
spaced sections. Unbiased stereology for placental volumes and surface areas was 
carried out as described by Coan et al. (2004). To clearly localise fetal blood spaces 
within the labyrinth at each individual age, different histological procedures were used. 
At E13, nucleated fetal blood cells were easy to distinguish with haematoxylin and 
eosin staining, while this was not appropriate at either E15 or E20. At E15 the in situ 
hybridisation marker Mest clearly identified the fetal endothelial cells (see table below 
for primer sequences) (Simmons et al., 2008b), while at E20, the endothelial marker 
Isolectin B4 (Sigma Aldrich, L5391) was used as per manufacturer’s instructions. 
Neither of these markers were appropriate at other ages. By doing so, all 
compartments of the placenta (decidua, junctional zone, labyrinth) and the fetal (FBS) 
and maternal blood spaces (MBS) were quantified. One or two placentas of each sex 
from each litter were used for analysis. For volume analyses, we utilised 7 males and 
6 females at E13 (4 litters), 9 males and 8 females from 6 litters at E15, and 12 males 
and 11 females from 6 litters at E20. 
Gene Direction Sequence (5’-3’) Product (bp) 
Mest 
Forward (T3) CTGCTCTGCACTCATGGAAG 
478 
Reverse (T7) CCGTCTTTGAGGAGCTTTTG 
Primer pair sequences for In Situ Hybridisation (ISH) probe synthesis. Forward 
primers included the addition of T3 - AATTAACCCTCACTAAAGGG to the 5’ end, and 
likewise for T7 – TAATACGACTCACTATAGGG.  
3.3.9 Transmission electron microscopy 
Labyrinth samples from E15 and E20 placentas were cut into 1mm3 were collected 
and fixed into 2.5% glutaraldehyde in 0.2M sodium cacodylate buffer until tissue 
processing. All samples were washed in 0.1M sodium cacodylate buffer at 250 Watts 
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(W) and fixed further in 1% osmium tetroxide in cacodylate buffer at 80W under 
vacuum in a Biowave (Pelco). Samples were rinsed with water at 250W prior to 
counterstaining in 2% uranyl acetate (aq) at 150W under vacuum to enhance contrast. 
Samples were dehydrated in ethanol series (30%, 50%, 70%, 90%, 100%, 100%) at 
250W and were infiltrated in increasing series of epon resin (1:3, 1:1, 3:1, 100%, 
100%) under vacuum. Resin was polymerised for 48h at 60°C. Thick sections were 
cut at 500nm and stained with Toluidine blue to confirm localisation in the labyrinth. 
Thin sections of 100nm were post-stained with lead citrate prior to visualisation with 
an electron microscope (Jeol JEM-101). Two blocks per labyrinth samples were used 
to gather a minimum of 6 interhemal membranes (IHM) of which were averaged per 
block, with a total average for each animal.  
3.3.10 Gene expression studies 
Total RNA from labyrinth samples at E13 and E15 were extracted using RNeasy kits 
with on column DNase digestion (Qiagen). 1ug RNA was reverse transcribed using 
the iScript cDNA kit (Bio-Rad). qRT-PCR was performed using TaqMan (Qiagen) or 
SYBR green (Qiagen) reagents, with 100ng cDNA used per reaction. Expression 
profiles of two replicates per sample were analysed relative to the geometric mean of 
18S, Rplp0 and Rpl13a for outgrowths, while E13 whole placenta and E15 labyrinth 
cDNA used 18S and Rpl13a. Relative gene expression was determined in outgrowths 
for genes associated with trophoblast stem cell maintenance (Eomes), and early TGC 
differentiation (Ascl2, Prl3d1, Hand1). Placental labyrinth samples were examined for 
mRNA expression of trophoblast differentiation markers (Mest, Syna, Gcm1), and 
genes associated with placental growth and vasculogenesis (Igf1, Igf2, Vegfa, Pgf), 
their respective receptors (Igf1r, Igf2r, Kdr, s-Flt).  
Gene Direction Sequence  
Rplp0 
 
Forward  GAG TGA CAT CGT CTT TAA ACC 
Reverse  AAG CAT TTT GGG TAG TCA TC 
Rpl13a 
Forward  GCA CAA GAC CAA AAG AAG 
Reverse  CGC TTT TTC TTG TCA TAG GG 
Prl3d1 
Forward  AGA CCT TAT ACA ACA GGA CTC 
Reverse  ATG GCA AAA GAT GAG TGT C 
SYBR primer sequences for qRT-PCR.   
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Gene of 
Interest ID # 
Gene of 
Interest ID # 
18S 4333760F Igf2 Rn01454518_m1 
Ascl2 Rn00580387_m1 Igf2r Rn01636937_m1 
Ctsq Rn01448613_m1 Kdr Rn00564986_m1 
Eomes Rn01746545_m1 Mest Rn01500324_m1 
Flt1 Rn00570815_m1 Pgf Rn00585926_m1 
Fgf2r Rn01266940_m1 Sry Rn04224592_u1 
Gcm1 Rn00820824_g1 Syna Rn01500024_m1 
Hand1 Rn00572139_m1 Tpbpa Rn00597134_g1 
Igf1 Rn00710306_m1 Vegfa Rn01511602_m1 
Igf1r Rn00583837_m1   
TAQman primers for qRT-PCR.  
 
3.3.11 Statistical analysis 
For embryo studies, statistically significant differences (*P<0.05; **P<0.01) were 
analysed using student’s t tests to examine sex differences. All pre-implantation 
embryos were pooled for analyses. To analyse changing outgrowth area between 
sexes over time, repeated measures ANOVA was used with litter averages used as 
each litter was cultured separately. Subsequent outgrowth analyses also used litter 
averages for cell counts, ploidy, and gene expression assays. For analysis of placental 
morphology, a two-way ANOVA with sex and zone/compartment as factors was used, 
with Tukey’s post-hoc analysis used where appropriate. As expected, this revealed a 
strong effect of zone and thus subsequent analysis testing for sex differences was 
performed at each individual age using a student’s t-test. When student’s t tests 
showed unequal variances, Mann-Whitney’s non-parametric tests were used. Mean 
relative gene expression of treatments were standardised to the control male group, 
displayed as mean ± standard error of the mean. Gene expression studies from E13 
and E15 were analysed by using a two-way ANOVA where ‘gene’ and ‘sex’ were 
factors. All graphs and statistics were performed using GraphPad Prism 6 software 
(GraphPad Software, Inc., San Diego, CA).  
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3.4 Results  
3.4.1 Embryo studies 
To localise the distinct cell lineages of the pre-implantation embryo, CDX2 
immunoreactivity was used to positively label the trophectoderm (TE), with all cell 
nuclei marked with DAPI as shown in Figure 3.1A. Cells negative for CDX2 staining 
were counted as ICM cells. No differences were observed between embryos from 
dams on a chow diet compared to those on a liquid diet.  When male and female 
embryos were compared, no differences were found in total, ICM or TE cell numbers 
(Figure 3.1B-D), or when expressed as percentages or ratios (Figure 3.1E and F). 
When E5 embryos from naturally cycling dams were cultured for 6 days, trophoblasts 
outgrowths showed no differences between sexes for outgrowth area, number of 
trophoblasts, P-TGCs, their nuclear area or DNA content (Figure 3.2 A-G). This result 
was also reflected in outgrowth gene expression profiles for markers of trophoblast 
stem cell maintenance and differentiation (Figure 3.2 H-K).  
3.4.2 Placental biometry at E15 and E20 
E15 and E20 fetal and placental weights and dimensions are shown in Table 3.1. 
Although all parameters increased in weight with age (PAge < 0.0001 for all 
parameters), there were no sex differences in placental length, width, or depth were 
found, nor weights of labyrinth or junctional zone compartments. Overall, placental 
weight at E15 and E20 was lower in females (PSex=0.05) being 12% lower at E15 and 
5% lower at E20. Fetal body weight also differed between the sexes (PSex <0.05) but 
there was also an interaction with age (PInt<0.05). Post hoc analysis demonstrated 
no significant difference in fetal body weight at E15, but males were heavier than 
females by E20. No changes to placental efficiency (placental weight:body weight 
ratio) were exhibited at either age.  
3.4.3 Placental morphology from early to late gestation 
To further explore the placental compartments in more detail, stereological analysis 
was carried out at E13, E15 and E20. Placental tissues were stained as outlined in the 
methods, clearly distinguishing fetal and maternal blood spaces as well as the gross 
compartments of the labyrinth and junctional zones (see Figure 3.3B, D, F and Figure 
3.4A, D, G for higher magnification). Analysis of total, labyrinth and junctional zone 
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volumes showed each compartment expanded with age (Figure 3.3A, C, E). At E13, 
there were no difference between the sexes in any placental compartment (Figure 
3.3A). However, the E15 placenta showed marked sex differences; overall, the whole 
placenta tended to be smaller but this was not statistically significant (PSex = 0.15). 
However, the labyrinth volume was lower in females compared to males (P<0.05, 
Figure 3C). The LAB:WP ratio was similar between the sexes (data not shown).  
Given growth of the labyrinth appeared to be sexually dimorphic, fetal and maternal 
blood compartments were analysed in more detail. Fetal and maternal blood spaces 
increased with age, but the placenta from females at E15 had a lower volume in both 
compartments (PSex<0.05, FBS P<0.01, MBS P<0.05), which was not present earlier 
(E13) or later (E20) in gestation (Figure 4 B, E, H). The placentas from females also 
showed reduced blood space surface area (PSex<0.01), primarily in the fetal 
compartment at E15 (P<0.05, Figure 3.4F). The volume of the labyrinth trophoblast 
was not different between sexes at any age (Figure 3.4B, E, H). Despite marked sex 
differences in fetal and maternal blood spaces at E15, further structural analysis of the 
interhaemal membrane showed no differences in thickness at either E15 or E20 
between males and females (Figure 3.5E, F).  
3.4.4 Labyrinthine expression profiles 
The E15 labyrinth showed clear sexual dimorphism in structure, so next we 
determined whether there were alterations in expression profiles for genes involved in 
differentiation, vasculogenesis, growth factors and branching morphogenesis at both 
E13 and E15 (Figure 3.6 A, B). Firstly, we determined that expression profiles of many 
genes increased expression between E13 and E15 (Figure 3.7). Although there were 
no differences in expression of any individual genes between sexes at E13, there was 
a tendency for an increased in expression of genes overall (PSex=0.07, Figure 3.6 A). 
However, when genes were grouped into pathways (differentiation, growth, 
vasculogenesis), a significant increase in expression of genes related to 
vasculogenesis only was found (increases of 20-28%, PSex<0.05, Figure 3.6 A). 
Conversely, E15 female labyrinth samples showed a decrease in expression of the 
genes investigated (PSex<0.05, Figure 3.6 B), but this was not statistically significant 
for individual genes or when analysed for any particular pathway. Although not 
statistically significant, genes regulating differentiation; Mest, Gcm1, Syna, and 
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growth; Igf2 and Igf2r at E15 were reduced by 20-34% in females. No changes were 
found in the Ct values of the geometric mean of the housekeepers for either E13 or 
E15 were found (Figure 3.6C, D).  
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Figure 3.1. Analysis of pre-implantation development at E5 for male and female 
in vivo derived embryos. A. Representative image of E5 blastocyst immunolocalised 
with CDX2 (green) marking the trophectoderm, and the counterstain for nuclei with 
DAPI (blue). B. Total cell count. C. Inner cell mass (ICM) count. D. Trophectoderm 
(TE) count. E. Ratio of trophectoderm to inner cell mass (TE:ICM). F. Percentage of 
inner cell mass to total cell count (% ICM). Data shows mean ± SEM, analysed by 
student’s t test. Pooled embryos from N = 22-27 male, N = 30-37 female from 11-13 
litters.  
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Figure 3.2. Gene profiles of trophoblast outgrowths after 6 days culture from in 
vivo-derived dams. All data are presented as mean ± SEM, analysed by student’s t 
test. White (male), black (female). A. Representative image of day 6 cultured 
trophoblast outgrowth from E5 stained with trophoblast specific marker pan-
cytokeratin (red) and DAPI (blue) at 20x magnification. B. Trophoblast outgrowth area 
over time from time 0 (E5 derived embryo). Pmatch of two-way repeated measures 
ANOVA analyses subjects (matching). Assessed at day 6 of culture were C; number 
of trophoblasts (nuclear area >200um2), D; DNA content copy number (C) relative to 
2N ICM cells, E; parietal trophoblast giant cell (P-TGC) number (nuclear area 
>1000um2), F; trophoblast nuclear area, G; P-TGC nuclear area and expression 
profiles H-K. H-K gene expression profiles displayed show the gene of interest relative 
to the geometric mean of 3 housekeeper genes (Rplp0, Rpl13a, 18S). Expression of 
Prl3d1 (K) showed unequal variance and was analysed by Mann-Whitney non-
parametric test. Data in (B) show litter averages from N = 4 litters, 2-9/sex/litter. Cell 
counts and DNA content (C-G) show litter averages of N = 4 litters, 1-3/sex/litter. 
QPCR (H-K) show N = 8/sex from 4 litters.  
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Table 3.1. Fetal weight and placental weight and dimensions in males and females at E15 and E20. All data are presented as 
mean ± SEM and analysed by two-way ANOVA for sex with age. † shows significant difference P<0.01 between sexes from 
Tukey’s post-hoc analysis. E15 parameters – N = 9 litters, E20 parameters – N = 12-14 litters.  
Variables Male E15 Female E15 Male E20 Female E20 Statistics 
Fetal weight (g) 0.208 ± 0.007 0.2062 ± 0.007 2.676 ± 0.038 † 2.534 ± 0.035 †  
PSex < 0.05 
PAge < 0.0001 
PInt < 0.05 
Placental weight (g) 0.247 ± 0.023 0.217 ± 0.006 0.561 ± 0.01221 0.536 ± 0.012 
PSex = 0.05 
PAge < 0.0001 
PInt = 0.86 
Placenta:BW ratio (g/gbw) 1.128 ± 0.059 1.127 ± 0.041 0.181 ± 0.010 0.188 ± 0.011 
PSex = 0.92 
PAge < 0.0001 
PInt = 0.89 
Labyrinthine wet weight (g) 0.0863 ± 0.009 0.094 ± 0.006 0.317 ± 0.018 0.306 ± 0.018 
PSex = 0.93 
PAge < 0.0001 
PInt = 0.57 
Junctional zone wet weight (g) 0.102 ± 0.008 0.096 ± 0.006 0.184 ± 0.019 0.196 ± 0.022 
PSex = 0.88 
PAge < 0.0001 
PInt = 0.62 
Placental length (mm) 12.090 ± 0.352 12.140 ± 0.232 14.080 ± 0.267 13.910 ± 0.196 
PSex = 0.84 
PAge < 0.0001 
PInt = 0.69 
Placental width (mm) 11.410 ± 0.245 11.040 ± 0.187 12.650 ± 0.216 12.590 ± 0.241 
PSex = 0.38 
PAge < 0.0001 
PInt = 0.52 
Placental depth (mm) 2.979 ± 0.104 2.833 ± 0.079 4.187 ± 0.086 4.056 ± 0.092 
PSex = 0.16 
PAge < 0.0001 
PInt = 0.94 
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Figure 3.3. Sexually dimorphic outcomes of zonal volumes within the placenta 
from E13-E20 during gestation. Volumes of placental zones - WP; whole placenta, 
LAB; labyrinth, JZ; junctional zone, DEC; decidua were estimated at E13 (A), E15 (C), 
and E20 (E). B; Haematoxylin and eosin stain of an E13 placenta, scale bar = 2mm. 
D; In situ hybridisation for Mest at E15, scale bar = 3mm and Isolectin B4 at E20 (F), 
scale bar = 4mm, both marking fetal endothelial cells of the fetal blood space of the 
labyrinth. See Figure 3.4 for higher magnification images of A, D, G. White (male), 
black (female). Data shows mean ± SEM, analysed by two-way ANOVAs for sex with 
zone. *P<0.05 post-hoc by student’s t test. For E13 N = 6-7 samples/sex from 4 litters, 
E15 N = 8-9 samples/sex from 6 litters, E20 N = 11-12 samples/sex from 6 litters.  
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Figure 3.4. Quantification of labyrinthine blood spaces in males and females in 
the immature, definitive and late-gestation placenta. A. Haematoxylin and eosin 
staining of the E13 labyrinth. D. In situ hybridisation for Mest marking the fetal 
endothelial cells of the fetal blood spaces in the E15 labyrinth. G. Isolectin B4 marking 
the fetal endothelial cells of the E20 labyrinth. White (male), black (female). Data 
shows mean ± SEM, analysed by two-way ANOVAs for sex with zone. *P<0.05, 
**P<0.01 from student’s t test. Fetal (FBS) and maternal (MBS) blood spaces, and 
labyrinth trophoblast (LAB TROPH) (*) were estimated for volume for E13 (B), E15 (E) 
and E20 (H). Similarly, surface areas for FBS and MBS were estimated for E13 (C), 
E15 (F), and E20 (I). For E13 N = 6-7 samples/sex from 4 litters, E15 N = 8-9 
samples/sex from 6 litters, E20 N = 11-12 samples/sex from 6 litters.   
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Figure 3.5. Estimation of interhemal membrane thickness of the male and female 
labyrinth. Semi-thin sections stained with toluidine blue of the placental labyrinth at 
E15 (A) and E20 (B). Electron micrographs of the labyrinth at E15 (C) and E20 (D). 
White scale bars in D and E are 10um. Interhaemal membrane thicknesses at E15 (E) 
and E20 (F). Data shows mean ± SEM, analysed by student’s t test. White (male), 
black (female). Data averaged 6 individual membranes from 2 blocks. E15 N = 5/sex 
from 3-4 litters. E20 N = 4/sex from 4 litter.  
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Figure 3.6. Expression profiles of male and female placentas at E13, and the 
labyrinth at E15. Expression profiles from whole placenta at E15 (A) and labyrinth 
samples at E15 (B). Relative expression profiles were calculated relative to the 
geometric mean of two housekeepers (Rpl13a, 18S) for E13 (C) and E15 (D), with Ct 
values displayed. White (male), black (female). Data shows mean ± SEM analysed by 
two-way ANOVA for sex with differing gene. Data was standardised to control male at 
each age. E13 - N = 8/ sex from 4 litters, and E15 – N = 8/sex from 8 litters.    
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Figure 3.7. Temporal gene expression profiles of male and female placentas from E13 to E15. All data shows mean ± SEM, 
standardised to E13 control male. The geometric mean of 2 housekeepers (Rpl13a, 18S) were used.  
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3.5 Discussion 
This comprehensive ontogeny study has assessed sexual dimorphism in cell number 
and differentiation of the pre-implantation embryo, and subsequent placental structure 
throughout gestation in the rat. E15, a time of rapid placental growth in the rat was 
identified as a critical point during development whereby reduced/slowed 
differentiation of the placental labyrinth and its blood compartments in females is likely 
to be a contributing factor to the lower weight of females by late gestation. This 
highlights the importance of assessing male and females separately in all 
developmental studies as differences exist in placental growth, morphology and 
function even in pregnancies without application of a stressor.  
3.5.1 Pre-implantation development and differentiation 
In the blastocyst, no sex differences were found. Cell counts were not different 
between sexes and were also similar to counts from Wistar rat embryos obtained at a 
similar time point (Master et al., 2015). Investigation of TE differentiation using culture 
of in vivo derived embryos also showed no changes to outgrowth rate, number of 
trophoblasts, P-TGCs, ploidy or expression of TS and trophoblast differentiation 
markers. This suggests that males and females have equal developmental potential 
to differentiate and implant. While this is contrary to the majority of literature which 
suggests that males are more developed than females, previous studies may be 
confounded by the use of in vitro fertilisation or superovulation. Indeed, as 
aforementioned, in vitro derived embryos show reduced cell counts due to an increase 
in apoptosis when compared to in vivo derived embryos (Hardy, 1997, Kamjoo et al., 
2002, Giritharan et al., 2007). Tan et al. (2016b) recently demonstrated female specific 
perturbation of proliferation and differentiation is caused by the in vitro fertilisation 
(IVF) procedure. More specifically, they showed IVF in the mouse caused a reduced 
cell count and increased in apoptosis in female blastocysts during pre-implantation. 
This was associated with reduced ectoplacental cone formation and elevated mortality 
by late gestation, resulting in an altered sex ratio at birth (57% male) (Tan et al., 2016a, 
2016b).  
However, we do concede that models which do use these in vitro procedures also 
have shown no differences to cell count and allocation. These include studies in 
mouse (Bermejo-Alvarez et al., 2012), human (Dumoulin et al., 2005, Richter et al., 
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2006, Weston et al., 2009), bovine (Holm et al., 1998, Rizos et al., 2008, Bermejo-
Alvarez et al., 2010a), and porcine (Kaminski et al., 1996, Lechniak et al., 2000) 
models. Reasons for this could include choice of culture media, such as the addition 
of serum (Rizos et al., 2008, Bermejo-Alvarez et al., 2010a), or the addition (Bermejo-
Alvarez et al., 2012) or removal (Peippo and Bredbacka, 1995) of glucose. In humans, 
as suggested by Richter et al. (2006), rather the differences in outcomes may be due 
to alternate selection criteria for embryo quality prior to transfer, which no longer 
prioritises the largest blastocysts, which are more likely to be male. Many studies also 
do not also report whether multiple embryos were cultured in the same microdrop, 
which could affect embryonic growth through the production of autocrine factors.  
Artificial reproductive technologies (ART), in addition to IVF, use high, 
supraphysiological doses of gonadotropins to initiate ovulation.  Adverse outcomes 
are also associated with these procedures, including reduced viability and imprinting 
disorders (DeBaun et al., 2003). The hormonal contribution to these disorders has 
been investigated primarily in mice, with gonadotropin administration in vivo being 
associated with altered genomic imprinting and DNA methylation in offspring (de Waal 
et al., 2012). Embryo transfer experiments show that when control derived embryos 
implant into a hormone-stimulated dam, fetal and placental weights are reduced at 
E18.5, and do not show any differences in placental DNA methylation profiles (Mainigi 
et al., 2014). This suggests that gonadotropin exposure can affect both embryo 
epigenetic reprogramming and the uterine responses for implantation by different 
mechanisms, with both affecting long term fetal and placental development. This 
highlights the importance of using naturally mated dams without additional hormonal 
intervention when investigating sex specific developmental outcomes. 
3.5.2 Placental morphogenesis 
To explain the reduced fetal weight in females which is only exhibited in late gestation 
(E20), the placenta was investigated for sexually dimorphic morphogenic differences 
at E13, a very early time point of definitive placental development and at E15, a time 
of rapid placental growth. Analysis of gross placental weight and stereology showed 
sex specific structural changes began in the rat at E15. At this age, placental weight 
was lower in females and this was associated with a smaller relative placental volume 
and reduced labyrinth vasculature. Further exploration into the labyrinthine blood 
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spaces showed both the FBS and the MBS were affected. Curiously, while both FBS 
and MBS showed reduced relative volume in females, only the FBS showed reduced 
surface area. Overall, this suggests that the female placenta has lower potential 
capacity for nutrient exchange to facilitate growth at this gestational age.  
Investigation of the labyrinthine blood spaces are also of particular importance, as they 
are also affected in a sexually dimorphic manner in response to maternal 
perturbations. For example, exposure of mid-late gestational hypoxia shows a 
decrease in labyrinthine blood spaces in females only, without affecting placental 
weight in either sex as above (Cuffe et al., 2014a). Examination of blood spaces may 
therefore be a more accurate marker altered placental development. This may suggest 
other programming models which similarly show placental weight to be unaffected, but 
do show other changes to gross placental zones, may still have other subtler changes 
in the vasculature, e.g. glucocorticoid exposure (Cuffe et al., 2012). Sexually dimorphic 
phenotypes are also likely to be masked by the pooling of sexes in perturbation 
models, particularly when their affects are divergent.   
3.5.3 Sex differences in placental gene expression 
Placentas were investigated for the molecular mechanisms behind this altered 
labyrinth morphogenesis with selected gene expression assays conducted at E13 and 
E15. The E13 female placenta showed generally increased expression of the 
investigated genes, while the E15 female labyrinth generally decreased gene 
expression. This was without change to expression of housekeeper genes between 
males and females. The E13 data is consistent with microarray data on E12.5 mouse 
placenta, which showed that 183 genes were expressed at a higher level in females 
whilst only 35 genes were more highly expressed in males (Mao et al., 2010). The E15 
data coincides with a mouse study at E15.5, which showed that females had greater 
global DNA methylation profile than males (3.3%) in unstressed conditions (Gallou-
Kabani et al., 2010). However, the same laboratory has also shown greater up-
regulation of genes in females than males at E15.5 (Gabory et al., 2011). Differences 
in the expression data at this latter time point are likely due the whole placenta being 
assayed by Gabory et al. (2011), while our study only utilised the labyrinth portion, 
allowing specific insight into labyrinth development. This is supported by a study in the 
human third trimester placenta, which showed unique expression of sexually 
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dimorphic genes between 4 different cell types; cytotrophoblasts, syncytiotrophoblast, 
arterial and venous endothelial cells (Cvitic et al., 2013). Collectively, with the 
structural data, this may suggest that the males may have already undergone the 
major rounds of proliferation and differentiation by E13, and therefore by E15 have 
rather switched to hypertrophic growth which continues to expand the placenta. Future 
analysis of gene expression profiles of male and placentas at E12-E12.5 would 
confirm this hypothesis.  
3.5.4 Sexual dimorphism; initiated by the fetal adrenal? 
The changes in placental morphogenesis in females only occurred at mid-gestation, 
which ruled out any contribution from double dosage of the X-chromosome, its 
inactivation, imprinting and so forth on cellular allocation in the early embryo. A likely 
candidate contributing to placental changes in mid-gestation, is the development and 
activation of the fetal adrenal gland. Development of the adrenal begins at E10 in the 
mouse, and its activation contributes to the divergence of ovary and testis 
developmental at E12.5-13.5, reviewed by Keegan and Hammer. (2002). This in turn 
upregulates androgen synthesis in XY males promoting further testis development, 
and reciprocal communication with the now masculinised adrenal, reviewed by Wen 
et al. (2016).  Females, however, go down a default morphogenic pathway without 
hormonal contribution, reviewed by Biason-Lauber and Chaboissier. (2015). The 
growth and development of the male placenta therefore has the potential to react to 
circulating androgens within the implantation site. Conversely, other interesting 
research by Penaloza, et al. (2009) has shown that cultured male and female 
embryonic cells from the E10.5 embryo can also react independently of hormonal 
effects when exposed to stressors, and therefore may be explained by chromosomal 
differences.  
3.6 Conclusion 
This study has identified mid-gestation E15 is an important timepoint during gestation 
to analyse basal sex differences, which may not be present in early and late gestation. 
At this time, the male fetus may have greater metabolic demands than the female 
fetus, which may lead to the male placenta growing larger, and increasing the 
development and expansion of the fetal and maternal blood spaces in the labyrinth. 
This in turn, is likely to lead to greater nutrient delivery to the male fetus, and result a 
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greater fetal weight in late gestation. This greater metabolic demand of the male fetus 
may also render it more susceptible to subtle changes to the nutrient environment, 
and be more vulnerable to perturbation. As this study showed no basal sex differences 
in pre-implantation development, this highlights the use of unstressed controls to 
analyse sexual dimorphism prior to application of a treatment.   
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Placenta short communication  
4.1 Abstract  
Maternal alcohol consumption is common prior to pregnancy recognition and in the rat 
results in altered placental development and fetal growth restriction. To assess the 
effect of ethanol (EtOH) exposure on the differentiation of trophoblast stem (TS) cells, 
mouse TS lines were differentiated in vitro for 6 days in 0%, 0.2% or 1% EtOH. This 
reduced both trophoblast survival and expression of labyrinth and junctional zone 
trophoblast subtype-specific genes. This suggests that fetal growth restriction and 
altered placental development associated with maternal alcohol consumption in the 
periconceptional period could be mediated in part by direct effects on trophoblast 
development.  
 
  
3-5 Key Words: Ethanol, Placenta, Differentiation, Programming, Apoptosis 
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4.2 Introduction  
Maternal perturbations during early pregnancy, including a low protein diet (Kwong et 
al., 2000, 2006, 2007), undernutrition (Edwards and McMillen, 2002, MacLaughlin et 
al., 2005), or alcohol (EtOH) exposure (Gardebjer et al., 2014, 2015), can result in fetal 
growth restriction and programming of adult disease. Alcohol is a common exposure 
during pregnancy, with current statistics being 47-58% of all pregnancies (Colvin et 
al., 2007, Wallace et al., 2007). Consumption of 5+ standard drinks has also been 
reported in the period prior to pregnancy recognition (14%) (Colvin et al., 2007, 
Wallace et al., 2007). In vivo rodent models of EtOH exposure during the 
periconception period (Gardebjer et al., 2014) and intermittently throughout gestation 
(Gundogan et al., 2013, 2015), have shown alterations to placental structure and 
expression of metabolic transporters. This is of interest as normal formation and 
function of the placenta is a critical determinant of fetal growth. Derived from the 
trophectoderm of the pre-implantation embryo, trophoblast cells contribute the majority 
of cells within the mature placenta and consist of a number of unique cell types with 
diverse morphologies and functions (Simmons et al., 2007). The definitive 
chorioallantoic placenta is organised into two zones containing specialised trophoblast 
cell types; the junctional zone which has a structural and endocrine role, while the 
labyrinth zone contains the fetal and maternal vasculature and is the location of 
nutrient exchange (Coan et al., 2004). Perturbations during pregnancy often result in 
modifications to placental growth (Kwong et al., 2006, MacLaughlin et al., 2005) and 
zonal allocation (Gardebjer et al., 2014) in late gestation, however few studies have 
determined whether alterations to trophoblast differentiation in early pregnancy may 
be mediating these effects. We have previously reported that periconceptional EtOH 
exposure prior to implantation in the rat causes an increase in glycogen trophoblasts 
(GlyT) in the junctional zone during late gestation (Gardebjer et al., 2014). In addition, 
high dose (18-37% vol/vol) EtOH exposure from implantation until close to term (E6-
E18) reduced invasion of trophoblast cells into the maternal decidua and caused 
labyrinth disorganisation (Gundogan et al., 2015). However, it is unknown if placental 
defects are due to direct exposure of the trophoblast stem cells of the trophectoderm 
to EtOH within the uterine cavity, or via other indirect mechanisms such as interactions 
with altered uterine cells. Here we utilise an in vitro model of differentiating mouse 
trophoblast stem (TS) cells to examine the direct effects of EtOH on proliferation and 
differentiation.   
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4.3 Methods  
4.3.1 TS cell culture 
Murine TS cells (EGFP line) were maintained as previously described (Himeno et al., 
2008). Cells were seeded at 5x104, and differentiated in 0% (control), 0.2%, or 1% 
EtOH in TS media. To assess cell proliferation, cells were lifted off the culture plates 
and counted using a hemocytometer on days 2, 4 and 6 of culture (N=3/treatment). 
Gene expression analysed on day 6 (N=9/treatment, 3 technical replicates per set). 
Media was changed every 2 days including the addition of fresh EtOH. The 0.2% EtOH 
dose was based on the maximum blood alcohol concentration from 12.5% v/v EtOH 
exposure in Sprague Dawley dams (Gardebjer et al., 2014), relating in women to the 
consumption of 5 standard drinks over 2 hours (Colvin et al., 2007). The 1% EtOH 
dose has been used previously in culture to demonstrate “proof of principle” using a 
supraphysiological dose (Chan and Chang, 2006).  In culture, as much as 50% 
evaporation occurs by 8 hours and 80-90% evaporation by 24h in tissue culture plates 
(Rodriguez, 1992). 
4.3.2 RNA extraction and qRT-PCR 
RNA isolation and qRT-PCR were carried out as previously described (Moritz et al., 
2002). Markers specific to labyrinth or junctional zone trophoblasts were analysed for 
gene expression relative to Rn18s using the ΔΔCt method (Moritz, 2002) (primer 
sequences in Table 4.1). Pro- and anti-apoptotic markers utilised TaqMAN gene 
expression assays (Qiagen), with assay on demand primers of Bax Mm00432051, 
Bcl2 Mm00477631, and 18S 4319413E (Thermofisher). Bax and Bcl2 were 
multiplexed to 18S.  
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Gene 
Trophoblast 
Marker 
Forward Primer Reverse Primer 
Junctional Zone 
Prl7a2 SpT, P-TGC 
GGGAGAATGTGGCCT
CTGTA 
TTGAGCTTCGTCCAGGTT
TT 
Prl7b1 GlyT/SpA-TGC 
GGGAGGACGTGGTCT
CTGTA 
TTTGGTGATTTGAGTGGC
AA 
Tpbpa 
JZ and 
progenitors 
AAGTTAGGCAACGAG
CGAAA 
AGTGCAGGATCCCACTTG
TC 
Prl3d1 
(Pl1) 
1° P-TGC 
CTGCTGACATTAAGG
GCA 
AACAAAGACCATGTGGGC 
Prl2c (Plf) 2° TGCs 
TGTGTGCAATGAGGA
ATGGT 
TAGTGTGTGAGCCTGGCT
TG 
Labyrinth 
Syna SynT-1 
ATGGAGAAACCCCTT
ACGCT 
TAGGGGTCTTTGTGTCCC
TG 
Ctsq S-TGC 
TTCATTGGCCCAATAC
CCTA 
GAAAGCTCCCAGAATTCA
CA 
Other 
18S Housekeeper 
GTAACCCGTTGAACC
CATT 
CCATCGAATCGGTAGTAG
CG 
Table 4.1. Mouse trophoblast markers and associated primer sequences for 
SYBR qRT-PCR. TS – trophoblast stem cell, SpT – spongiotrophoblast, GlyT – 
glycogen trophoblast, SpA-TGC – spiral artery-associated trophoblast giant cell, JZ – 
junctional zone, P-TGC – parietal trophoblast giant cell, TGC – trophoblast giant cell, 
SynT-1/2 – syncytiotrophoblast layer 1/2, S-TGC – sinusoidal trophoblast giant cell, 
18S – ribosomal RNA.   
 
4.3.3 Histological assessment of trophoblast number 
Fluorescent in situ hybridisation (FISH) localised Tpbpa and Prl7a2 positive 
trophoblasts (N=3-4/treatment) from day 6 cultures (Simmons et al., 2007). 
Fluorescein or DIG-labelled probes were made following manufacturer’s instructions 
(Roche) with primer sequences as described previously (Simmons et al., 2007, 
2008b). Prior to use on cultured cells, RNA probes were tested on either E12.5 or 
E14.5 mouse placenta fixed in 4% paraformaldehyde overnight to confirm subtype-
specific expression. Coverslips were imaged on an inverted microscope (Leica) in 
20x20 frames, 20x magnification, with all cells being utilised within this area for 
calculation. Cells were counted using ImageJ (NIH).   
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4.3.4 Fluorescent in situ hybridisation for localisation of trophoblast 
subtypes on cultured EGFP cells 
ISH for TS cell cultures were carried out as described (Simmons et al., 2007), with 
modifications for fluorescent localisation. Fluorescein or DIG-labelled probes were 
made for Tpbpa and Prl7a2 as per manufacturer’s instructions (Roche) with primers 
sequences as described previously (Simmons et al., 2007, 2008b). In brief, cells were 
fixed in 4% PFA for 15 min and transferred to 0.4% PFA until analysis. Cells were not 
treated with proteinase K, but were acetylated for 5 minutes prior to administration of 
FITC- or DIG-labelled probes at 1:200 which were hybridised overnight at 65°C. The 
following day, cells were washed in 5xSSC pre-warmed to 65°C for 3x20 min, followed 
by TN buffer (100mM Tris-HCl ph7.5, 150mM NaCl) for 5 mins prior to incubation in 
block consisting of 1× MABT (150 mM NaCl, 100 mM maleic acid, 0.1% Tween-20, 
pH 7.5), 2% blocking reagent (Roche), 20% heat inactivated horse serum, for 1h. 
Samples were incubated in anti-DIG-POD or anti-FITC-POD antibody (1:500, Roche) 
overnight. The following day, cells were washed in TNT buffer containing 0.05% 
Tween20 in TN buffer for 3x15 min prior to probe detection with 1:50 FITC- or Cy5-
Tyramide in amplification reagent (TSATM kit, Perkin Elmer) for 10 min. Samples were 
washed in TNT buffer for 3x5 min and counterstained with Hoechst (Sigma). 
Coverslips were mounted in 70% glycerol prior to imaging. Prior to use on cultured 
cells, probes were tested on either E12.5 or E14.5 mouse placentas fixed in 4% 
paraformaldehyde overnight. 
4.3.5 Imaging and Analysis 
Coverslips were imaged in 20x20 frames in z stacks of 5 using a 20x air objective on 
an inverted microscope (Leica) using set parameters. Prl7a2-FITC was imaged with 
the 488nm laser, Tpbpa-DIG was imaged with the 561nm laser and Hoechst with the 
405nm laser. Representative images were also taken of paraffin and cultured cells 
using either the 20x or 40x air objectives. Image analysis was carried out using ImageJ 
(NIH). Z stacks were compressed with the maximum projections for DAPI and merged 
(DAPI and FISH marker). The greyscale DAPI image was converted to 8 bit, 
underwent watershed to separate adjoining nuclei, and counted with the automated 
“Analyse Particles” function. FISH positive cells were counted from merged images 
using “Cell Counter”.  
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4.3.6 Statistical analyses 
Mean relative gene expression of treatments were standardised to the control group 
for each line. Expression data, proliferation and FISH counts were analysed by one-
way ANOVAs to compare treatments. Tukey’s post-hoc tests were used where 
appropriate, and when data was not normally distributed, a non-parametric Kruskal-
Wallis test was used. Statistical differences: *P<0.05, **P<0.01.   
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4.4 Results and Discussion  
To determine the mechanism by which EtOH exposure during early pregnancy may 
be mediating altered placental growth and function, we explored the direct impact of 
EtOH on TS cell proliferation and differentiation. To investigate EtOH exposure at a 
physiological level, 0.2% EtOH was chosen as this was the peak blood alcohol content 
found in a model of in vivo alcohol exposure in the rat at 30 minutes after initial 
consumption (Gardebjer et al., 2014). In addition, 0.2% EtOH is also the maximum 
dose that the TS cells would be exposed to when the media is applied, and due to 
alcohol evaporation (Rodriguez et al., 1992), would not be sustained at this level over 
the entire 6 days of treatment. In addition, TS cells express a well-validated set of 
genetic markers enabling identification of individual placental trophoblast cell types in 
the mouse (Simmons et al., 2007). This presents an opportunity to relate alterations 
in gene expression to potential changes in differentiation. 
4.4.1 Cell counts 
Proliferation rates were first characterised to determine the effects of EtOH over the 
course of TS cell differentiation. While no differences in cell count were found between 
treatments on day 2 or 4, marked reductions in cell counts in both the 0.2% (48% 
reduction) and 1% EtOH groups (44% reduction) were observed on day 6 (Figure 
4.1A). This time point coincides with terminal differentiation of trophoblasts, as 
expression of stem cell markers are rapidly lost by day 2 of culture and expression of 
markers of mature cell types is just commencing on day 4 (Watson et al., 2011). This 
result is consistent with studies that demonstrate reduced proliferation in response to 
20-40mM (0.09-0.18%) EtOH in cultured human cytotrophoblasts (first trimester 
villous explants and BeWo cells) (Lui et al., 2014). However, our observation of 
decreased cell numbers at day 6 of differentiation is unlikely the result of decreased 
proliferation, but more likely represents a loss of cell viability. This is supported by the 
observation of significant floating cells in the treatment but not control media on day 6 
(data not shown). In addition, human cytotrophoblasts undergo apoptosis when 
exposed to EtOH (Clave et al., 2014, Bolnick et al., 2014). To determine whether this 
also occurs in mouse trophoblasts exposed to EtOH, we analysed the expression 
profiles of pro- and anti-apoptotic markers (Bax and Bcl2 respectively) from days 2-6 
of culture. No changes were found to either gene on days 2 or 4 (data not shown). 
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However, on day 6, whist no change was found to Bax expression, Bcl2 expression 
was reduced by EtOH (see Figure 4.3A, B), suggesting a perturbed balance between 
pro- and anti-apoptotic signals. This may extend to an increase in apoptosis, however, 
to determine this definitively would require histological analysis. Collectively, these 
data indicate that placental trophoblasts are highly sensitive to EtOH during terminal 
differentiation.  
4.4.2 Junctional zone cell markers 
EtOH exposure caused dose-dependent decreases in gene expression of Tpbpa 
(Figure 4.1B), a marker of both fully differentiated junctional zone trophoblasts and 
their earlier ecto-placental cone progenitors (Adamson et al., 2002). Additionally, both 
Prl7a2, a marker of spongiotrophoblast (SpT) and parietal trophoblast giant cells (P-
TGCs), and Prl7b1 a marker of invasive glycogen trophoblast (GlyT) cells and spiral 
artery-associated TGCs (SpA-TGCs) were decreased by EtOH exposure (Figure 
4.1C, D). Curiously, this suggestion of reduced GlyTs in vitro conflicts with increased 
accumulation of this cell type in the junctional zone of periconceptionally exposed 
placentas in vivo (Gardebjer et al., 2014). It is tempting to speculate that altered GlyT 
differentiation may also affected their invasive behaviour as seen in other EtOH 
exposure models (Gundogan, 2013). No differences were found in the 0.2% EtOH 
groups for Prl7b1 or Prl7a2 relative to control or 1% groups.  
No alterations were found for Prl3d1 (Pl1, Figure 4.1E), or Prl2c (Plf, Figure 4.1F) 
which are expressed by secondary TGCs in vivo, indicating that EtOH exposure does 
not alter expression of all trophoblast subtype specific gene markers. When this same 
experiment was performed on another cell line – RS26, similar expression profiles 
were seen at day 6 for all junctional zone trophoblast markers with the exception of 
Tpbpa, which did not change (Figure 4.4A-G). This difference between the TS lines 
may be either due to clonal differences between cell lines, or alternately a sex-specific 
result, as the RS26 line is male and the EGFP line is female (data not shown). Maternal 
perturbations commonly result in sexually dimorphic impacts on placental structure, 
function, and differentiation - evidenced by GlyT cell accumulation in the junctional 
zone of females only following periconceptional EtOH exposure (Gardebjer et al., 
2014). Further examination of multiple male and female cell lines would be required to 
determine this possibility.  
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The trophoblast subtype markers in this study have been used previously to infer 
effects of differentiation of specific trophoblast subtypes. However, it is also possible 
that EtOH may be directly altering gene expression levels, rather than the 
differentiation of the trophoblast subtypes per se. Therefore, to confirm whether EtOH 
reduces the number of differentiated trophoblast subtypes, FISH was carried out on 
cells collected from day 6 cultures to examine the number of Prl7a2 and Tpbpa 
positively labelled cells. Each marker was first localised in paraffin sections of mouse 
placentas to confirm reported trophoblast subtype specific labelling (Figure 4.2.A, D). 
Quantification of Prl7a2 positive (Figure 4.2.B, C, G) and Tpbpa positive (Figure 4.2.E, 
F, H) trophoblasts in vitro showed no difference between treatments although there 
was considerable variability in the cells cultured in 1% EtOH. This suggests that 
exposure to EtOH did not overtly affect the number of differentiated trophoblasts of 
each subtype, but may indicate either less maturity of trophoblasts or more simply, 
reduced expression of the genes themselves. Considering the heterogeneous cell 
populations marked by these genes, it is possible that subtle differences in number of 
trophoblast subtypes may still be apparent.   
4.4.3 Labyrinth zone cell markers 
Finally, we examined the impact of EtOH on expression of labyrinthine-specific 
trophoblast markers. While no alteration was found in Ctsq (Figure 4.1G) expression, 
representing sinusoidal TGCs (S-TGCs), EtOH exposure did cause a dose-dependent 
decrease in gene expression for Syna (Figure 4.1H), marking syncytiotrophoblast 
layer 1 (SynT-I). Syna expression was significantly decreased in the 1% group relative 
to the control whilst Syna expression in 0.2% EtOH exposed cells was intermediate 
and not significantly different to control or 1% EtOH groups. Exposure of the RS26 line 
to EtOH also revealed reduced Syna expression in the 1% EtOH group, also with no 
changes to Ctsq (Figure 4.4F, G). This demonstrates that EtOH has the potential to 
affect trophoblast viability and differentiation in multiple placental compartments. 
Furthermore, these observations indicate that a commonly used vehicle for dissolving 
drugs in itself has a significant impact on trophoblast behaviour, and must be properly 
controlled for in vitro experiments. 
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Figure 4.1. Trophoblast stem cell proliferation and expression profiles when 
exposed to EtOH over 6 days during differentiation. Panel A. Proliferation analyses 
showing control (circle), 0.2% EtOH (square), 1% EtOH (triangle), N=3/treatment. 
Panels B-H show gene expression profiles of trophoblast subtype markers for 
junctional zone (B-F) and the labyrinth (G and H), with control (white bars), 0.2% EtOH 
(striped bars), 1% EtOH (black bars). All data analysed by one-way ANOVA with 
Tukey’s post-hoc tests. N=9/treatment. All data represented by mean ± SEM. *P<0.05, 
**P<0.01 compared to CON.  
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Figure.4.2. Quantification of Prl7a2 and Tpbpa positive trophoblasts by 
fluorescent in situ hybridisation. Panels A-C show representative images of Prl7a2 
(green) expression in SpT and P-TGCs in the E12.5 mouse placenta at low (10x) (A) 
magnification. B and C show representative images of EGFP cells cultured to day 6. 
Panel G shows percentage Prl7a2 positive cell counts of total cultured cells at day 6 
(N=3/trt). Panels D-F show representative images of Tpbpa (red) expression in SpT, 
GlyT, and junctional zone progenitors in the E14.5 placenta mouse placenta at low (D) 
magnification. E and F show representative images of cells cultured to day 6. Panel H 
shows percentage Tpbpa positive cell counts of total cultured cells at day 6 (N=3/trt). 
All nuclei stained with Hoechst (blue). All data represented by mean ± SEM. Data 
analysed by one-way ANOVA with Tukey’s or Kruskal-Wallis post-hoc test. 
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Figure 4.3. Gene expression of pro-apoptotic marker Bax and anti-apoptotic 
marker Bcl2. All data analysed by one-way ANOVA with Tukey’s post-hoc tests. 
N=9/treatment. All data represented by mean ± SEM. *P<0.05, **P<0.01, ***P<0.001 
compared to CON.   
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Figure 4.4. Expression profiles of RS26 differentiated trophoblasts at day 6 after 
EtOH exposure. Panels A-G show gene expression profiles of trophoblast subtype 
markers for junctional zone (A-E) and the labyrinth (F and G), with control (white bars), 
0.2% EtOH (striped bars), 1% EtOH (black bars). RS26 line was seeded at 10,000 
cells per well to control for proliferative capacity. All data analysed by one-way ANOVA 
with Tukey’s post-hoc tests. N=9/treatment. All data represented by mean ± SEM. 
*P<0.05, **P<0.01, ***P<0.001 compared to CON.   
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4.5 Conclusions 
This study demonstrates that EtOH exposure can directly alter the viability of mature 
trophoblasts and the expression of trophoblast subtype markers for both labyrinth and 
junctional zones. Alterations to labyrinthine cell types may alter barrier thickness or 
labyrinth architecture potentially impacting appropriate nutrient exchange, whilst 
changes to invasive GlyT and SpA-TGCs may alter their invasive behaviour and lead 
to poor invasion. Future studies on how alterations of these cell types in vivo may lead 
to altered placental structure and function is now paramount in determining the 
impacts of EtOH exposure.  
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Chapter 5. Periconceptional alcohol exposure: effects on the pre-
implantation embryo and the maternal environment.  
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5.1 Abstract 
Periconceptional ethanol (PC-EtOH) exposure in the rat causes fetal growth 
restriction, increased resorptions, sex-specific changes to placental morphology in late 
gestation, and metabolic dysfunction in adult offspring. Previous models investigating 
environmental stressors such as IVF, suggest that females may be more susceptible 
to alterations in cell allocation and epigenetic modifications in the pre-implantation 
period. Therefore, this study investigated whether PC-EtOH exposure altered sex-
specific development of the pre-implantation embryo, differentiation of the 
trophectoderm (TE) to invasive trophoblast giant cells, and the influence of the 
maternal environment in mediating these outcomes. Sprague Dawley rat dams were 
administered 12.5% v/v EtOH from 4 days prior (E-4) to 4 days after conception at 
embryonic day (E) 4 in a liquid diet and blastocyst were examined at E5.  
PC-EtOH exposure decreased ICM cell number in female but not male embryos at E5, 
without changing total or TE counts. However, TE nuclear CDX2 fluorescence was 
reduced in PC-EtOH embryos of both sexes. Culture of E5 blastocysts in vitro showed 
PC-EtOH decreased outgrowth rate on day 6, and number of trophoblasts in both 
sexes. Investigation of primary parietal trophoblast giant cells (P-TGCs) showed only 
female PC-EtOH exposed embryos to have reduced cell count, suggestive of 
perturbed differentiation. Outgrowths from PC-EtOH females, however, also showed 
reduced expression of Prl4a1, a gene exclusively expressed by TGCs for 
communication with decidual natural killer cells (dNK).  
Maternal hormone analysis showed no change to levels of plasma estrogen or 
progesterone over the peri-implantation period. However, hormone receptor mRNA 
expression in the uterus was altered by PC-EtOH; Esr1 was decreased at E5, while 
Pgr was reduced by PC-EtOH at E5, but increased at E7. Investigation of downstream 
estrogen response genes (Muc1, Hbegf, Vegfa, Lif) were unchanged by PC-EtOH. 
Uterine expression of progesterone response genes, however, showed reductions in 
Bmp2 and Coup-TFII at E5, but were unchanged at E7. No differences in expression 
of the remaining genes (Hand2, Ihh, Areg, Igfbp1, Cnr1) genes were found. As these 
alterations occur during implantation, they are likely to be a consequence of perturbed 
signalling from the embryo, leading to alterations in the uterine responses for 
implantation. Additionally, a reduction in decidual natural killer (dNK) genes Vdup1 
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and Ifng, involved in dNK maturation and function were also reduced at E5, but 
curiously without any change to dNK marker gene Prf1. By E11 in the immature 
placenta, a 25% increase in decidual dNK cells was found in PC-EtOH females, which 
may suggest that reduced dNK cell homing has resulted from perturbed TGC 
communication.  
This study shows that PC-EtOH can alter trophoblast differentiation, with female 
embryos in particular, most susceptible to modification. These trophoblast defects may 
lead to reduced capacity for invasion, and perturbed communication with maternal 
immune cells required for ongoing placentation. These outcomes may contribute to 
placental defects, decreased embryonic viability, fetal growth restriction and adult 
onset disease associated with this model.   
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5.2 Introduction 
The periconception period is increasingly being shown to be susceptible to maternal 
perturbations, leading to increased predisposition to adult disease in a sex specific 
manner (Kwong et al., 2000, 2006). Maternal nutrient perturbations often result in 
altered development of the early embryo, including changes to total cell number or cell 
allocation to the primary lineages of the blastocyst – the inner cell mass (ICM) and the 
trophectoderm (TE) (Kwong et al., 2000, Bloise et al., 2012, Tan et al., 2016a, 2016b). 
Alterations in either may lead to fetal growth restriction as the ICM provides a 
progenitor pool to the embryo proper, while the TE gives rise to the unique trophoblast 
subtypes to facilitate invasion into the uterine epithelium, and establish the definitive 
chorioallantoic placenta. Sexual dimorphism in programming of adult disease is 
becoming increasingly prevalent, and can be traced back to changes in the early 
embryo and formation of the placenta (Kalisch-Smith et al., 2017a). Studies by Tan et 
al. (2016a, 2016b), show that IVF can impact epigenetic reprogramming in the pre-
implantation period, formation of the ectoplacental cone, and placenta, in a sex 
specific manner. Therefore, assessing the impacts of alcohol exposure on sex-specific 
pre-implantation phenotypes will offer further insight into periconceptional 
programming.   
A common exposure which may be experienced by the early embryo is alcohol. Prior 
to pregnancy recognition, 47% of women have reported alcohol consumption, with 15-
39% categorised as receiving high doses of 5+ standard drinks on one occasion 
(Colvin et al., 2007, Wallace, 2007, Muggli et al., 2016). Specifically, during the 
periconception period, approximately 27% of women drink alcohol, with 87% of these 
women ceasing their drinking activities after pregnancy recognition (Muggli et al., 
2016). This cessation is a common finding (Parackal et al., 2013, Alvik et al., 2006), 
and is likely to be contributed by unplanned pregnancies, which are at approximately 
50% in both Australia and the United States (Colvin et al., 2007, Finer and Zolna, 
2016). Therefore, the early pre-implantation embryo may be highly exposed to alcohol 
during this periconceptional period.  
We have recently characterised a model of PC-EtOH exposure in the rat and reported 
fetal growth restriction, sex-specific structural and metabolic alterations to the late 
gestational placenta, and compromised metabolic outcomes in adulthood (Gardebjer 
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et al., 2014, 2015). Of particular interest is the origin of the fetal growth restriction, and 
whether this derives from early alterations to pre-implantation development, and if they 
occur in a sex-specific manner. As discussed in Chapter 3, many in vitro models 
suggest males to develop at a faster rate than females, but this is likely due to an 
artefact of in vitro culture or superovulation techniques. This highlights the use of 
appropriate embryo derivation in determining sex-specific outcomes, especially in 
programming models.  
Effects of maternal perturbations including alcohol exposure on the maternal 
physiology, hormone-dependent uterine environment and establishment of pregnancy 
are rarely investigated. There is some evidence from maternal low protein diets during 
pregnancy (Eckert et al., 2012) and diabetic models (Dehertogh et al., 1989), which 
have shown reduced estrogen levels during the peri-implantation period, may impact 
on the window of uterine receptivity and the capacity for implantation. Indeed, ovarian 
hyperstimulation in artificial reproductive technologies (ART) (Walton et al., 1982, 
Ertzeid and Storeng, 2001), can have dramatic impacts on implantation, as high 
estrogen levels can rapidly close the window of receptivity and reduce embryonic 
survival (Ma et al., 2003). Alcohol has been shown to alter both estrogen and 
progesterone levels after 4.8g/day EtOH for 2 weeks (Emanuele et al., 2001), and 
30% v/v EtOH after 3h (LaPaglia et al., 1997). However, the more subtle impacts of 
an altered hormonal environment such as may occur with maternal alcohol 
consumption, have not been considered to their long-term impacts on implantation, 
and the post-implantation development.   
This thesis chapter aims to quantify effects of PC-EtOH exposure on development of 
the early embryo, primary differentiation of the TE, the influence of the uterine 
environment, and the necessary communication between them for successful 
pregnancy progression.   
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5.3 Methods  
5.3.1 Ethics, animal treatment and sample collection 
All animal experiments and procedures were approved by The University of 
Queensland Animal Ethics Committee (AEC approval number SBS/022/12/NHMRC) 
prior to commencement of this study. PC-EtOH exposure was administered in vivo to 
Sprague Dawley dams in a liquid diet containing 12.5% v/v EtOH as previously 
described (Gardebjer et al., 2014, 2015). It was important to include a standard chow 
group to eliminate any possible effects of administration of ethanol in a liquid diet. Dam 
weight was at least 230g before entering the protocol. Vaginal impedance was 
measured daily with an EC40 oestrous cycle monitor (Fine Science Tools), with 4.5 x 
103 Ω or higher indicating oestrus and allocation to the diet regime. Dams were treated 
over two oestrus cycles, one prior to mating and the establishment of the pre-
implantation period (denoted as embryonic day (E) -4 to E4). Dams were time-mated 
on E0 from 1200h to 1700h if impedance exceeded 4.5x103Ω. If pregnancy was 
established, the following day was considered E1. At 900h on E5, dams were 
sacrificed via guillotine prior to dissection of the uterine horns and embryo collection. 
Oviducts and uteri were flushed in Hepes-KSOM media (Lawitts and Biggers 1993) 
and allocated to either staining (N = 12-18 dams/treatment) or culture procedures (N 
= 4 dams/treatment). All embryos were genotyped for sex as described in sections 
2.9.1 and 3.3.6). E7, and E11 cohorts were similarly treated, with dams returning to 
standard laboratory chow on E5, and also sacrificed at 900h on the day of post-
mortem. E5 uteri and E7 implantation sites (N = 5-8 litters/treatment) were collected 
for either molecular or histology procedures. E11 placentas (N = 4 litters/treatment) 
were dissected from the embryos, and placentas separated from uterine tissue for 
molecular experiments. A subset of placentas in each litter remained attached to the 
uterine tissue histology. Maternal plasma was collected at post-mortem from trunk 
blood into either heparin or EDTA coated tubes. Samples were spun at 3500 rpm for 
10 minutes at 4°C, and plasma collected.  
 
5.3.2 Blastocyst viability and lineage allocation 
At post-mortem E5, embryos were flushed and scored for developmental progression 
and any abnormalities noted. Those that had achieved the correct developmental 
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stage at E5 (blastocysts), were prepared for immunohistochemistry as previously 
described (Pantaleon et al., 2010), and section 2.10.2. Briefly, embryos were fixed in 
2% PFA in 1x PBS for 20 minutes at room temperature (RT), washed in PBS, and 
immobilized on Cell-Tak (Collaborative Biomedical Products) coated coverslips. 
Embryos were permeabilised in 0.25% Triton in PBS and washed before blocking with 
10% normal goat serum/BSA/Tween-20/PBS (PBT) for 1 h RT. Embryos were 
incubated in 1:50 anti-Mouse CDX2 (BiogenX, MU392A-UC) overnight at 4°C. On the 
following day, embryos were extensively washed in PBT prior to exposure of goat anti-
mouse labelled secondary antibody Alexa 488 (1:1000, Molecular Probes) for 1 h RT. 
Embryos were counterstained with DAPI (Sigma Aldrich Inc, B2388) in PBS for 15 min 
and transferred through increasing concentrations of glycerol in PBS before mounting 
with Vectashield (Vector Labs, H-1000).  
 
5.3.3 Trophoblast outgrowth assays 
E5 embryos were placed into preheated microdrops of TS media on tissue culture 
plates or gelatine coated coverslips and cultured in a humidifying chamber (Cook, 
Australia) at 37°C 5% CO2 / 5% O2 / 90% N2 under paraffin oil. They were cultured for 
6 days, with media changed every 2 days, and imaged with an inverted phase contrast 
microscope (Leica).  Area occupied by outgrowths were traced in ImageJ using 
calibrated settings. A subset of outgrowths was immunolabelled as for staining 
procedures above with anti-rabbit pan-cytokeratin (DAKO, Z0622) to distinguish 
cytoskeleton, goat anti-rabbit af568 secondary antibody, and DAPI (Sigma Aldrich Inc, 
B2388) to assess number and ploidy of trophoblast nuclei. The remaining outgrowths 
were collected and extracted for DNA and RNA with Trizol (Life Technologies), and 
cDNA synthesis from Quantitek reverse transcription kit (Qiagen) using as per 
manufacturer’s protocol.  
 
5.3.4 Immunofluorescence and Image Analysis 
Embryos and outgrowths were visualised using an inverted microscope (Leica, DMi8). 
Pre-implantation embryos utilised a 40x air objective and captured in z stacks of 40, 
while outgrowths were imaged at 20x in z-stacks of 10 using a tile scan. Excitation 
filters of 488nm (green), 561nm (red) and 405nm (blue) fluorescence were imaged 
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separately. CDX2 immunoreactivity (green) was localised to the TE of the E5 
blastocyst. Cells devoid of CDX2 immunoreactivity were assumed to be ICM. TE and 
ICM cells were counted individually using Image J (NIH). ICM proportion was 
calculated as: ICM (%) = (Number of ICM cells/ Number of total cells) x 100. LD control 
and PC-EtOH exposed embryos when E5 on the same day, were assessed for nuclear 
CDX2 fluorescence. A mask was created around the DAPI channel using Imaris 
(Bitplane), and the sum CDX2 within TE nuclei counted.  
For trophoblast outgrowths, Z-stacks of the DAPI channel were compressed using the 
average intensity for manual cell counts and ploidy analysis using ImageJ. Smallest 
trophoblasts with positive staining for pan-cytokeratin had nuclear sizes exceeding 
200um2. ICM cells (2N) were found to be less than 200um2 in size. Nuclear sizes 
above 1000um2 were considered P-TGCs. DNA content, a surrogate marker of ploidy, 
was quantified from fluorescent intensity of nuclear DAPI. DNA content of all 
trophoblasts and P-TGCs were normalised to ICM cells of the same image to obtain 
relative ploidy to 2N. 
 
5.3.5 Genotyping for sex  
After analysis, the pre-implantation embryos and blastocyst outgrowths were removed 
mechanically from coverslips and digested overnight at 55°C in 5ul of lysis buffer with 
1ul of 20mg/mL proteinase K. Proteinase K was then inactivated for 10 mins at 95°C. 
The total 6ul sample was used to amplify male determining gene Sry and B-Actin as 
a control. Amplification of both genes was carried out in the same reaction due to 
limited DNA content. Primers for Sry (317bp) and B-Actin (220bp) were derived from 
Miyajima et al. (2009) for use in the rat. A 2% gel was run for 35 mins at 100V to 
separate the bands. Double bands indicated male embryos and a single band 
represented a female embryo. A number of samples (~10%) failed to result in clear 
bands and were eliminated from analysis. E11 extraembryonic tissue was collected 
into QuickExtract (Epicentre) and DNA extracted as per manufacturer’s instructions, 
and genotyped as previously described by Gardebjer et al. (2014).  
 
5.3.6 In situ hybridisation and immunohistochemistry 
In situ hybridisation (ISH) was carried out as previously described (Simmons et al., 
2007, 2008b), and explained in detail in section 2.10.3. Prf1 was used to identify 
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infiltrating decidual natural killer cells into maternal uteri (E7) and later, the placental 
decidua (E11), while Prl8a2, was used to identify the primary decidual zone of the 
early implantation site at E7. Primer sequences for probe synthesis of these two genes 
are shown in Table 5.1. cDNA probe templates were isolated by gel extraction 
(QIAquick Gel Extraction Kit, Qiagen). DIG-labelling of cRNA probes were carried out 
as per manufacturer’s instructions (Roche). Uterine and placental tissues were fixed 
in 4% PFA at 4°C for 2 days prior to processing into paraffin and sectioning at 5um. 
Probes (1:200) hybridisation was carried out overnight at 65°C in a humidified 
chamber and included negative antisense (T3) controls. All other steps were carried 
out as described in section 2.10.3.  
 
Gene Direction Sequence (5’-3’) Product (bp) 
Prf1 
Forward (T3) AGCCAGTGTCTCAAGCGAAT 
414 
Reverse (T7) CAGTCCTGGTTGGTGACCTT 
Prl8a2 (dPRP) 
Forward (T3) TGCATCAGTTCCTGCTTGTC 
871 
Reverse (T7) TTTCCCTGTTATGCGACACA 
Table 5.1 In situ hybridisation primers and product length. T3 ; 
AATTAACCCTCACTAAAGGG and T7 ; TAATACGACTCACTATAGGG sequences 
were added to the beginning of forward and reverse primers respectively. Note; Prl8a2 
is also known as decidual prolactin-related protein (dPRP).  
 
5.3.7 Stereology of uterine and placental samples  
Stereology for stromal volume, decidual volume, total placental volume and dNK total 
cell counts using the Cavalieri principle, as described for placental compartments 
(Coan et al., 2004). In brief, E7 samples embedded in paraffin were serially section at 
5um, with 5 sections spaced equally apart at 1:10 taken for IHC or ISH and quantified. 
Similarly, for E11, 5 sections were collected 1:50. dNK cells were counted in ImageJ. 
The decidual-myometrial border was clearly demarcated in high resolution 20x 
images.  
5.3.8 Plasma analyses 
Maternal plasma samples taken from post-mortem were analysed for glucose 
concentrations using the COBAS Integra 400 Plus (Roche), and underwent 
radioimmunoassays for quantification of estrogen (Beckman Coulter, DSL4800), 
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protocol in section 2.7.2.1, and progesterone as described by Curlewis et al. (1985), 
using progesterone antiserum C-9817 (Bioquest), described in section 2.7.2.2.  
5.3.9 RNA extraction, cDNA synthesis and qPCR 
Outgrowth and E11 RNA were extracted with TRIzol (Thermo Fisher Scientific) as per 
manufacturers protocol (see section 2.8.1.2). E5 and E7 uteri (including the 
conceptus) were extracted with an RNeasy Mini Kit (Qiagen) as per manufacturer’s 
instructions. E11 samples underwent on column DNase digestion and RNA clean-up 
(Qiagen). Trophoblast outgrowth RNA was reverse transcribed using Quantitek 
reverse transcriptase kit (Qiagen) as per manufacturers protocol with a total of 6ul 
RNA with 1ul gDNA wipeout buffer. All other samples were reverse transcribed into 
cDNA using iScript (Biorad), using 1000ng RNA per reaction. Samples then underwent 
either TaqMan (Qiagen) or SYBR green (Qiagen) qPCR.  
 
TaqMan reactions utilised 1uL (100-200ng) cDNA with 5ul TaqMan (Qiagen), 0.2ul 
TaqMan assay-on-demand primers (Thermofisher), and multiplexed with 18S (0.2ul), 
with the remainder to 10ul made up with H2O. SYBR reactions utilised 5ul SYBR green 
reagent (Qiagen) with 3ul H2O, 1ul of 4uM forward and reverse primers, and 1ul (100-
200ng) cDNA. Samples were run in duplicate. The 96-well plates were run in a 
StepOneTM Real-Time PCR System (Applied Biosystems), for 1 hour. Primers and 
product codes are shown in Tables 5.2 and 5.3.  
Results were used to calculate relative gene expression using the ΔΔCT method 
(Moritz et al., 2002). The difference between the cycle thresholds (CT) of the gene of 
interest and the geometric mean of housekeepers (18S, Rpl0 and Rpl13a) were 
calculated for each sample (ΔCT). Relative expression was generated compared to 
the mean ΔCT for control, or control males (for when analysing treatment with sex). 
Preliminary analysis of expression of housekeeper genes showed no differences in 
expression when analysed for sex, time or treatment.   
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Gene Name AOD ID Number 
18S 4333760F 
Rpl19 Rn00821265_g1 
Eomes Rn01746545_m1 
Ascl2 Rn00580387_m1 
Hand1 Rn00572139_m1 
Prl4a1 Rn00566830_m1 
Ifng Rn00594078_m1 
Prf1 Rn00569095_m1 
Lif Rn00573491_g1 
Areg Rn00567471_m1 
Nr2f2 (CoupTF-II) Rn00756179_m1 
Hbegf  Rn01405658_m1 
Bmp2 Rn00567818_m1 
Table 5.2 TaqMan primers. 
 
 
Gene Name 
Forward Primer 
(5’-3’) 
Reverse Primer 
(3’-5’) 
Rpl13a GCA CAA GAC CAA AAG AAG CGC TTT TTC TTG TCA TAG GG 
Prl3d1 AGA CCT TAT ACA ACA GGA CTC ATG GCA AAA GAT GAG TGT C 
Hand2  CTC CAA AAT CAA GAC TCT GC  CAT TCA GCT CTT TCT TCC TC  
Ncoa6  AAA AGA TCT TCT CGA CCT G  GTA TCA AGT CAT CTT CCT GC  
Usag1 
(Sostdc1) 
ACT GGA TCG AAA TAG TCG AG  TCC AGT ACT TTG TTC CGT AG  
Vdup1 (Txnip) CGT CAA TAC TCC TGA CTT AAT G  AAA TGT CAT CAC CTT CAC AG  
Esr1  ATA TGA TCA ACT GGG CAA AG  CAT TTA CCT TGA TTC CTG TCC  
Pgr  TCT AAT CCT GAA TGA GCA GAG  GAC TTT CAT ACA GAG GAA CTC  
Fgf2 AAA CTC GGA TCC AAA ACG  TGT CTA AAG AGA GTC AGC TC  
Fgf9  ACT ATA AAT GCT TCA TGC GG  CAA TAA ATC AAG CAA GTG GC 
Igfbp-1 AAA CTG AAA GTT GTT TCC TCC ATA CAA ACC CAC TTG TAC ATC 
Cyp26a1 CAA GCA GCG AAA GAA GGT GA  CTT CAG CAA TCA CTG GCA CG  
Cnr1 (CB1) CAC CCA TGG CTG AGG GTT CC  CCC ACG TAG AGG AGG TCT GT  
Klf5 AAT CCA AAT TTA CCT GCC AC  TGC AAC CAT CAT AAT CAC AG  
Ihh AAA GAC GAG GAG AAC ACC  AAGATTCCTCTGAGTGATGG  
Muc1 CGG AAG TCA ATG TGA ATG AG  CAA AAT ACA GAC CAG TAC CAG  
 
Table 5.3 SYBR green primer sequences.  
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5.3.10 Statistical analyses 
For analysis of embryonic stage and number from flushing experiments, preliminary 
cell counts and uterine stereology QPCR, one-way ANOVAs were used to analyse 
statistically significant differences between treatments (chow control, liquid diet 
control, PC-EtOH). For embryo and trophoblast outgrowth analyses, data was 
analysed using two-way ANOVAs to examine the effects of treatment and sex. All pre-
implantation embryos were pooled for analyses. Subsequent outgrowth analyses used 
litter averages for cell counts, ploidy and gene expression analyses. Maternal plasma 
analyses also utilised two-way ANOVAs to examine treatment over gestational age. 
Mean relative gene expression of treatments were standardised to the control or 
control male group (if more than one sex), displayed as mean ± standard error of the 
mean. All graphs and statistics were performed using GraphPad Prism 6 software 
(GraphPad Software, Inc).   
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5.4 Results 
5.4.1 Effects of PC-EtOH on number of flushed embryos and cell counts 
To examine the developmental competence of early embryos exposed in utero to PC-
EtOH, developmental stage, and cell numbers for total, TE and ICM were recorded. 
Immunofluorescent labelling for CDX2 (see Chapter 3 Figure 3.1A) was carried out to 
localise TE cells, with cells showing negative staining assumed to be ICM. When all 
individual embryos (unsexed) were assessed, preliminary analysis showed the 
administration of a liquid diet alone had an effect on blastocyst development, causing 
a reduction in number of blastocysts (P<0.01), average number of blastocyst (P<0.01) 
and embryos (P<0.05) per litter, and blastocyst cell counts [total (P<0.01), TE 
(P<0.0001) and ICM cell number (P<0.05)], when compared to chow control (Table 
5.4 and Figure 5.1 A-E).  When compared to the liquid diet control (LD Control), PC-
EtOH exposure had no statistically significant effect on the number of embryos 
reaching the blastocyst stage on E5 (Table 5.4).  Importantly however, when taken as 
a litter average (Figure 5.1 F-J), analyses showed there was no effect of the liquid diet 
on any embryo parameter.  
When a subset of embryos from LD control and PC-EtOH were subsequently sexed 
after cell counting, subsequent statistical analysis showed female embryos exposed 
to PC-EtOH had a reduced ICM count (Figure 5.2C). There were no differences in total 
cell number suggesting variation in TE counts in the PC-EtOH group. When LD control 
and PC-EtOH embryos were quantified for nuclear CDX2 fluorescence in the TE, an 
indicator of TE pluripotency, PC-EtOH exposure markedly reduced levels in both 
males and females (Figure 5.2F).  
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Treatment Oocytes Morulae Aberrant Blastocysts 
Average 
Blastocysts 
/ Litter 
Average 
Embryos/ 
Litter 
Chow 
Control 
13/473 
(2.7%) 
1/473 
(0.2%) 
14/473 
(2.9%) 
452/473 
(94.2%)  
12.91 ±  
0.48 A 
13.52 ± 
0.50 A 
Liquid Diet 
Control 
13/274 
(4.8%) 
1/274 
(0.4%) 
15/274 
(5.6%) 
240/274 
(89.2%)  
10.91 ± 
0.74 AB 
12.46 ± 
0.91 AB 
PC-EtOH 
4/285 
(1.4%) 
2/285 
(0.7%) 
8/285 
(2.8%) 
271/285 
(95.1%) 
10.54 ± 
0.68 B 
10.96 ± 
0.67 B 
P Value P = 0.10 P = 0.45 P = 0.29 P < 0.01 P < 0.05 
 
Table 5.4. Flushing statistics of pre-implantation embryos derived from 
embryonic day 5. Data was analysed using a one-way ANOVA with Tukey’s post-hoc 
tests. Morulae was analysed using a non-parametric one-way ANOVA for unequal 
variances (Kruskal-Wallis test). N = 22-33 litters/treatment. Data presented as 
percentages or mean ± SEM. Different letters (A, B) show significant differences 
(P<0.05) between treatments, with AB not being different to either A or B. 
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Figure 5.1. In vivo PC-EtOH exposure does not alter cell counts of E5 blastocyst 
but does show effect of a liquid diet. A. Total cell count. B. Trophectoderm (TE) cell 
count. C. Inner cell mass (ICM) count. D. Ratio of trophectoderm to inner cell mass 
(TE:ICM). E. Percentage inner cell mass count of total cell count (% ICM). All data are 
presented as mean ± SEM and analysed by one-way ANOVA with Tukey’s post hoc 
tests, *P<0.05, **P<0.01, ***P<0.001. Total cell counts in panel A and F contain 12-18 
dams per treatment, with 82-106 embryos. Panels B-E and G-J have 6-10 dams per 
treatment, with 49-62 embryos.  
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Figure 5.2. In vivo PC-EtOH exposure causes sex-specific alterations to pre-implantation blastocyst development. A. Total 
cell count. B. Trophectoderm (TE) cell count. C. Inner cell mass (ICM) count. D. Ratio of trophectoderm to inner cell mass (TE:ICM). 
E. Percentage inner cell mass count of total cell count (% ICM). F. Nuclear CDX2 fluorescence intensity. All data are presented as 
mean ± SEM and analysed by two-way ANOVA with post hoc tests, *P<0.05, **P<0.001. Embryos were pooled from each litter for 
analyses. Panels A-E N = 5-7 dams per treatment, 14-26 embryos. Panel F shows N = 2 dams per treatment, 6-8 embryos.
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5.4.2 Trophoblast outgrowth assays from PC-EtOH treated embryos 
To further examine the ongoing programming of the TE by alcohol, in vivo treated LD 
control and PC-EtOH embryos were cultured simultaneously to assess trophoblast 
outgrowth capacity. PC-EtOH exposure resulted in reduced embryo outgrowth area at 
day 6 and a reduction in the number of trophoblasts in both sexes. Interestingly, PC-
EtOH females also showed reduced numbers of the large P-TGCs (Figure 5.3E). 
Trophoblast and P-TGC DNA content analysis, a marker of ploidy, showed males 
tended to increase ploidy of trophoblasts (P=0.07) and P-TGCs (P=0.09), while 
females remained unchanged. Gene expression analysis showed no alteration to 
trophoblast stem cell marker Eomes, P-TGC marker Prl3d1, or downstream EPC and 
chorion genes Ascl2, and Hand1 (Figure 5.4A-D) following PC-EtOH. However, PC-
EtOH exposed female embryos showed a reduction in expression of Prl4a1 (P<0.05, 
Figure 5.4E), a gene exclusively expressed by TGCs for communication with maternal 
dNK cells.  
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Figure 5.3. In vivo PC-EtOH exposure reduces trophoblast outgrowth rate and 
sex-specific alterations to P-TGC differentiation and DNA content. Panel A. 
Control day 6 culture stained with pan-cytokeratin (red) and DAPI (blue). Control 
(white) and PC-EtOH (black) bars. All data are presented as mean ± SEM and 
analysed by two-way ANOVA with post hoc student’s t tests. Panel B; N = 4 
litters/treatment, 2-10 per sex. Panels C-F N = 4 litters/treatment, 1-4 per sex.  
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Figure 5.4. Expression profiles of trophoblast outgrowths exposed to PC-EtOH. 
A; Eomes (TS maintenance), B; Prl3d1 (P-TGC marker), C; Ascl2 (junctional zone 
marker), D; Hand1 (TGC marker). Control (white) and PC-EtOH (black) bars. All data 
are presented as mean ± SEM and analysed by two-way ANOVA with post hoc 
student’s t tests. N = 7-10 from 4 litters. Gene expression is relative to control male 
group, and standardised to a geometric mean of 2 housekeepers (18S and Rpl13a). 
Gene expression assays were carried out in duplicate. 
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5.4.3 Effects of PC-EtOH on the peri-implantation uterine environment and 
early placenta 
To further examine the influence of the maternal environment in mediating the effects 
of PC-EtOH, E5 uteri and E7 implantation sites were assessed for expression profiles 
for genes involved in receptivity and decidualisation, as both of these are critical 
events for the establishment and maintenance of pregnancy. Firstly, levels of 
reproductive hormones estrogen and progesterone were examined over the peri-
implantation period (E5-E7), and were unaffected by PC-EtOH, although they did 
change with gestational age (Figure 5.5).  
Estrogen and progesterone receptor expression was also investigated. Expression of 
Esr1 was decreased at E5 (P<0.01), but was unchanged at E7 (P<0.05) by PC-EtOH 
exposure (PInt<0.01, Figure 5.6A). Curiously, the majority of downstream estrogen 
response genes (Hbegf, Vegfa, Lif, Fgf2, Fgf9 Figure 5.6B-G) were unchanged. One 
gene; Muc1, showed an interaction with treatment and age when analysed at E5 and 
E7 (PInt<0.05). PC-EtOH did, however, cause reduced expression of Pgr at E5 
(P<0.01), and increased expression at E7 (P<0.01, Figure 5.6F). No significant 
changes to receptivity genes Lif, Ihh or Usag1 were found, albeit a 46% decrease in 
Usag1 was shown at E5 (P=0.19). Conversely, progesterone response genes Bmp2 
and Coup-TFII were decreased by PC-EtOH at E5 only (Figure 5.6K, L), with no other 
changes found for Ihh, Areg, Hand2 or Igfbp1 (Figure 5.6M-P). Some of the genes 
investigated however, did show temporal profiles with gestational age examined 
(Figure 5.6).  
Further characterisation of histology at E7 implantation sites showed no gross 
changes to stromal or decidual volume (Figure 5.7). Expression of genes involved in 
dNK cell maturation; Vdup1 (P<0.05, Figure 5.6Q), and function; Ifng (P<0.05 Figure 
5.6R), were markedly decreased at E5 by PC-EtOH, but did not show any change to 
dNK cell function and common marker gene Prf1 (Figure 5.6S). At E11, no changes 
to implantation site volume, or dNK cells were found, although female PC-EtOH 
exposed implantation sites had 25% more dNK cells than control females, although 
this was not statistically significant (P=0.16, Figure 5.8A,B). However, PC-EtOH did 
cause increased Prf1 expression at E11 in both sexes (Figure 5.8C).  
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Figure 5.5. PC-EtOH exposure on maternal hormone profiles of throughout 
gestation. Control (white), PC-EtOH (black). Data shows mean ± SEM, analysed by 
two-way ANOVA. E5 data N = 9/trt, E6 N = 3/trt, E7 N = 3/trt, E15 N = 7-9/trt, E20 N = 
7/trt. 
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Figure 5.6. Uterine expression profiles over the peri-implantation period at E5 and E7. Panels A-E show estrogen response 
genes, J-O show progesterone response genes, and Q-S show genes involved in dNK maturation and function. Control (white) and 
PC-EtOH (black) bars. All data are presented as mean ± SEM and analysed by two-way ANOVA. Due to significant differences in 
age, treatments were analysed at each gestational age with student’s t tests. N = 6/trt (E5) and N = 10/trt (E7) from 5 litters per 
treatment. Gene expression is relative to control group at E5, and standardised to geometric mean of Rpl19 and B-actin. 
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Figure 5.7. PC-EtOH does not alter stromal or decidual volume at E7. A; 
Quantification of uterine stroma from sections localised with vimentin. B; Quantification 
of primary decidual zone [PDZ] volume from sections stained with Prl8a2. Data shows 
mean ± SEM, analysed by student’s t test. N = 4-7/treatment.  
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Figure 5.8. PC-EtOH exposure causes sex-specific infiltration of maternal 
decidual natural killer cells at E11. A; Quantification of total placental volume at E11. 
B; Quantification of decidual natural killer (dNK) cells at E11. dNK cells were marked 
with in situ hybridisation probe Prf1. C. QPCR of E11 placentas for Prf1. Data shows 
mean ± SEM, analysed by two-way ANOVAs for treatment with sex. N = 7-8 from 4 
litters/treatment. Black bar shows scale of 2 mm, black dotted lines show barrier 
between decidua and uterus (myometrium), and red dotted lines show invading ecto-
placental cone.   
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5.5 Discussion  
5.5.1 PC-EtOH exposure - a rodent model of early programming 
Historically in the field of developmental programming, the rat has been preferred over 
the mouse as a model system for investigation of the physiology of adult offspring. 
Conversely, the mouse has been well characterised for studying developmental 
biology. However, in more recent times, the rat has been used to investigate 
pregnancy outcomes including hormone profiles in the peri-implantation period 
(Kennedy, 1980), programming of the placenta (Mark et al., 2011, Gao et al., 2012, 
Gardebjer et al., 2014), as well as the development of the early embryo (Kwong et al., 
2000, Master et al., 2015). The PC-EtOH project was thus extended to trace 
phenotypes from adulthood (Gardebjer et al., 2015) and the late gestation placenta 
(Gardebjer et al., 2014), back through earlier time points during development to 
determine the contribution of either the embryo or the uterus to programming of fetal 
growth restriction.   
5.5.2 PC-EtOH exposure on development of the pre-implantation embryo 
The model of PC-EtOH exposure was first established by Gardebjer, et al. (2014) for 
administration in a liquid diet. This study altered the ethanol containing diet to 
contribute equal energy percentages of protein, fat and calories compared to the 
control diet. This eliminated any potential effects of undernutrition which has been 
shown to alter pre-implantation development. To first assess the developmental 
competence of embryos exposed in vivo to PC-EtOH, flushed embryos were assessed 
for number and stage. No changes to formation of the blastocyst, or aberrant embryos 
were shown between treatments. Although a number of parameters investigated 
(number of blastocysts/ total embryos and cell counts), displayed an effect due to 
administration of a liquid diet, these effects were not significant when embryos form a 
single litter were averaged together suggesting any differences due to the LD were 
very subtle. Additionally, this first analysis of all embryos did not take into account 
embryo sex. In a recent review, we illustrated that regardless of the type of stressor, 
or the critical window exposed, that many programming models showed marked sex 
differences throughout placental development (Kalisch-Smith et al., 2017a). These 
included changes to blastocyst cell number, differentiation to TGCs, and placental 
formation; assessed by weight, volume stereology and gene profiles. We therefore 
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assessed embryo sex following analysis in a subset of pre-implantation embryos 
exposed to either the liquid diet control or PC-EtOH. This revealed that female PC-
EtOH embryos had a reduced ICM count. This sex-specific outcome was an 
interesting finding as another pre-implantation perturbation of IVF, as well as mutant 
mouse models of X-linked genes, have shown female embryos to develop more 
deleterious phenotypes than males, including increased cell death and perturbed 
differentiation (Ghys et al., 2015, Tan et al., 2016a, 2016b, reviewed by Kalisch-Smith 
et al. (2017a). This is contrary to the current dogma that males appear to be more 
affected in response to developmental perturbations, as in models of undernutrition 
when assessed at pre-implantation (Kwong et al., 2006), or postnatal (Kwong, 2000, 
Jungheim et al., 2010). This suggests that at least in the early stages of development, 
female embryos may be most at risk of periconceptional perturbations, regardless of 
the type of stressor; be that genetic or environmental.  
Although not investigated for embryonic sex, a decrease in cell number of the ICM is 
also seen in other perturbation models such as culture in vitro per se (reviewed by 
Hardy (1997) and maternal low protein diet (Kwong et al., 2000). In vitro, the ICM is 
considered more sensitive to cell death by apoptosis (10-20%) than the TE (3%), 
despite being only 30-40% of cells within the developing embryo (Hardy and 
Handyside, 1996, Brison and Schultz, 1997). The ICM is also suggested to be more 
metabolically active than the TE in terms of glucose utilisation, which may render it 
more sensitive to nutrient stress (Hewitson et al., 1996).  
Compared to our PC-EtOH model, an in vivo model of a similar ethanol dose (10% 
EtOH) in the mouse, has shown reduced cell counts, hatching and increased 
apoptosis (Perez-Tito et al., 2014). While these outcomes were more deleterious than 
those observed in our model, alcohol was administered in their model in the drinking 
water, and thus is likely to be confounded by undernutrition, as food intake is often 
reduced in this model by 10-30% (Shankar et al., 2007). Other in vitro models of EtOH 
exposure on the developing embryo also show more deleterious outcomes than our in 
vivo PC-EtOH model, likely due to the added effects from suboptimal embryo culture 
(Kalisch-Smith, et al. 2017b). Doses of 0.2% EtOH, which are similar to the maximum 
dose in maternal plasma that PC-EtOH dams receive show reduced blastocyst 
development and expansion (Page-Lariviere et al., 2017), while 0.3% EtOH in culture 
is enough to induce apoptosis and cause reduced cell counts (Huang et al., 2007). 
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These higher doses of alcohol, however, are unlikely to be reached routinely in 
women, even when binge drinking raising questions regarding the clinical relevance 
of such studies.     
5.5.3 Influence of PC-EtOH exposure on trophoblast differentiation and 
invasive capacity 
Whilst no changes were found in TE cell count in PC-EtOH males or females, marked 
reductions in nuclear TE CDX2 fluorescence were found, regardless of sex. This 
suggests that PC-EtOH may result in reduced TE pluripotency (Strumpf et al., 2005). 
Trophoblast outgrowth experiments showed that both male and female PC-EtOH 
embryos had reduced outgrowth capacity and trophoblast number. However, it was 
only the females that showed reduced P-TGC number, suggestive of a differentiation 
defect. As the ICM also secretes various factors including FGF4 which aid in 
maintenance of TE stem cell fate (Tanaka et al., 2001), this may account for greater 
reductions in trophoblast differentiation in PC-EtOH females. Despite these changes 
in trophoblast number, however, no differences in expression profiles were found 
between control or PC-EtOH, suggesting that even though there are less 
trophoblasts/P-TGCs, they are likely at the same developmental stage as the control 
group.  
We further investigated this by examining DNA content (ploidy) of all trophoblasts, and 
separately, the P-TGCs. Trophoblasts and P-TGCs from male embryos exposed to 
PC-EtOH tended to increase ploidy. This may suggest that trophoblasts from males 
can increase cell maturity after a perturbation, and that they may contain some sex-
specific mechanisms which may be protective during this early stage. This would 
agree with the hypothesis there are male specific compensatory mechanisms that 
occur later in placental development (Clifton, 2010). Additionally, males may have 
greater influence over cell cycle machinery, as occurs in the divergent development of 
male and female germ cells (Bowles and Koopman, 2010). Currently, sexual dimorphic 
pathways of P-TGC differentiation in programming models have not been investigated. 
However, a mouse mutant of X-linked genes Eed, showed mutant females to show 
marked reductions in P-TGC numbers (Wang et al., 2001). Although not investigated, 
perturbation to the P-TGCs is also a likely mechanism to the phenotype of altered EPC 
formation in females after IVF (Tan, et al. 2016b).  
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P-TGC differentiation is known to be a default pathway, with TS cells preferentially 
differentiating in response to perturbations including in vitro administration of retinoic 
acid (Yan et al., 2001), HIF (hypoxic inducible factor) (Maltepe et al., 2005), TGFb or 
activin (Erlebacher et al., 2004), and FGF4 removal (Tanaka et al., 2001). However, 
when TS cells are exposed to a poor environment in culture, such as hyperosmolar 
stress (Liu et al., 2009), or hypoxic stress (Yang et al., 2016), TGC differentiation is 
promoted, despite continued application of FGF4. This suggests that cellular stress 
promotes differentiation over that of TS renewal. Experiments in drosophila show that 
cells may enter the endocycle instead of undergoing apoptosis, as a protection against 
genotoxic stressors (Mehrotra et al., 2008). However, these in vitro studies may not 
necessarily mimic what may be happening in vivo. Culture in vitro is a stressor in itself, 
and therefore when coupled to an additional perturbation, would be more deleterious. 
The in vivo models mentioned above, rather suggest that differentiation is reduced, 
leading to fewer P-TGCs (as in PC-EtOH), and smaller EPCs (as in IVF, Tan et al., 
2016a). These alterations therefore may be acting through alternate mechanisms to 
in vitro experiments.  
One such proposal is altered epigenetic profiles. IVF procedures including fertilisation 
and embryo culture have been associated with altered imprinted X chromosome 
inactivation (Xist), the exposed females of which exhibit reduced Xist and Rnf12 
expression in 8-cell and morulae, which both contribute to initiation and maintenance 
of X chromosome inactivation (XCI) (Tan et al., 2016a). They also show decreased 
H3K27me3 profiles in TE and EPCs, a marker of XCI and a known repressive 
modification to gene transcription (Tan et al., 2016a). The authors went on to rescue 
this phenotype in females with the morphogen retinoic acid (RA), as it is known to 
upregulate Xist expression in embryonic stem cells (Ahn and Lee, 2010). Significantly, 
alcohol has also been associated with global reductions in RA, as EtOH metabolism 
preferentially utilises the same enzymes required for RA synthesis from vitamin A 
(Duester, 1991, Yelin et al., 2005). Moreover, application of RA on TS cells shows 
giant cell differentiation (Yan et al., 2001), showing a reciprocal phenotype to that of 
PC-EtOH. RA may therefore be a common mechanistic conduit in the effects of PC-
EtOH and IVF, as altered RA synthesis and secretion in the oviduct and/or uterus may 
compromise the epigenetic erasure and reprogramming of the female embryos as they 
proliferate and differentiate (Hore et al., 2016). As the early embryo resets its 
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epigenome, it removes 5-methylcytosine (methylation) and oxidises to 5-
hydroxymethylcytosine, a process enhanced by retinol (Hore et al., 2016). 
Furthermore, a global reduction in retinol may cause a reduction in this oxidation, 
leading to global hypermethylation, which may be reflected by reduced CDX2 
expression after PC-EtOH. A recent study in male and female induced pluripotent stem 
cell experiments (converting mouse embryonic feeder fibroblasts into embryonic stem 
cells) in vitro, has additionally shown females to undergo more pronounce global, 
untargeted demethylation during reprogramming, while targeted loss of methylation 
marks; (hypomethylated) genes required for cell identity (e.g. pluripotency factors) 
were similar between sexes (Milagre et al., 2017). This may further delineate sexually 
dimorphic phenotypes during the pre-implantation period, particularly to the ICM 
lineage, after an altered maternal environment. However, whether these outcomes are 
consistent with other nutritional perturbations such as a low protein diet, currently 
remains unknown.  
Collectively, these results suggest females are at most risk of environmental 
perturbations during the periconception and pre-implantation periods, most likely due 
to their greater requirements for epigenetic reprogramming. Males, however, seem 
less affected, despite being exposed to the same in utero environment. However, 
given that in the postnatal environment, males and females experience the same 
disease susceptibility of altered glucose tolerance and insulin insensitivity (Gardebjer 
et al., 2015), this may suggest that other factors may be at play during placental 
formation and organ development. These early experiments also demonstrate that 
CDX2 fluorescence may be a more sensitive indicator of reduced developmental 
potential of the trophoblast lineage than TE cell count.  
5.5.4 Influence of PC-EtOH on the maternal uterine responses for the 
establishment of pregnancy  
As subtle changes in early embryonic development arose from PC-EtOH prior to 
implantation, the question now arises as to whether these changes are accounted for 
by either a direct effect of EtOH on the embryo, as assessed by in vitro experiments 
of TS cell differentiation (see Chapter 4), or rather – indirectly, through alterations to 
the uterine and/or maternal hormonal environment. To determine the impacts of PC-
EtOH exposure on uterine responses required for the establishment of implantation 
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and pregnancy success, we first examined maternal hormone profiles for estrogen and 
progesterone over the peri-implantation period (E5-7), and later in gestation (E15 and 
E20). Similar to other studies in the rat investigating the peri-implantation period 
(following nidation), estrogen levels peaked at E7 and decreased thereafter. As 
aforementioned, a nidatory estrogen surge is usually present late on E4/early E5 
(Shaikh, 1971, Singh et al., 1996) and is required for uterine sensitisation and marks 
the onset of receptivity. While this did not result in our animals at E5, this is likely due 
to the alternate light-dark cycle, which shifted the investigated window by 0.5 days. 
We thus may have not sampled our animals at the appropriate time. During the peri-
implantation period, progesterone levels peaked at E6 at the onset of implantation, 
similar to other studies in the rat (Barkley et al., 1979, Garland et al., 1987), and 
declined until term. No changes were shown in either hormone profile during uterine 
receptivity (E5), or decidualisation (E6-7) in the PC-EtOH group.  
Other studies investigating the effects of EtOH in the rat on hormones during 
pregnancy are varied. Lower doses of alcohol over a chronic period (60 days of 10% 
v/v EtOH) did not alter either estrogen or progesterone when assessed on the morning 
of estrus (Chuffa et al., 2013) nor did 4.8g/day EtOH after 2 months’ exposure 
(Emanuele et al., 2001). Short-term exposures, however, including 4.8g/day EtOH, 
increased estrogen without showing any change to progesterone after 2 weeks 
(Emanuele et al., 2001), while another model of high dose of 30% v/v EtOH (injected 
as a bolus) caused reduced estrogen and progesterone after 3h (LaPaglia et al., 
1997). This suggests the effect of EtOH on hormonal profile is dosage and time 
dependent, with high doses eliciting a rapid change to hormone levels. This may be a 
limitation of our study at E5 as dams were not sampled during peak alcohol 
consumption but rather several hours after they had ceased consumption. 
Although the short-term impact of EtOH on hormone levels was not investigated in this 
model, we were able to determine expression of their receptors which may reflect more 
chronic changes in hormone concentrations. These receptors control the major 
signalling pathways for receptivity and decidualisation. Of great interest, PC-EtOH 
reduced expression of estrogen receptor alpha (Esr1) and the progesterone receptor 
(Pgr) in the receptive E5 uterus. Conversely the Pgr was elevated at E7 following the 
PC-EtOH. A study by Chuffa et al. (2013) has also showed similar findings, with a 
similar dose of 10% EtOH. They showed reduced Pgr and Esr1 in the uterus after 60 
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days of alcohol administration. Associated with these changes to the hormone 
receptors, a select group of downstream hormone response genes were altered. At 
E5, progesterone response genes Bmp2, Coup-TFII (Nr2f2) were found to be 
downregulated. Coup-TFII is expressed in the sub-epithelial stroma, and is involved in 
the regulation of uterine implantation by controlling estrogen receptor activity (Kurihara 
et al., 2007). Knock out studies of Coup-TFII show embryo attachment and 
decidualisation are impaired (Kurihara et al., 2007), and this has adverse 
consequences for placental formation through trophoblast differentiation and labyrinth 
vascularisation, which leads to miscarriage by mid-gestation of pregnancy (Petit et al., 
2007). Bmp2 is also downstream of Coup-TFII and is involved in decidualisation and 
the initial attachment reaction (Paria et al., 2001). At E7 PC-EtOH caused reduced 
expression of Klf5, a hormone independent gene expressed in the uterine epithelial 
and stromal cells, which is involved in conferring uterine receptivity to implantation 
(Sun et al., 2012). Considering no changes to receptivity genes were apparent, the 
above results suggest that implantation may be slightly delayed, and is most likely due 
perturbed signalling to the luminal epithelium and stroma from an immature blastocyst.     
One interesting outcome from the uterine expression profiles, was a reduction in 
Vdup1 at E5 and E7 after PC-EtOH exposure. Vdup1 has been shown as a marker of 
a refractory uterus, is expressed in the uterine stroma (Simmons and Kennedy, 2004), 
and is also involved in dNK cell maturation (Lee et al., 2005, Kim et al., 2007). 
Quantification of dNK cells at E11 by ISH for Prf1 showed a tendency (25%) for 
elevated counts in PC-EtOH females and significantly increased Prf1 expression in 
both sexes. Reduced signalling by the P-TGCs in PC-EtOH females through 
production of Prl4a1, could also affect the dNK cell homing, production of IFNg, and 
thus influence their maturation and survival (Ain et al., 2004, Muller et al., 1999). Prl4a1 
is also one of the most highly expressed genes on chromosome 13 in the prolactin 
cluster, and is the 29th most highly expressed gene in the whole P-TGC genome 
(Hannibal and Baker, 2016), which shows that it is highly endoreplicated and its 
importance in development. dNK cells are known to decrease around E11 (Paffaro et 
al., 2003), which suggests that PC-EtOH females may be slightly delayed in 
development. We hypothesise that reduced dNK cell maturation is the result of 
reduced embryo-uterine cross-talk. Conversely, these dNK cells may have greater 
activation after PC-EtOH, as can also occur in placental pathologies. Another 
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possibility is that the reduced decidualisation at E5 may also result in a 
developmentally delayed uterus, also causing reduced dNK infiltration/maturation, 
which may explain why males also have increased Prf1 expression at E11, but not 
dNK cell count. However, the uterine genes investigated here at E7 did not support 
this proposition. In addition to dNK cells producing cytokines such as Ifng (Ashkar et 
al., 2000), they also secrete other pro-angiogenic factors that help attract invasive 
TGCs into decidual spiral arteries (Chakraborty et al., 2011). The trophoblasts then 
regulate spiral artery remodelling into low resistance, high flow vessels to facilitate the 
late gestational fetal growth spurt through increased placental perfusion (Wallace et 
al., 2012). This outcome of altered trophoblast differentiation and communication with 
maternal factors, may be a primary mechanism by which periconceptional perturbation 
models affect long term placentation.  
5.5.5 Future investigations 
Further investigation into the maternal hormonal environment will help establish 
whether there are long term consequences to subtle changes in estrogen and 
progesterone signalling, and whether these can contribute to changes in the uterine-
embryo cross-talk for implantation, and further placentation (see Chapter 6). Validation 
of expression profiles also requires determination of protein levels where possible, 
before definitive conclusions can be made. Future experiments should also investigate 
X chromosome dosage and inactivation in females exposed to in utero perturbations 
during early development and differentiation. This will aid in determining whether all 
females show the most deleterious phenotypes during this period, or if this is only 
specific to exposures of IVF and PC-EtOH exposure.  
 
5.6 Conclusions 
This chapter has shown that by E5, PC-EtOH exposure has programmed the 
development of the pre-implantation embryo in a sexually dimorphic manner. Female 
exposed embryos show alterations to both embryonic (ICM) and extraembryonic (TE) 
compartments, while males only show mild changes to the TE. This suggests that 
female embryos are more susceptible to implantation defects and placentation than 
males following PC-EtOH exposure. Furthermore PC-EtOH resulted in a mildly 
perturbed maternal environment indicated by altered expression of hormone receptor 
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genes within the uterus and some of their downstream constituents, suggesting there 
may be mild effects to uterine decidualisation, and embryo-uterine cross-talk. These 
results suggest PC-EtOH result in perturbations to both the embryo and the uterine 
environment which may contribute to altered implantation and placentation.  
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Chapter 6. Periconceptional alcohol exposure: effects on the 
morphological development of the placenta  
 
Contributions to Chapter 6 
Contributor Statement of contribution 
Kalisch-Smith, J.I. Experimental design (20%) 
Animal treatment (10%) 
Sample collection (100%) 
Data collection (100%) 
Interpretation of results (40%) 
Simmons, D.G. Experimental design (35%) 
Interpretation of results (20%) 
Pantaleon, M. Experimental design (10%) 
Interpretation of results (5%) 
Moritz, K.M.  Experimental design (35%) 
Interpretation of results (35%) 
Note: The remaining animal treatment with liquid diets was performed by members 
of the Moritz laboratory PC-EtOH project, with animals coordinated by Lisa Akison. 
Special thanks to Sarah Walton, Jenn Outhwaite and Moritz lab members who 
helped with post-mortem euthanasia.  
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6.1 Abstract 
Periconceptional ethanol (PC-EtOH) exposure in the rat causes fetal growth 
restriction, increased resorptions, and sex-specific changes to placental morphology 
in late gestation (E20). This study continued to investigate the impacts of PC-EtOH 
exposure on structural morphogenesis and remodelling of the placenta from mid- to 
late- gestation in a sexually dimorphic manner. Sprague Dawley rat dams were 
administered 12.5% v/v EtOH from 4 days prior (E-4) to 4 days after conception at 
embryonic day (E) 4 in a liquid diet. Placental samples were collected to analyse the 
immature (E13), definitive (E15) and mature (E20) placenta. Placentas was assessed 
for volume and surface area of compartments (labyrinth and junctional zone), and a 
subset taken for gene expression analysis.  
PC-EtOH caused an increase in resorptions at E15, which were not present at earlier 
ages (E11, E13). Similarly, at E15, PC-EtOH reduced labyrinthine wet weight and the 
placental depth. No other changes to weights of the whole placenta, junctional zone, 
or measurements of the length or width were found. Stereological analysis from E13-
E20 showed differences only at the E15 time point to be significant between treatment 
groups. Whilst no change to volume of the whole placenta, decidua, labyrinth or 
junctional zone were found, PC-EtOH exposure reduced maternal blood space (MBS) 
volume in both sexes. Curiously, this was without any change to the MBS surface 
area. These changes were not observed at E13 or E20, suggesting the definitive 
placenta is most affected by PC-EtOH, and that by E20, compensatory growth has 
occurred. This growth of the placenta, however, was not able to ameliorate the fetal 
growth deficit which occurred at E20 but was not present at E13 or E15.  Gene 
expression profiles of nutrient transporters showed that expression of the glucose 
transporter Glut3 in the labyrinth was reduced by PC-EtOH at E13 in both sexes 
whereas at E15, males tended to decrease placental Glut3 expression and females 
increased expression. No other changes in gene expression were found to occur 
following PC-EtOH for other nutrient transporters at either age (Slc38a1, Slc38a2, 
Slc38a4). 
As a major alteration to placental structure was found at mid-gestational E15, we 
questioned whether this was due to altered remodelling of the uterine spiral arteries 
by inadequate trophoblast invasion earlier in gestation. When the E13 implantation 
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site was assessed, only PC-EtOH females showed reduced invasion, exhibiting little 
infiltration past the decidua into the mesometrial triangle. Considering the findings of 
reduced in MBS in both sexes, this perturbed invasion in females has most likely led 
to blunted or delayed spiral artery remodelling. We hypothesise this may have altered 
uterine blood flow overall, reducing the nutrients delivered to implantation sites of both 
sexes. This would explain why the placenta of both males and females exposed to 
PC-EtOH show reduced MBS expansion at E15.  Overall, PC-EtOH led to a reduction 
is MBS at E15 which likely is the origin of fetal growth restriction in this model. This 
data will contribute to our knowledge on placental pathologies, the origins of fetal 
growth restriction, and the programming of adult disease.  
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6.2 Introduction 
Appropriate formation and function of the placenta is crucial in meeting the nutritional 
demands of the fetus, to enable growth and viability. A suboptimal in utero 
environment is increasingly being established to program placental growth and 
development, having adverse outcomes for fetal growth, and leading to programming 
of adult disease. Insults to poor maternal nutrition such as a low protein (Gao et al., 
2012), as well as exposure to alcohol (Gardebjer et al., 2014), glucocorticoids (Cuffe 
et al., 2011), hypoxia (Cuffe, 2014a) and embryo culture (Tan et al., 2016a), can all 
cause fetal growth restriction through modification to the structure and function of the 
placental zones. These adaptations to the placenta can also occur in a sexually 
dimorphic manner regardless of the critical window of exposure (Kalisch-Smith et al., 
2017a). The placental zones carry out important functions, with the labyrinth housing 
the fetal (FBS) and maternal (MBS) blood compartments which mediate nutrient 
exchange across the interhemal membrane. The junctional zone has a primary 
endocrine role, and contains specialised trophoblast subtypes; spiral artery-
associated giant cells (SpA-TGCs) and glycogen trophoblasts (GlyT), which invade 
into the decidua and uterine spiral arteries. SpA-TGCs are of particular interest, as 
they mediate remodelling of the uterine spiral arteries into low resistance, high flow 
vessels, and enable the late gestation fetal growth surge, through increased blood 
supply through the central canal, and subsequently, the MBS, allowing greater 
perfusion (Wallace et al., 2012). The placental trophoblast subtypes also express 
lineage-restricted markers which allows investigation into differentiation both in vivo 
and in vitro (as investigated in Chapter 4).  
Despite considerable knowledge on the effects of poor of maternal nutrition on 
placental biology, alcohol consumption has not received as much attention. Alcohol 
consumption is widespread during pregnancy, especially in the periconception period 
prior to pregnancy recognition (Colvin et al., 2007, Wallace et al., 2007, Muggli et al., 
2016).  The majority of research to date has focused on a direct effect of alcohol on 
placentation during mid- to late-gestation, as alcohol can readily cross the placenta 
during nutrient exchange (Weinberg et al., 2008). However, few studies investigating 
alcohol exposure recognise the earlier periconceptional period in placental 
programming.  
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In the human, there is also evidence the periconceptional period may affect 
placentation: IVF studies have shown reduced endometrial vascularisation (Lai et al., 
2014) and greater incidences of hypertension in mothers of IVF babies (Westerlund et 
al., 2014). Of the animal models that have investigated alcohol exposure, they show 
dose dependent effects including reduced vascularisation, with perturbed vascular 
disorganisation, trophoblast differentiation, invasion, and placental blood flow, along 
with fetal growth restriction (Gundogan et al., 2013, 2015). However, one more recent 
model of first trimester alcohol exposure in the rhesus macaque suggests that some 
of these outcomes may be related to perturbations to periconceptional events (Lo et 
al., 2017). Along with reduced fetal weight, placental blood flow and oxygen delivery 
were reduced after alcohol exposure (Lo et al., 2017). These outcomes may therefore 
contribute to placental pathogenesis of gestational hypertension and preeclampsia as 
seen in women who have consumed alcohol during pregnancy (Meyer-Leu et al., 
2011, Salihu et al., 2011).  
We have recently described how PC-EtOH in the rat causes a late gestation placental 
phenotype, consisting of altered labyrinth and junctional zone cross-sectional areas, 
increased resorptions and fetal growth restriction, with males and females showing 
reductions of 8% and 7% respectively (Gardebjer et al., 2014). As described above in 
Chapter 5, PC-EtOH can cause sex-specific alterations to the pre-implantation embryo 
and trophoblast differentiation, with females showing the most deleterious outcomes. 
Of particular interest, was the long-term impacts of reduced trophoblast pluripotency 
and invasive capacity in PC-EtOH exposed embryos, particularly females. This raises 
some key questions; including why PC-EtOH females don’t show greater growth 
restriction than PC-EtOH males by late gestation, why males and females have the 
same postnatal disease susceptibility for glucose tolerance and insulin sensitivity, and 
what is the role of the placenta in mediating these outcomes? As discussed in Chapter 
5, PC-EtOH also tended to cause an increase in dNK cells in female exposed embryos, 
which may have long term consequences for the secondary wave of trophoblast 
invasion (Chakraborty et al., 2011).  
This chapter therefore aims to characterise structural changes to the immature, mid- 
and late-gestation placenta after PC-EtOH exposure, and their influence on fetal 
growth.     
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6.3 Methods  
6.3.1 Ethics, animal handling and liquid diet administration 
All animal experiments and procedures were approved by The University of 
Queensland Animal Ethics Committee (AEC approval number SBS/022/12/NHMRC) 
prior to commencement of this study. PC-EtOH exposure was administered in vivo to 
Sprague Dawley dams in a liquid diet containing 12.5% v/v EtOH as previously 
described (Gardebjer et al., 2014, 2015). Dam weight was at least 230g before 
entering the protocol. Vaginal impedance was measured daily with an EC40 oestrous 
cycle monitor (Fine Science Tools), with 4.5 x 103 Ω or higher indicating oestrus and 
allocation to the diet regime. Dams were treated over two oestrus cycles, one prior to 
mating and the establishment of the pre-implantation period (denoted as embryonic 
day (E) -4 to E4). Dams were time-mated on E0 from 1200h to 1700h if impedance 
exceeded 4.5x103Ω. If pregnancy was established, the following day was considered 
E1. On E5, dams were returned onto standard laboratory chow until sacrifice.  
 
6.3.2 Post-mortem and tissue collection  
At 900h on E13 (N = 4-5 litters/treatment), dams were sacrificed via guillotine prior to 
dissection of the placental tissues. Dams in E15 (N = 9 litters/treatment) and E20 (N = 
6 litters/treatment) cohorts were heavily anaesthetised with 50:50 ketamine:xylazil 
(0.1ml/100g body weight, Lyppard Australia Ltd, QLD, AUS) as previously described 
(Gardebjer et al., 2014). Fetal and placental weights were taken at post-mortem for 
the E15 cohort, and placentas were separated from the uterus/decidua, with the 
junctional zone and labyrinth and weighed separately. Placental measurements were 
also taken for length, width and depth using digital callipers (LCD Display Calliper 
Vernier Micrometer, Scientrific Pty. Ltd., Yamba, NSW, AUS). Placentas from all E13, 
E15 and E20 cohorts were collected for RNA and histological procedures. For 
histology, placentas were cut in half with uterus and decidua attached and fixed in 4% 
PFA prior to processing into paraffin for stereology. E13 placenta samples were 
processed as above into paraffin, or processed for cryo-sectioning. A subset of 
labyrinth samples from E15 and E20 placentas were cut into 1mm3 and fixed in 2.5% 
glutaraldehyde in 0.2M sodium cacodylate buffer until tissue processing for 
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transmission electron microscopy (section 2.10.5). All cohorts collected fetal tissue for 
genotyping for sex as previously described (Gardebjer et al., 2014).  
 
6.3.3 Histology 
6.3.3.1 Haematoxylin and eosin 
Slides were dewaxed in xylene for 3 x 2 min, rehydrated in 2 x 100% EtOH, and 1x 
90% EtOH, 1x 70% EtOH for 2 min, and 1x dH2O for 2 min. Slides were incubated in 
Meyer’s haematoxylin for 2 minutes prior to extensive washing in dH20. Slides were 
incubated in 1% alcoholic eosin for 15 minutes. Slides were dehydrated in 95% EtOH, 
2x 100% EtOH and 2x xylene washes prior to mounting in DPX mounting medium 
(Ajax Finechem). 
6.3.3.2 Immunofluorescence on cryo-sections 
Immunolocalisation was carried out as previously described (Pantaleon et al., 2010) 
and in section 2.10.2, but on E13 midline placental cryo-sections. Placentas were cut 
at 10um, with every 10th section taken for staining. Sections were blocked with 10% 
normal goat serum/BSA/Tween-20/PBS (PBT) for 1 h RT prior to incubation with 
primary antibodies; 1:200 anti-rabbit pan-cytokeratin (DAKO, Z0622) to distinguish 
invasive placental trophoblasts, and 1:100 anti-mouse alpha smooth muscle actin 
(ab7817, Abcam) to distinguish uterine spiral arteries. The following day, embryos 
were extensively washed in PBT prior to exposure of goat anti-rabbit af555 and goat 
anti-mouse af488 secondary antibodies. All slides were counterstained with DAPI 
(Sigma Aldrich Inc, B2388), and mounted in glycerol prior to image analysis.  
 
6.3.3.3 In situ hybridisation 
In situ hybridisation (ISH) was carried out as previously described (Simmons et al., 
2007, 2008b), and explained in detail in section 2.10.3. Mest was used to identify fetal 
endothelial cells of the FBS in E15 tissue. Primer sequences for probe synthesis of 
these two genes are shown in the table below. cDNA probe templates were isolated 
by gel extraction (QIAquick Gel Extraction Kit, Qiagen). DIG-labelling of cRNA probes 
were carried out as per manufacturer’s instructions (Roche). Uterine and placental 
tissues were fixed in 4% PFA at 4°C for 2 days prior to processing into paraffin and 
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sectioning at 5um. Probes (1:200) hybridisation was carried out overnight at 65°C in a 
humidified chamber and included negative antisense (T3) controls. All other steps 
were carried out as described in section 2.10.3.  
 
Gene Direction Sequence (5’-3’) Product (bp) 
Mest 
Forward (T3) CTGCTCTGCACTCATGGAAG 
478 
Reverse (T7) CCGTCTTTGAGGAGCTTTTG 
Primer pair sequences for In Situ Hybridisation (ISH) probe synthesis. Forward 
primers included the addition of T3 - AATTAACCCTCACTAAAGGG to the 5’ end, and 
likewise for T7 – TAATACGACTCACTATAGGG.  
 
6.3.3.4 Lectin histochemistry 
Paraffin slides were dewaxed and rehydrated as above, and placed into dH2O. Slides 
underwent antigen retrieval in sodium citrate buffer (10mM sodium citrate, 0.05% 
Tween 20, pH 6.0) was performed for 1.5 hours using a pressure cooker. Tissue was 
blocked for endogenous peroxides using 0.9% H2O2 in dH2O for 10 minutes. Slides 
were incubated in 0.1% triton with 0.1mM ions (MgCl2, CaCl2, MnCl2) for 10 minutes, 
prior to incubation of 1:200 IsolectinB4 (conjugated, Sigma, L5391, derived from 
Bandeiraea simplicifolia) in 1x PBS for 2h RT. A 1x PBS wash for 5 minutes followed 
prior to colour development with NovaRED peroxidase (Vector Labs, SK-4800). Slides 
were counterstained with haematoxylin for 2 minutes, and were dehydrated and 
mounted as per section 2.10.3.2.  
 
6.3.4 Imaging parameters and analysis 
All chromogen slides were scanned with Aperio and snapshots taken with 
Imagescope. Placental cryo-sections were imaged on an upright fluorescence 
microscope (BX61 Olympus) using DAPI, GFP and Cy3 filters at 4x and 10x 
magnification using set parameters.  Placentas were measured for distance of 
trophoblast invasion from the TGC layer, and number of invaded decidual and uterine 
arteries.   
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6.3.5 Stereology for placental volumes 
Stereology for placental compartments; total, decidua, junctional zone, labyrinth, FBS 
and MBS were estimated using the Cavalieri principle as described by Coan et al. 
(2004). Placental halves were sectioned at 5um for 5-6 equally spaced sections with 
sampling fractions of 1:50 (E13), 1:100 (E15) and 1:150 (E20) used. E13 placentas 
utilised H&E staining, E15 placentas utilised ISH for Mest, and E20 samples utilised 
IsolectinB4, the latter two of which both marked fetal endothelial cells of the FBS. 
Volume and surface areas of placental compartments were estimated in ImageJ.  
 
6.3.6 Gene expression assays  
Total RNA from labyrinth samples at E13 and E15 were extracted using RNeasy kits 
with on column DNase digestion (Qiagen). 1ug RNA was reverse transcribed using 
the iScript cDNA kit (Bio-Rad). qRT-PCR was performed using TaqMan (Qiagen) or 
SYBR green (Qiagen) reagents, with 100ng cDNA used per reaction, see primer 
information below. Expression profiles of two replicates per sample were analysed 
relative to the geometric mean of 18S and Rpl13a.  
 
Gene of Interest ID # 
18S 4333760F 
Ctsq Rn01448613_m1 
Gcm1 Rn00820824_g1 
Glut3 (Slc2a3) Rn00567331 
Mest Rn01500324_m1 
Sry Rn04224592_u1 
Syna Rn01500024_m1 
Slc38a1 (Snat1) Rn00593696_m1 
Slc38a2 (Snat2) Mn00628416_m1 
Slc38a4 (Snat4) Rn00593742_m1 
TAQman primer information 
 
Gene Forward Primer (5’-3’) Reverse Primer (3’-5’) 
Rpl13a GCA CAA GAC CAA AAG AAG CGC TTT TTC TTG TCA TAG GG 
SYBR primer information  
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6.3.7 Statistical analyses 
To analyse treatment with sex, or zone, data was analysed using two-way ANOVAs 
with Tukey’s post-hoc tests. In cases where the sexes were analysed separately, 
student’s t-tests analysed significant differences between control and PC-EtOH. 
Stereological analyses utilised at most 2 samples per sex per litter. Mean relative gene 
expression of treatments were standardised to the control male group, displayed as 
mean ± standard error of the mean (SEM). All graphs and statistics were performed 
using GraphPad Prism 6 software (GraphPad Software, Inc). 
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6.4 Results 
To characterise the placental biometry prior to E20, placental samples were collected 
at E13 and E15. Examination of litters at post-mortem showed PC-EtOH caused an 
increase in resorptions at E15 (P<0.05, Table 6.1), which were not exhibited earlier 
ages (E11, E13, data not shown). Analysis of sex ratios showed a greater percentage 
of male fetuses at E15 after PC-EtOH (P=0.05, Table 6.1). Similarly, at E15, PC-EtOH 
reduced labyrinthine wet weight and the placental depth (Table 6.1). There were no 
other gross differences between treatment groups in weight of the whole placenta, 
junctional zone, or measurements of the length or width were found at E15 (Table 6.1), 
nor ratios of labyrinth to junctional zone, labyrinth to whole placenta, or junctional zone 
to whole placenta (data not shown).  
To determine whether any structural changes had occurred to the placenta, and the 
critical time points during gestation they may arise, E13 (immature), E15 (definitive), 
and E20 (mature) placentas were assessed by stereology for compartment volume 
and surface area of the vasculature. Stereological analysis showed significant 
differences between treatment groups at E15. Whilst no change to volumes of the 
whole placenta, decidua, labyrinth or junctional zone were found in males (Figure 6.1), 
females exposed to PC-EtOH showed markedly reduced placental volume, with all 
compartments contributing to this effect (P<0.01). Further examination of the placental 
vasculature for fetal and maternal blood compartments showed the placenta of 
females exposed to PC-EtOH to have significantly reduced MBS (P<0.05, Figure 6.2). 
When MBS volume was analysed with males and females together by two-way 
ANOVA, a treatment effect was found after PC-EtOH (PTrt<0.01). No change to MBS 
surface area was found between treatments for either sex (Figure 6.3). Along with 
MBS and FBS volume, PC-EtOH females also tended to reduce labyrinth trophoblast 
volume (PZone<0.05, Figure 6.3), but was not significant between treatments by post-
hoc analysis. Despite the alteration in MBS, the thickness of the interhemal membrane 
remained unchanged (Figure 6.4).  
As the alteration in placental development was found at mid-gestational E15, we 
questioned whether this was due to altered remodelling of the uterine spiral arteries 
by inadequate trophoblast invasion earlier in gestation. When the E13 implantation 
site was assessed by histological staining for trophoblast marker pan-cytokeratin, 
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there was a tendency for reduced maximum invasion in the placentas of females 
exposed to PC-EtOH (Figure 6.5, P=0.08), with little invasion past the decidua into the 
mesometrial uterine spiral arteries (Figure 6.5, P<0.05).  
To investigate other changes to placental development from PC-EtOH exposure, E13 
and E15 placentas were assessed by QPCR for markers of trophoblast differentiation 
(Mest, Ctsq, Gcm1, Syna), and nutrient transporters for glucose (Glut3), and amino 
acids (Slc38a1, Slc38a2, Slc38a4). At E13, PC-EtOH exposure reduced expression 
of Mest (PTrt<0.01, Figure 6.6); marking fetal endothelial cells, particularly in males 
(P<0.05). Expression of the nutrient transporter Glut3 was also decreased (PTrt<0.01), 
particularly in females (P<0.05). No changes were found in the remaining markers or 
genes at this age. At E15, although no statistically significant changes were shown in 
the abovementioned genes, several interactions were found for Mest (PInt<0.05), 
Syna (PInt<0.05) and Glut3 (PInt<0.05), suggesting that male PC-EtOH placentas 
decreased their expression, and female PC-EtOH increased expression of all genes.  
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Table 6.1. Fetal and placental 
biometry at post-mortem at E15. 
All data are presented as mean ± 
SEM and N = 8-9 litters per 
treatment. *P < 0.05 for Bonferroni 
post-hoc compared with controls of 
same sex. Note: litter size includes 
resorptions.
Variables Male Control Male PC-EtOH Female Control Female PC-EtOH Statistics 
Fetal parameters 
Body weight (g) 0.208 ± 0.007 0.219 ± 0.006 0.206 ± 0.007 0.209 ± 0.005 
PTrt = 0.27 
PSex = 0.34 
PInt = 0.49 
Crown-rump 
length (mm) 
12.405 ± 0.245 12.601 ± 0.048 12.226 ± 0.195 12.142 ± 0.092 
PTrt = 0.74 
PSex = 0.06 
PInt = 0.40 
Litter size 
(number) 
Control: 16.330 ± 0.500 PC-EtOH: 17.000 ± 0.645 P = 0.43 
Resorptions 
(number) 
Control: 0.440 ± 0.294 PC-EtOH: 1.889 ± 0.539 P < 0.05 
Sex Ratio 
(Male:Female) 
Control: 0.94 PC-EtOH: 1.41 P = 0.11 
Male Fetuses 
(%) 
Control: 44.26 PC-EtOH: 56.69 P = 0.05 
Placental parameters 
Placental weight 
(g) 
0.247 ± 0.023 0.212 ± 0.015 0.217 ± 0.006 0.218 ± 0.009 
PTrt = 0.23 
PSex = 0.41 
PInt = 0.22 
Placenta:BW 
ratio (g/gbw) 
1.128 ± 0.059 1.036 ± 0.111 1.127 ± 0.041 1.083 ± 0.060 
PTrt = 0.37 
PSex = 0.76 
PInt = 0.75 
Junctional zone 
wet weight (g) 
0.102 ± 0.008 0.102 ± 0.007 0.096 ± 0.006 0.118 ± 0.008 
PTrt = 0.27 
PSex = 0.34 
PInt = 0.49 
Labyrinthine wet 
weight (g) 
0.086 ± 0.009 0.078 ± 0.006 0.094 ± 0.006 0.075 ± 0.004 
PTrt = 0.06 
PSex = 0.75 
PInt = 0.39 
Placental length 
(mm) 
12.087 ± 0.352 12.111 ± 0.212 12.144 ± 0.232 12.297 ± 0.155 
PTrt = 0.15 
PSex = 0.63 
PInt = 0.80 
Placental width 
(mm) 
11.411 ± 0.245 11.027 ± 0.233 11.037 ± 0.187 11.191 ± 0.209 
PTrt = 0.60 
PSex = 0.64 
PInt = 0.23 
Placental depth 
(mm) 
2.979 ± 0.104* 2.590 ± 0.097 2.836 ± 0.079* 2.653 ± 0.083 
PTrt < 0.01 
PSex = 0.65 
PInt = 0.26 
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Figure 6.1. PC-EtOH exposure reduces whole placental and zonal volumes in 
females only at E15. Data shows mean ± SEM, analysed by two-way ANOVA. 
*P<0.05. Control (white bars), PC-EtOH (black bars). E13; N = 5-7/sex, 4 
litters/treatment. E15; N = 7-9/sex, 5-7 litters/treatment, E20; N = 10-12/sex, 6 
litters/treatment.  
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Figure 6.2. PC-EtOH reduces labyrinthine MBS volume in both sexes. Data shows 
mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-EtOH 
(black bars). E13; N = 5-7/sex, 4 litters/treatment. E15; N = 7-9/sex, 5-7 
litters/treatment, E20; N = 10-12/sex, 6 litters/treatment.   
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Figure 6.3. PC-EtOH does not alter labyrinth blood space surface areas. Data 
shows mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-
EtOH (black bars). E13; N = 5-7/sex, 4 litters/treatment. E15; N = 7-9/sex, 5-7 
litters/treatment, E20; N = 10-12/sex, 6 litters/treatment.  
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Figure 6.4. PC-EtOH does not alter interhaemal membrane thickness. Data shows 
mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-EtOH 
(black bars). E13; N = 5-7/sex, 4 litters/treatment. E15; N = 7-9/sex, 5-7 
litters/treatment, E20; N = 10-12/sex, 6 litters/treatment.
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Figure 6.5. PC-EtOH exposure reduces trophoblast invasion into the mesometrial triangle in females only. Images show 
placental cryosections at E13 stained for pan-cytokeratin (red) marking invading trophoblasts, alpha smooth muscle actin (aSMA, 
green), and dapi (blue). White dashed line shows barrier between uterus and decidua below. Large images are at 4x, with smaller 
images at 10x magnification. Data shows mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-EtOH (black 
bars). N = 6-12/sex/treatment.   
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Figure 6.6. QPCR on placental tissues from whole placentas at E13. Panels A-D show markers of placental cell types; A: Mest 
(fetal endothelial cells), B: Ctsq (S-TGCs), C: Gcm1 (SynT-II), D: Syna (SynT-I). Panels E-H show placental nutrient transporters. 
Data shows mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-EtOH (black bars). N = 7-8/sex/treatment.  
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Figure 6.7. QPCR on placental labyrinth tissues from E15. Panels A-D show markers of placental cell types; A: Mest (fetal 
endothelial cells), B: Ctsq (S-TGCs), C: Gcm1 (SynT-II), D: Syna (SynT-I). Panels E-H show placental nutrient transporters. Data 
shows mean ± SEM, analysed by two-way ANOVA. *P<0.05. Control (white bars), PC-EtOH (black bars),  N = 8/sex/treatment.
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6.5 Discussion  
Analysis of the effects of PC-EtOH on the early embryo, trophoblast differentiation and 
the uterine environment in Chapter 5 suggested that the female PC-EtOH embryo 
exhibited greater morphological defects than the male pre-implantation embryo, with 
reduced ICM number, P-TGC differentiation during trophoblast outgrowth experiments 
and increased dNK cells at E11. Both sexes however, showed reduced trophoblast 
pluripotency and outgrowth capacity. This study therefore aimed to investigate long 
term impacts of these early outcomes on the formation of the placenta by ontogeny 
analysis from E11, E13, E15 and E20 in a sexually dimorphic manner.  
6.5.1 PC-EtOH reduces fetal viability at E15 
Firstly, control and PC-EtOH litters were examined at post-mortem. E20 examination 
had already been carried out and published by Gardebjer et al. (2014), and showed 
reduced viability after PC-EtOH. Further investigation at earlier time points showed 
that PC-EtOH reduced the number of viable fetuses by 1-2 per litter at E15, which was 
not seen at earlier ages of E11 or E13. This suggests that E15 is a critical point during 
development which is susceptible to programming by PC-EtOH. Preliminary analyses 
suggest neither sex to be at more risk of resorption than the other (data not shown). 
E15 placentas also showed reduced gross labyrinthine weight after PC-EtOH. The 
placental compartments were next examined more rigorously for changes in volume 
and surface area of the placental compartments and vascular spaces.  
6.5.2 PC-EtOH causes structural changes to the mid-gestation E15 placenta  
When assessed by stereology, again E15 was the only significant time point affected 
by PC-EtOH, with no changes in any parameters investigated (volume, surface area) 
to E13 or E20. At E15, female fetuses were shown to have the most deleterious 
outcomes, exhibiting reduced whole placental volume, with all placental zones 
contributing to this effect. Males, conversely did not show any gross changes to 
volume. Basal sex differences were found between males and females at E15, with 
females showing reduced growth than males, and were investigated in depth in 
Chapter 3. The labyrinth was then investigated for FBS and MBS volume and surface 
area. Females again showed the most deleterious outcomes, with a significant 
reduction in MBS volume. When males were assessed with females for MBS volume, 
they too contributed to a reduction after PC-EtOH. Curiously, neither males nor 
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females showed alterations to blood space surface area, when analysed alone or with 
both sexes. As no changes to E20 parameters were found, this is suggestive of 
adaptive placental growth, which may occur both through maternal energy 
conservation from increased embryo resorption, and altered nutrient transport across 
the labyrinth.  
To date, only one other study other than PC-EtOH has shown an MBS defect only; a 
PKBα/Akt1 deficiency study by Plaks, et al. (2011). Using contrast enhanced MRI with 
an albumin-based tracer, specific to maternal vasculature, they showed reduced 
enhancement of the maternal blood supply to the labyrinth. Similar to PC-EtOH, this 
was also without any changes to the interhemal membrane. Akt1 is highly expressed 
in TGCs where it is the predominant isoform, which may be a common pathway to PC-
EtOH, as perturbed activation of AKT in trophoblast stem cells causes alterations in 
differentiation to invasive phenotypes (Kamei et al., 2002, Yang et al., 2003, Kent et 
al., 2010). Alterations in Akt1 are also associated with perturbed glycogen cell 
differentiation (Sharma et al., 2016), which is also shown in PC-EtOH (Gardebjer et 
al., 2014).  
Reductions in MBS volume has also been shown by other programming models 
including hypoxia (Higgins et al., 2016), undernutrition (Coan et al., 2010), and a high-
fat high-sugar diet (Sferruzzi-Perri et al., 2013). However, these models do not show 
reduced MBS alone, and also include additional reductions to the FBS vasculature. 
Adaptation of the labyrinth morphogenesis in this high-fat high-sugar model shows 
that reduced MBS at E19 is secondary to reduced fetal capillary volume, surface area 
and increased interhemal membrane at E16 (Sferruzzi-Perri et al., 2013), suggestive 
of reduced differentiation of the labyrinthine trophoblasts and branching of the vascular 
tree. Conversely, Coan et al. (2010) showed reduced placental weight and junctional 
zone volume at E16 preceded reduced volume and surface area of MBS and FBS at 
E19. Despite these marked changes in labyrinth vascular structure at E19, glucose 
uptake was maintained and system A amino acid transport was elevated, showing the 
labyrinth has the capacity to compensate for these structural defects. As PC-EtOH 
placentas at E13 and E20 showed volume and surface area to be unchanged, different 
mechanisms are suspected to occur to these other programming models. Importantly, 
in the models mentioned above, these perturbations occur directly during placental 
morphogenesis.  
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Adaptation of the placenta after PC-EtOH exposure is also likely as suggested by the 
alterations in the expression of nutrient transporters. At E13, reduced expression of 
Glut3 was found in both sexes after PC-EtOH. Curiously, this was without changes to 
other system A amino acid transporters. By E15, however, sexually dimorphic 
outcomes resulted, exhibiting reduced expression of Glut3 in PC-EtOH males, but 
increased expression in PC-EtOH females. Future investigations for placental 
function, through capacity of nutrient exchange will determine whether PC-EtOH 
placentas can adapt to reduced MBS volume to maintain fetal growth.  
Considering that structural changes to the placenta (MBS) were only observed at E15, 
this suggested that an earlier structural malformation may have occurred. As the MBS 
only contributes to one side of the vasculature, this pointed us towards a maternal 
vascular defect. One major event of placentation which occurs during this time at E13 
in the rat, is remodelling of the maternal spiral arteries, and were thus investigated in 
response to PC-EtOH.  
6.5.3 Structural changes in the laby3.rinth are preceded by reduced 
secondary trophoblast invasion in PC-EtOH females 
E13 placentas were analysed for the second wave of trophoblast invasion (specifically 
the SpA-TGCs) into the uterine mesometrial triangle through localisation with invasive 
trophoblasts marker pan-cytokeratin (Figure 6.5). Female PC-EtOH exposed embryos 
were again shown to have the most deleterious outcomes, exhibiting reduced depth 
of invasion and little infiltration into the uterine spiral arteries compared to control 
females. Conversely, male PC-EtOH placentas were unremarkable, showing similar 
measures to control males. As MBS volume was restored by E20, this may suggest 
that this reduction in invasion is only transient. The duration of this aberrant invasion 
is not clear, and would be achieved by analysis of E15 placental samples. Further 
histological investigation into replacement of vascular smooth muscle with elastin 
fibres would also contribute to our understanding of perturbed spiral artery remodelling 
in this model.  
A delay in spiral artery remodelling in PC-EtOH females may also affect uterine blood 
flow, and potentially blood pressure, as multiple female conceptuses in one litter would 
amplify these effects. Indeed, reduced placental blood flow has already been shown 
in a first trimester model of alcohol exposure in the rhesus macaque (Lo et al., 2017), 
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which suggests at least a local effect on an individual conceptus. A maternal systemic 
effect may then explain why male PC-EtOH conceptuses too show reduced MBS 
volume, albeit not as severely as the PC-EtOH females, and why both PC-EtOH 
causes fetal growth restriction in both sexes, and postnatally, leads to the same 
disease susceptibility. These results also may suggest a role of the spiral arteries and 
maternal blood flow in expanding the MBS of the labyrinth.  
6.5.4 Physiological impacts of reduced spiral artery remodelling and reduced 
MBS 
Defects in utero-placental perfusion have long been suspected to originate at 
implantation (Roberts and Cooper, 2001, Kajantie et al., 2010, Burton et al., 2016), but 
until now have been unproven in animal models. Altered placental perfusion, as 
estimated in humans by “surface area” (in this case estimated by placental length, 
width and depth), has been shown to lead to maternal disorders in pregnancy including 
hypertension and preeclampsia (Barker et al., 2010, Kajantie et al., 2010). One 
mechanism in leading to these disorders is perturbation to spiral artery remodelling, 
which occurs in women experiencing hypertension with or without proteinuria, 
spontaneous abortion, preterm labor, and even uncomplicated pregnancies which 
show fetal growth restriction (Khong et al., 1986, Roberts, 1998, reviewed by 
Pijnenborg et al. 2006 and Brosens et al. 2011). Unsurprisingly, it has recently been 
shown that placental surface area is inversely related to uterine artery resistance 
(Salavati et al., 2016), which may be a phenocopy PC-EtOH. However, despite a major 
focus in pregnancy on preeclampsia, which occurs in 5% of pregnancies, an additional 
30% of pregnancies experience hypertension, as shown by a study on Helsinki 
mothers (Kajantie et al., 2010). The influence of other nutritional perturbations, 
particularly during the periconceptional period, affecting trophoblast differentiation, 
invasion, spiral artery remodelling, and placental hemodynamics is now an important 
area of research. Furthermore, additional effects of placental malperfusion, such as 
causing oxidative stress, endoplasmic reticulum stress, infarction, damage to 
syncytiotrophoblast layers, hypoxemia and the roles they play in influencing fetal 
growth (Burton et al., 2016), also requires further exploration.  
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6.5.5 Future investigations 
To validate that reduced MBS volume after PC-EtOH causes fetal growth restriction, 
in vivo functional experiments are required. Firstly, investigation of blood flow or 
perfusion to the placenta by doppler ultrasound or functional MRI and any sexually 
dimorphic outcomes, would determine if both male and female conceptuses are 
affected by the maternal circulation. Secondly, radiotracer experiments for glucose 
and system-A amino acid transport would determine whether there is reduced nutrient 
transport across the placenta to the fetus, or merely just changes in the expression of 
the nutrient transporters. Thirdly, ex-vivo placenta assays, as described by Goeden 
and Bonnin (2013), would determine the isolated effects of altered placental structure 
without any additive maternal effects on placental transport and consumption of 
oxygen and nutrients, secretion of proteins, and effects on the fetal circulation.  
6.6 Conclusions 
This thesis chapter has identified critical points during gestation after PC-EtOH 
exposure, during which the growth and morphogenesis of the placenta if affected. PC-
EtOH reduced the secondary wave of trophoblast invasion, and may contribute to 
reduced or delayed spiral artery remodelling. Further into gestation, a reduction in 
MBS is likely to have led to reduced nutrient exchange within the labyrinth, and is 
suspected to be origin of fetal growth restriction in this model.   
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Chapter 7. General discussion 
7.1 Thesis Summary  
This thesis has focused on determining the effects of EtOH during the PC period; 
including the development of the pre-implantation embryo, TS differentiation, the 
maternal hormonal environment for implantation and structure of the developing 
placenta. All studies considered the potential for sexually dimorphic outcomes. The 
first goal was to characterise sex specific growth patterns of the early embryo and the 
placenta from in vivo derived embryos. This demonstrated that male placentas 
exhibited greater growth than females at mid-gestation (E15). We next examined a 
direct effect of EtOH on trophoblast differentiation, and showed reductions in cell count 
and expression of markers for several different trophoblast subtypes, which may 
indicate reduced cell maturity. Thirdly, we investigated the impacts of in vivo PC-EtOH 
exposure on the early embryo, maternal environment, and the programming of 
placental development. A major finding was that female PC-EtOH exposed embryos 
showed more deleterious outcomes throughout gestation than males, exhibiting 
perturbed cell allocation, differentiation, invasion and placental formation, (see Figure 
7.1). Male fetuses exposed to PC-EtOH were also affected, albeit to a lesser extent. 
While we found little evidence that PC-EtOH was able to affect the maternal hormonal 
environment, we did show altered communication with maternal derived dNK cells 
following implantation, highlighting that perturbation to the trophoblast can have long 
term impacts during gestation through perturbed placental development. This data 
provides much needed evidence of the potential impacts of drinking alcohol around 
conception, and its long-term impacts on placentation, fetal growth and programming 
of adult disease. The following chapter will summarise the findings from this thesis, 
associate the data in a broader context of the literature, and other avenues for future 
research in this area.  
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Figure 7.1 Summary of major findings of in vivo PC-EtOH exposure on sex-
specific programming of pre-implantation and placental development. 
Abbreviations: dNK; decidual natural killer cells, ICM; inner cell mass, JZ; junctional 
zone, LAB; labyrinth, MBS; maternal blood space, P-TGC; parietal trophoblast giant 
cells, SpA-TGC; spiral artery trophoblast giant cells, TE; trophectoderm, vol; volume. 
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7.2 Summary of results 
Before determining the effect of alcohol on early growth of the embryo and 
placenta, it was first necessary to establish if there were underlying differences 
between males and females. Chapter 3 demonstrated the importance of utilising in 
vivo derived dams for investigating outcomes in pre-implantation development. Prior 
in vitro models had suggested males to grow at a faster rate than females. We 
subsequently found that this was likely to only be an effect of culture conditions, as no 
sexual dimorphism was present in the early embryo when assessed for cell count, and 
allocation to either TE or ICM lineages when derived in vivo. Sexual dimorphism did 
arise however, in the mid-gestation E15 placenta, with females showing reduced 
placental weight and volume, particularly to the labyrinth compartment. Females also 
showed reduced volume and surface area of the fetal and maternal blood spaces 
which is likely to contribute to reduced fetal growth by late gestational E20.  
Next, to assess the ability of alcohol to directly affect the differentiation of 
trophoblast cells, we turned to in vitro cell culture. Chapter 4 demonstrated that 
alcohol could exert a direct effect on TS proliferation and differentiation. The 
physiologically relevant dose of 0.2% EtOH in addition to the supraphysiological 1% 
EtOH dose, showed marked reductions in cell count on day 6 of culture, without 
affecting those on day 2 or 4. This coincided with reduced expression of Bcl2, an anti-
apoptotic gene, which may promote cells down the apoptotic pathway. Also on day 6, 
were reductions in expression of several trophoblast subtype specific markers, during 
terminal differentiation. While we could not conclude of which trophoblast subtypes 
may be specifically reduced, these results may point to reduced cell maturity.  
The major aim of this thesis was to determine the effects of periconceptional 
alcohol exposure on the early embryo and subsequent placental development. 
Chapter 5 explored the effects of PC-EtOH exposure on morphological phenotypes in 
the pre-implantation embryo, trophoblast differentiation, and the influence of the 
maternal hormonal environment in mediating the uterine responses for pregnancy. At 
E5, PC-EtOH exposure reduced ICM cell count in females, and reduced TE 
pluripotency in both sexes. Trophoblast outgrowth experiments showed reduced 
outgrowth capacity, as well as reduced number of trophoblasts in both sexes on day 
6 after PC-EtOH. Female PC-EtOH embryos additionally showed reduced 
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differentiation to the P-TGC lineages, and expression of Prl4a1, a gene known to 
communicate with dNK cells. These results are significant, as they provide critical 
evidence that PC-EtOH has reduced the capacity of the early embryo to differentiate 
and communicate with the uterus for implantation. This evidence also allowed this 
study to expand to show altered dNK cell signalling and hypothesise that the second 
wave of trophoblast invasion in the immature placenta may also be altered. 
Furthermore, the sexually dimorphic outcomes provide much needed evidence that 
males and females respond differently to maternal perturbations depending on the 
critical window of exposure.  
Chapter 6 further investigated sexually dimorphic outcomes in placental structure after 
PC-EtOH exposure in the immature to late gestation placenta. Again, it was only in 
females that PC-EtOH resulted in markedly reduced invasion of secondary SpA-TGCs 
into the mesometrial triangle, and reduced infiltration around the maternal spiral 
arteries at E13. While the effects of PC-EtOH on maternal physiology, such as blood 
pressure, flow and perfusion to the placenta have not been investigated, both male 
and female PC-EtOH placentas showed markedly reduced MBS volume, suggestive 
of a greater maternal effect. Reduction in MBS volume is also likely to have affected 
capacity for nutrient exchange to the fetus, and is likely to have led to the growth 
restriction in PC-EtOH exposed fetuses in late gestation.  
 
7.3 PC-EtOH on programming of adult disease  
Our model of PC-EtOH has been associated with glucose intolerance and increased 
insulin insensitivity in adulthood (Gardebjer et al., 2015). Our laboratory is also 
exploring other post-natal outcomes that occur as a result of PC-EtOH, including 
alterations to brain and behaviour, cardiovascular and renal outcome, as well as 
influences to the hypothalamic-pituitary-adrenal axis, as occurs in other 
periconceptional exposures (Kwong et al., 2000, Watkins et al., 2008a, 2008b, Scott 
et al., 2010, Fernandez-Gonzalez et al., 2004). We are also interested in the effects 
on ovary development in female PC-EtOH offspring, potential impacts to their fertility, 
as well as their influence on programming the second F2 generation.  
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The data obtained from this PhD project may help to explain the pathways through 
which alcohol exerts it effects. My data suggests there are two points of ‘stress’ during 
gestation in this model. Firstly, the primary stressor during the pre-implantation 
exposure of the embryo to alcohol from E0-E5, which is likely to alter epigenetic 
reprogramming and expression of imprinted genes. Secondly, a sustained stress may 
also be programmed even when the alcohol has ceased through perturbed placental 
formation. Reduced MBS formation and nutrient transport capacity in the placenta, is 
likely to cause placental insufficiency and lead to nutrient stress in the fetus. This latter 
time point in mid-gestation, is more likely to lead to programming of adult disease 
through alterations to formation of the fetal organ structure and function. Further 
investigation of epigenetic modifications to both embryonic and extraembryonic 
tissues would gain much insight into the mechanisms (and time points) behind 
programming of PC-EtOH.  
 
7.4 Sex specific programming of the early embryo 
As discussed in Chapter 3, a major limitation of periconceptional and pre-implantation 
nutrient deficiency models is the lack of investigation into embryonic sex in pre-
implantation outcomes. For this reason, procedures were optimised in this model to 
genotype for sex after fixation and imaging of immunolocalised blastocysts. A very 
significant finding of this project was the sexually dimorphic outcomes following PC-
EtOH, which carried from the blastocyst stage, through to trophoblast differentiation 
and invasion of SpA-TGCs of the immature placenta. This may suggest that males 
have some resistance or adaptive capacity to an adverse maternal environment in the 
periconceptional window. However, while PC-EtOH and IVF (Tan et al., 2016a, 2016b) 
models show many female-specific effects, other periconceptional nutritional models 
rather show male specificity. In vivo undernutrition reduced expression of the imprinted 
gene H19 in the male blastocyst, and reduced H19 and Igf2 expression in the male 
fetal liver at E20 in rats (Kwong et al., 2006). A model of a periconceptional methyl 
deficient diet in sheep found males in particular had altered methylation in fetal livers 
(Sinclair et al., 2007). Until other nutrient models assess blastocyst cell counts in a 
sexually dimorphic manner, we cannot determine whether these are deleterious or 
protective outcomes. However, in mid-gestation, if maternal blood flow is altered by 
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PC-EtOH, rather, this critical window may affect both males and females (Kalisch-
Smith, et al. 2017a), which would explain the reduced MBS and fetal growth restriction 
in both sexes. This also increases the complexity of determining when during which 
critical window adult phenotypes may originate.  
 
7.5 Mechanisms by which PC-EtOH can affect the early blastocyst  
Epigenetic reprogramming  
The early pre-implantation embryo is exquisitely sensitive to its environment, as it 
undergoes epigenetic and metabolic reprogramming as it progresses from the oviduct 
to the uterus (Fleming et al., 2004). The embryo undergoes genome wide 
reprogramming, whereby demethylation of the genome DNA continues to the 
blastocyst stage, where methylation levels are at their lowest stage. This sensitive 
period may render the embryo more susceptible to stressors, and may allow any 
adaptive epigenetic marks to be carried into post-natal life, affecting genome stability. 
Different models have begun to investigate sexually dimorphic epigenetic 
reprogramming in the pre-implantation period, but remains limited to X-chromosome 
inactivation in IVF (Tan et al., 2016a), and the influence on active and passive 
demethylation required to induce pluripotent stem cells in vitro (Milagre et al., 2017). 
Additional environmental perturbation models performed in vivo are now required to 
investigate the potential effects on DNA methylation and gene profiles in the 
blastocyst. While this is yet to be explored, evidence of altered epigenetic profiles in 
late gestation after PC-EtOH may suggest altered reprogramming during the pre-
implantation period. Unpublished data from our laboratory suggests a marked 
decrease in global methylation (hypomethylation) of E20 female placentas following 
PC-EtOH (P<0.001). In addition, gene expression profiles for Dnmt1, Dnmt3a, and 
Dnmt3b were all increased after PC-EtOH in the E20 fetal liver (Gardebjer et al., 2015), 
which may indicate maintenance of a hypermethylated genome. These results may 
also suggest that this differential methylation pattern to the placenta and embryo may 
be traced back to TE and ICM lineages.  
 
 
 212 
Evidence of imprinting 
In the early embryo, imprinted regions escape the global DNA demethylation event, 
which enables gene expression from parent of origin alleles in embryonic and 
placental tissues (reviewed by Messerschmidt et al. 2014). Imprinted genes can direct 
growth of the fetus, with maternally expressed genes reducing fetal growth, and 
paternally expressed genes increasing fetal growth (Angiolini et al., 2006). Knock-out 
models of implicated genes associate these modifications to fetal growth, with 
alterations in the nutrient exchange capacity of the placental labyrinth, including 
changes to labyrinth surface area and interhemal membrane thickness (reviewed by 
Angiolini et al. 2006). Evidence of altered imprinted genes in E20 placentas after PC-
EtOH includes increased expression of paternal Igf2 in the junctional zone of PC-EtOH 
females at E20, but no changes to paternally expressed Slc38a4, or maternally 
expressed Igf2r (Gardebjer et al., 2014). Further investigation of other imprinted genes 
in both maternal and paternal exposures is required to understand the influence on 
genomic imprinting.   
Changes to maternal physiology 
Triglycerides  
Whilst not a major focus in this thesis, another curious finding at E5 was an increase 
in maternal plasma triglycerides, which also continued into late-gestation at E20. This 
is indeed a common finding after alcohol exposure, as shown in plasma of human 
males (Nestel and Hirsch, 1965,  Mishra et al., 1991). Culture of hepatocytes in EtOH 
also shows increased lipid storage (Mahli et al., 2015). During pregnancy, an elevation 
in triglycerides, as occurs in maternal obesity, can cause increased lipid transfer 
through the placenta to the fetus, and result in fetal overgrowth (Di Cianni et al., 2005, 
Scifres et al., 2011). This increase in maternal triglycerides, may be a compensatory 
adaptation to minimise the fetal growth deficit after PC-EtOH, and also may hint to a 
potential pathway that can cause metabolic programming. Perturbation to serum 
triglycerides may also be indicative of other metabolic changes throughout pregnancy 
such as altered insulin and leptin, and are currently being investigated by our 
laboratory. 
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Glucose homeostasis 
Additional unpublished data suggests that there may be mild hyperglycaemia in dams 
during alcohol administration (from E-4 to E4). In addition to glucose, further insight 
into maternal insulin levels and other metabolic growth factors (e.g. IGF1/IGF2), to 
plasma and/or uterine fluid, will aid in determining the mechanisms behind 
programming of alcohol exposure. In a different model of midgestational glucocorticoid 
exposure, our laboratory has associated elevated maternal glucose levels with 
alteration to the nutrient stress associated hexosamine signalling pathway in the 
placenta, and curiously in a sexually dimorphic manner (Pantaleon et al., 2017). 
Considering this pathway is also active in the early emrbyo (Pantaleon et al., 2010), 
this may be another pathway in which alcohol could exert sexually dimorphic effects 
to cell cycle or apoptosis, known downstream modifications of this pathway.  
  
7.6 Additional periods of early life programming  
Pre-conceptional oocyte 
In this thesis, a major focus has been on structure and differentiation of the pre-
implantation blastocyst. However, we have not investigated other mechanisms after 
PC-EtOH such as altered oocyte stress (oxidative, mitochondrial, endoplasmic 
reticulum), and their effects on oocyte quality, maturation and ovulation, as occurs in 
obesity (Wu et al., 2015), and diabetes (Wang et al., 2009). EtOH can affect the 
production of reactive oxygen species causing oxidative stress, endoplasmic reticulum 
stress, cellular signalling, and cell survival, regardless of the cell type (reviewed by 
Goodlett et al. 2005), and may also exert these effect on the oocyte.  
Paternal exposure 
We have also not determined potential effects of paternal alcohol exposure on sperm 
survival and competence, and their indirect actions on the female environment 
required for embryo development. For example, a model which excised the male 
seminal glands reduced female fertility and embryo development, due to oxidative 
injury in the female reproductive tract (Bromfield et al., 2014). Other models of paternal 
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obesity have additionally found delayed pre-implantation development, mitochondrial 
dysfunction, and altered cell allocation to the TE or ICM when assessed in vitro, as 
well as fetal growth restriction and reduced placental weight after embryo transfer 
(Mitchell et al., 2011, Binder et al., 2012a, 2012b).  
 
7.7 Limitations and future directions 
 
While this project has explored much into the effects of PC-EtOH on the developing 
embryo, placenta and maternal environment, functional and mechanistic experiments 
are currently lacking. Now that the characterisation of a periconceptional insult is 
apparent, it is now important to separate pre-conception and pre-implantation effects 
of EtOH. Assays of the uterine fluid are also important to determine the concentrations 
of EtOH within, and the nutrient profile in which the embryos are exposed. One 
possible mechanism that should be explored in more detail, is changes in maternal 
retinoic acid concentrations, and these may be behind the structural and differentiative 
changes after PC-EtOH. This could be explored by analysis of serum RA levels, or 
abundance of retinol binding protein 4 (analogous to retinol levels) over the PC period. 
If this is indeed the case, addition of RA during PC-EtOH exposure may rescue the 
phenotypes from this model. Single cell RNAseq of pre-implantation embryos would 
also provide an unbiased approach to investigate new unexplored pathways of PC-
EtOH that may impact the development, differentiation potential and metabolism of the 
ICM and TE.  
 
Embryo transfer experiments would also help to delineate the effects of PC-EtOH to 
the embryo separately to the maternal uterine environment. In addition, if male pre-
implantation embryos were identified with transgenic fluorescent labelling, male or 
female embryos could be separately transferred into a single dam. This would 
determine whether the reduction in PC-EtOH male MBS volume was programmed 
from pre-implantation, or conversely, whether this was only due to a maternal systemic 
effect caused by defective PC-EtOH female embryos. We do concede, however, that 
the embryo transfer technique has an effect on embryonic survival (Tran et al., 2014), 
and would therefore be harder to investigate subtle phenotypes seen in PC-EtOH. In 
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addition, the dietary treatment regime (with control and PC-EtOH liquid diets) would 
also provide an additional level of complexity to completing these experiments.  
 
Further investigation into the placental phenotypes would also confirm whether PC-
EtOH causes a systemic hypertensive effect on the maternal physiology to placental 
blood flow, and consequently placental perfusion. This could be achieved through 
blood pressure telemetry or tail cuff, doppler ultrasound or functional MRI. Finally, to 
determine whether there is indeed a reduced capacity for nutrient exchange in the 
placenta after PC-EtOH exposure, functional experiments during placentation for 
radiolabelled nutrient tracers (e.g. C14-aminoisobutyric acid, C-14 glucose), would 
determine whether adequate nutrients are being transferred to the fetus, and would 
clarify if this is the cause of fetal growth restriction in this model.  
 
7.8 Clinical implications  
Despite NHMRC guidelines advocating abstinence, women continue to drink alcohol 
during pregnancy, especially around conception. This study has provided much 
needed evidence of the deleterious outcomes of alcohol exposure in this 
periconceptional period, showing that there is no safe window during pregnancy for 
consumption. The PC-EtOH model is relevant to humans in that the periconceptional 
window is conserved among species, with implantation taking place at day 5.5 in rats, 
and day 7 in humans. The PC-EtOH model was previously developed by Gardebjer, 
et al. (2014) to simulate moderate levels of alcohol consumption reported in an 
epidemiological study by Colvin et al. (2007), and more recently, levels are also 
supported in studies by Muggli et al. (2016) and Green et al. (2016). However, in the 
human, a major challenge in understanding the effects of periconceptional alcohol 
consumption on development, still results from women being unable to definitively 
report the amount of alcohol they have consumed. Surveys of women asking 
questions about their alcohol consumption usually occur many months into pregnancy 
or even after a child is born (Colvin et al, 2007), and many questionnaires do not ask 
women specifically about consumption around conception. This is despite 
epidemiological data consistently reporting that alcohol consumption is associated 
with higher miscarriage rates prior to 10 weeks (Avalos et al, 2007) suggesting early 
exposure has deleterious effects. More recent prospective studies where women are 
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asked about alcohol consumption in early pregnancy and then at regular intervals 
throughout pregnancy (Muggli et al, 2016) are likely to yield important information 
about exposure to alcohol around conception.  
Future studies could also be developed to include reporting of alcohol exposure with 
or without pre-pregnancy supplements including folic acid. Folic acid, along with 
choline, are methyl donors in the one-carbon metabolism pathway, and are known to 
contribute to DNA methylation (reviewed by Zeisel and da Costa, 2009) which is 
known to be altered by alcohol (Refsum et al., 2006). Choline supplementation has 
been associated with prevention of brain deficits after alcohol exposure (Otero et al., 
2012) and is increasingly becoming an intervention to prevent other developmental 
abnormalities. Epidemiological studies could therefore be used to gauge whether folic 
acid or choline may be able to reduce the adverse outcomes caused by PC-EtOH.  
Choline supplementation – a potential intervention after PC-EtOH 
In a preliminary study, PC-EtOH was investigated to use dietary choline as an 
intervention at mid-gestation E10, post-pregnancy recognition. Preliminary data at E5 
firstly showed PC-EtOH to reduce maternal choline levels by approximately 50%. A 
cohort of dams was then investigated at E20 and showed choline supplementation 
was able to ameliorate the fetal growth deficit in PC-EtOH (unpublished). These results 
suggest that the outcomes of PC-EtOH are related at least in part to defects in DNA 
methylation and epigenetic reprogramming. Choline supplementation remains an 
exciting area of research and provides a possible treatment to the adverse effects of 
alcohol. 
 
7.9 Final conclusions 
This thesis has explored the effects of PC-EtOH on the developing pre-implantation 
embryo, placenta and maternal influences. We have shown PC-EtOH can affect the 
cell allocation of the blastocyst in a sexually dimorphic manner, and these changes 
persist into differentiation of the P-TGCs and further into formation of the placenta and 
the MBS compartment of the labyrinth. In turn, altered formation of the placental 
structure may impact of nutrient availability and influence growth of the fetus. This data 
is critical in providing evidence to support public health messages warning against the 
consumption of alcohol in the period around conception.   
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